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AbsTrAcT
Upon  acute exercise skeletal muscle is immediately and heavily recruited, while other 
organs appear to play only a minor role during exercise. These other organs show significant 
changes and improvements in function, although they are not directly targeted by exercise. 
These improvements suggest  that skeletal muscle can communicate with other organs. 
In the past 15 years it became clear that skeletal muscle produces and secretes a variety 
of signalling proteins that are able to interact and communicate with other organs. These 
signalling proteins are called myokines and are likely the link between exercising muscle 
and the rest of the body.
The aim of the research presented this thesis is to study the signalling role of skeletal 
muscle during exercise and to gain further insight in the local molecular changes in skeletal 
muscle induced by exercise.
In the first part of this thesis the focus was on the local changes induced in skeletal muscle 
by acute exercise and exercise training. The aim was to gain more insight in the molecular 
basis of exercise-induced changes in skeletal muscle. For exercise training we performed 
a microarray analysis on human muscle biopsies taken from endurance, resistance and 
combined exercise training interventions. We showed that despite a substantial overlap 
between the three  exercise training types, each of the exercise training types had an 
unique gene expression print. The combined exercise training gene expression print lacked 
some specific oxidative and PPAR related components compared to endurance exercise 
training. For acute exercise  microarray analysis was performed on muscle biopsies taken 
before and after an one-legged cycling intervention from resting and exercising skeletal 
muscle. Results showed that acute exercise induced large gene expression changes in 
active skeletal muscle. Furthermore, results showed that acute exercise also induced 
gene expression changes in resting skeletal muscle and that these changes were likely 
systemically induced via free fatty acids.
In the second part of this thesis the focus was on the signalling role of skeletal muscle during 
exercise. Secretome analysis was performed on the microarrays of the muscle biopsies taken 
before and after the one-legged cycling intervention. This secretome analysis resulted in 
a list of putative myokines of which a selection was measured in the plasma. CCL2 (MCP-
1) and CX3CL1 (Fractalkine) were the myokines that were induced both in plasma and at 
the mRNA level.  In that same study we showed that the increase in Angptl4 mRNA levels 
was higher in the resting leg compared to the exercising leg. Follow-up studies using cell 
culture and mice models revealed that Angptl4 levels were increased in the resting leg 
via free fatty acids that activated PPARs. In the exercising leg the increased Angptl4 levels 
were inhibited via AMPK activation. This resulted in an influx of triglyceride derived fatty 
acids in the exercising, but not in the resting skeletal muscle.
In conclusion, we showed that exercise not only elicits molecular changes in active or 
trained skeletal muscle, but also in non-active organs such as resting skeletal muscle. 
Furthermore, we were able to identify several myokines produced by skeletal muscle during 
exercise, of which CCL2, CX3CL1 and Angptl4 were the most promising. CCL2, CX3CL1 
and Angptl4 all increased plasma levels during acute exercise. It remains unclear what 
the systemic role is of these myokines. For Angptl4 we were able to provide more insight 
in the mechanism and local functioning during exercise. We concluded that Angptl4 is 
important in the substrate distribution during exercise. From the results presented this 
thesis we conclude that skeletal muscle has an important signalling role during exercise, 
but that it remains unclear  how important this signalling role is systemically.
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Diabetes type 2
Diabetes type 2 and other metabolic diseases such as obesity and metabolic syndrome 
are affecting an increasing number of people, placing a large burden on health care 
and society. The increased prevalence of obesity and diabetes is likely attributable 
to increased prosperity and over-availability of a wide variety of (un)healthy foods in 
combination with a more sedentary lifestyle [1,2]. The increase in global prevalence of 
metabolic disease rates shows no signs of slowing down, largely due to the steep incline 
in metabolic diseases in former developing countries [3]. 
Diabetes type 2 is characterized by increased insulin resistance in peripheral tissues 
such as liver, adipose tissue and skeletal muscle [4]. Insulin resistance is one of the first 
hallmarks of diabetes type 2 [5]. Another hallmark of type 2 diabetes is insufficient insulin 
production by beta cells [5]. Obesity is one of the major risk factors for diabetes type 2 
and insulin resistance, together with the other characteristics of metabolic syndrome, 
such as high blood pressure, dyslipidaemia, high fasting blood glucose levels [6]. Insulin 
resistance in peripheral tissues is characterized by impaired GLUT4 translocation, 
allowing less glucose to enter the cells [7]. Furthermore, insulin receptor substrate (IRS-1) 
phosphorylation and phosphatidylinositol (PI) 3-kinase activity are impaired in insulin 
resistance [8]. What causes these impairments in insulin signalling pathway remains 
unclear, but a role for toxic lipid metabolites such as diacylglycerol, ceramide and fatty 
acyl CoA is suggested [9]. 
Several strategies are used to treat type 2 diabetes. Lifestyle and pharmaceutical 
interventions are currently the most common strategies. Most often diabetic patients are 
treated with metformin and receive dietary advice to lose weight. In addition, exercise is 
prescribed as lifestyle intervention to improve health of diabetic patients. Exercise is also 
often used in the prevention of diabetes type 2. Research shows that of all treatments 
available to type 2 diabetic patients, exercise is probably the most efficient and most 
cost-effective [6,7,10-12]. Several large scale interventions studies in humans show that 
long-term lifestyle interventions consisting of only exercise training or the combination 
of exercise training and dietary counselling significantly reduces the incidence of type 
2 diabetes [12-15]. Short- and long-term exercise training intervention studies show a 
dramatic effect of exercise training on insulin resistance [16,17]. Accordingly, extensive 
research is carried out aimed at understanding the exact effects of exercise on health. Also 
the mechanism behind the positive health effects are extremely important to reveal, since 
this will provide more insight in the effects of exercise in the context of type 2 diabetes.
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exercise
Exercise training generally leads to enhanced performance. Athletes train to get stronger, 
faster and more skilled. Many studies have addressed the effect of exercise training on 
the body and have shown that the effects are large and multifactorial. Maximal oxygen 
uptake increases by more efficient oxygen transport and uptake, leading to improved 
endurance performance [18,19]. Lactate and CO2 are more easily removed, reducing the 
fatigue during acute exercise [20]. Heart rate at a fixed intensity decreases, allowing to 
perform at a higher intensity [21]. Neural activation of skeletal muscle improves, allowing 
more efficient movement [22,23]. Since exercise training improves neural activation and 
induces hypertrophy, muscles get stronger which increases strength and power [22]. All 
these effects are examples of exercise training induced changes and how these changes 
result in performance enhancement.
Exercise training also has a large impact on health, especially in diseased conditions. 
Besides being beneficial for diabetes type 2 and other metabolic diseases, also 
cardiovascular disease can be prevented or treated by exercise training. Exercise causes a 
reduction of insulin resistance of peripheral tissues [16,17]. Furthermore, exercise training 
has been shown to improve factors such as cholesterol levels and blood pressure [24]. 
Reductions in blood pressure and cholesterol levels reduce the risk for cardiovascular 
disease and slow down the progression of cardiovascular disease. Another example of 
the health effects of exercise training is that recovery after chemotherapy is accelerated 
when exercise is performed [25]. The large impact of exercise training on health implies 
that exercise is a very important and interesting target for further research. 
It is important to realize that acute exercise and exercise training have very different 
effects. Acute exercise elicits a more stress-like response compared to a chronic adaptive 
response that is seen after exercise training. Studies assessing the role of exercise on 
health have focussed on endurance training and/or resistance training. Some studies 
combined resistance and endurance exercise training. Combined exercise training is 
thought to be the most effective type of exercise to reduce insulin resistance in diabetes 
type 2 [26]. 
To understand how exercise positively affects health and performance, it is important to 
gain more insight into the molecular biology of exercise and to elucidate the molecular 
pathways and processes triggered by exercise. Changes and adaptations induced by 
acute exercise and exercise training occur throughout the body. Changes in enzymes 
activity levels are known to play a crucial role, but also changes in mRNA levels are critical 
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in the regulation of the response to exercise. Literature has shown that whole genome 
gene expression profiling or transcriptomics is an efficient and valuable way to gain 
insight into molecular mechanisms [27], as it provides a complete overview of the gene 
expression changes on a specific time point.
transcriptomics
In the past, when researchers wanted to assess the effect of treatments on mRNA levels, 
most common techniques were Northern Blotting and qPCR. Both techniques allow 
only a limited number of genes to be measured at a time. Currently qPCR is still in use, 
but as technology evolved, high throughput gene expression profiling techniques 
became available. These high throughput gene expression profiling techniques include 
microarray and RNA-sequencing, allowing simultaneous measurement of all ~20,000 
genes present in the human genome. The general term for high throughput mRNA 
profiling is transcriptomics, covering all techniques assessing mRNA levels of large subsets 
of genes. Microarray analysis or transcriptomics is used in many different research fields, 
assessing a wide variety of questions. Besides the human genome, also the genome of 
other species and plants are mapped and available for transcriptomics. 
In human studies microarrays are used for many applications, including determination 
of the effects of pharmaceutical compounds or nutrition on gene expression. Microarray 
analysis is also used in exercise studies to assess effects on several organs such as adipose 
tissue [28] and peripheral blood mononuclear cells (PMBCs)[29]. Research in humans is 
limited by the fact that not all organs are reachable for tissue collection. The organ most 
heavily influenced by exercise is skeletal muscle, and this tissue can be relatively easily 
sampled. Several studies therefore focus on the changes in gene expression induced by 
exercise in skeletal muscle [27,30,31].
skeletal muscle
As stated before, of all organs skeletal muscle is probably the most influenced by exercise. 
Skeletal muscle generates movements during exercise, which necessitates the initiation 
of many biological pathways. Mechanical work has to be performed, substrates and 
oxygen have to be taken up and metabolized and waste products have to be carried out 
of the muscle. What is remarkable, is that all these actions and many more occur in a very 
limited timespan, showing that skeletal muscle is an extremely rapidly and effectively 
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responding organ. Skeletal muscle is metabolically very active, since skeletal muscle is 
one of the main utilizers of glucose and free fatty acids and has a high turnover of ATP 
[32]. During exercise, glucose, liver and muscle glycogen storages, albumin-bound free 
fatty acids, intramyocellular triglyceride content and triglyceride-derived free fatty acids 
are used as fuel [33-35]. The balance between those substrates is largely determined 
by the intensity of the exercise: the higher the intensity, the higher the rate of glucose 
utilization [33]. The amount of energy derived from triglyceride-derived free fatty acids 
was long underestimated, but currently the opinion is that this source of energy is also 
important during exercise [36]. 
Besides all acute effects of exercise described in the previous paragraph, exercise training 
causes a more adaptive response in skeletal muscle. Exercise training for example affects 
the protein synthesis and degradation balance, causing hypertrophy [37]. Another 
example is that mitochondrial oxidative capacity is increased during exercise training, 
allowing more ATP to be generated via oxidative pathways [38]. These two examples 
illustrate all the adaptations induced by exercise training in skeletal muscle and show 
how closely exercise and skeletal muscle are linked. 
signalling proteins from non-traDitional secretory 
organs
Since the initial discovery of secretion, numerous hormones have been identified. Until 
approximately 25 years ago, the general belief was that only traditional hormone-
producing glands could excrete hormones, including the pituitary gland and islet of 
Langerhans. The discovery of leptin as first adipocyte-produced hormone profoundly 
changed our view on circulating signalling proteins and their origin [39]. While previously 
white adipose tissue was thought to merely serve as a depot for energy storage and for 
insulation [40], the identification of leptin led to the realization that white adipose tissue 
is a very active endocrine organ [39]. Extensive research has shown that white adipose 
tissue plays a crucial role in lipid and glucose metabolism and energy balance [40]. The 
revelations about white adipose tissue as an endocrine organ also resulted in interest 
in other organs. Subsequent studies showed that organs such as the brain, heart and 
bone could also secrete signalling proteins [41-43]. 
Until recently skeletal muscle was seen as an organ that hardly interacted with other 
organs, except via substrate fluxes. Whereas skeletal and cardiac muscle are immediately 
and heavily recruited upon exercise, other organs appear to play only a minor role during 
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exercise. Despite that these organs are not directly targeted by exercise, they still show 
significant changes and improvements in function [44], suggesting that skeletal muscle 
can communicate with other organs. In the last decade it has become clear that skeletal 
muscle produces and secretes a variety of signalling proteins that are able to interact 
and communicate with other organs [45]. 
myokines
Signalling proteins produced and secreted by skeletal muscle are called myokines [44]. 
The definition of a myokine is that the signalling protein is produced by skeletal muscle 
during any condition, which implicates that a myokine does not have to be produced 
during exercise. Myokines, but also other compounds, produced by skeletal muscle 
during exercise are called exercise factors [44]. Exercise factors are a specific group of 
myokines that are characterized by production during exercise. After the identification 
of IL-6 as the first myokine, many studies have been performed to further establish the 
field of myokines [45]. The number of identified myokines increased and the role of those 
myokines in health and during exercise was studied. Well-known examples of recently 
identified myokines are Irisin [46], FGF-21 [47], Angptl4 [36], IL-8 [48] and IL-15 [49]. 
Exercise is an important and strong modulator of health, suggesting that identification 
of crucial mediators of exercise effects could potentially be relevant in gaining more 
insight in the effect of exercise on health. Myokines have a great therapeutic potential, 
since they may be the link between working muscle and the positive health effects of 
exercise. Currently, many myokines have been identified using a variety of approaches 
[50-52]. However, some knowledge on the physiological function is available for only a 
few myokines. Potential effects on development of (metabolic) diseases have remained 
an uncharted territory up to now. 
outline of thesis
The aim of the research presented in this thesis is to study the signalling role of skeletal 
muscle during exercise and to gain further insight in the local molecular changes in 
skeletal muscle induced by exercise. 
In chapter 2 an overview of the myokine field is given. In this review, all myokines 
identified in humans are discussed and their role in exercise is addressed. In chapter 3 
microarray analysis is used to study the molecular effects of several types of exercise 
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training to generate more insight in the differences in training effects. We show that 
combined, endurance and resistance exercise training result in distinctive gene expression 
patterns. The most remarkable finding is that combined exercise training (endurance 
and resistance) lacks some crucial oxidative gene expression changes compared to 
endurance exercise training, implying that combining endurance and resistance exercise 
training might interfere with some favourable changes induced by endurance exercise 
training alone. In chapter 4 a human acute one-legged cycling model is used. With that 
model we assess the effects of acute exercise on gene expression in exercising and non-
exercising skeletal muscle. The aim is to gain more insight into whether exercise can 
directly influence skeletal muscles that are not active during exercise. We show that acute 
exercise also has a large impact on gene expression in non-exercising skeletal muscle, 
besides an even larger effect on exercising muscle. These changes in the non-exercising 
muscle are induced via circulating factors. The presence of many PPAR target genes 
implicate a role for free fatty acids in the induction in the non-exercising leg. In chapter 
5 a screening is performed to identify new myokines in the acute one-legged cycling 
study. In this chapter a secretome analysis is performed, resulting in a list of new putative 
myokines, of which a selection is measured in plasma. CCL2 and CX3CL1 are identified as 
myokines in chapter 5. Known myokines such as IL-6 and Irisin are not or partly confirmed 
as myokines. In chapter 6 the mechanism and role of one of the myokines identified in 
the acute one-legged cycling study is studied. This myokine Angptl4 plays an important 
role in the fuel substrate distribution between exercising and non-exercising skeletal 
muscle. Higher levels of Angptl4 in the non-exercising skeletal muscle direct triglyceride 
derived fatty acids to the working muscle where the substrates are needed. Finally, the 
general discussion and conclusions are presented in chapter 7.
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ABSTRACT
Regular exercise has been shown to positively affect the risk for numerous chronic 
diseases. Exercise not only impacts the contracting skeletal muscle, but also elicits 
systemic alterations and impacts distant organs. The exact mechanisms driving the 
more systemic changes have yet to be resolved, but exercise factors are thought to be 
an important missing link. Exercise factors are proteins that are released from skeletal 
muscle into the circulation specifically during exercise. They represent a subclass of 
the myokines, which are classified as proteins secreted from skeletal muscle serving 
a signalling role. Here we provide an overview of the current literature on myokines. 
Presently, many studies focus on the identification of new myokines using a variety 
of approaches, ranging from proteomic analysis of media of cultured myocytes 
subjected to electrical pulse stimulation, to transcriptomics analysis of skeletal muscle 
of exercising mice and humans. These studies have generated an extensive list of 
myokines, yet the functional relevance of many of these novel myokines remain 
unclear. Few of these myokines represent putative exercise factors. Currently, the 
myokines IL-6, SPARC, Angptl4, CX3CL1 and CCL2 (MCP-1) have the highest potential 
to serve as exercise factors, since for all these factors there is clear evidence that plasma 
levels increase during exercise. While some additional effort into the identification 
of novel human myokines may be warranted, future research should primarily be 
dedicated towards determining the functional role of already identified myokines/
exercise factors during exercise.
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INTRODUCTION
Exercise is a very powerful and comparatively simple way to treat and prevent metabolic 
diseases such as type 2 diabetes and obesity. Exercise positively influences many 
metabolic risk factors including fasting glucose levels [1], lipid profiles [2], blood pressure 
[3] and insulin sensitivity [4]. Currently, the mechanisms behind these changes are still 
partly unknown. Exercise has an impact on the entire body, but skeletal muscle is the 
organ that is activated most strongly by exercise, as skeletal muscle performs the energy 
demanding mechanical work. To provide the fuel for the contracting muscle, uptake 
and utilization of oxygen and energy substrates increase dramatically during exercise. 
All these changes occur within a very limited timespan, showing that skeletal muscle 
responds rapidly and effectively to physical stress. In addition to the rapid stress-like 
response during acute exercise, repeated exercise bouts as during chronic exercise 
training elicit an adaptive response. This adaptive response is associated with increased 
oxidative capacity and mitochondrial density, as well as by an increase in skeletal muscle 
insulin sensitivity [4-6]. The adaptations triggered by exercise training are not limited 
to skeletal muscle but influence the circulation and other organs, as illustrated by the 
exercise-induced reductions in blood pressure [3], reduced inflammatory status [7] and 
improved blood lipid profiles [2]. How exercise is able to affect and communicate with 
distant organs is not fully clear but the most plausible explanation is that these effects 
are mediated by proteins secreted from muscle called myokines, and more specifically 
myokines that are induced by exercise, which are often referred to as exercise factors. 
It is now well established that skeletal muscle is capable of secreting a variety of proteins. 
The first protein identified that was found to be released from muscle tissue into the 
circulation during exercise is IL-6 [8,9]. As such, IL-6 represents the first myokine. From that 
moment onwards the quest for other myokines started, resulting in an increasing number 
of papers published on the topic. A variety of different approaches have been used to 
identify new myokines. Previous reviews on myokines were published several years ago 
[10-13], or focused on crosstalk with specific organs [14]. Here we give an overview of 
the current status in the myokine field in humans, with a focus on exercise factors. First 
a brief explanation of the term “exercise factor” is given, followed by clarification of the 
distinction between known myokines and exercise factors. Finally, the contemporary 
literature on myokines and exercise factors in humans is discussed. 
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WhAT IS AN exeRCISe fACTOR?
An exercise factor has been defined as a humoral factor produced by skeletal muscle 
in response to exercise [15,16]. Exercise factors have to be secreted into the circulation, 
implicating that they potentially have systemic effects [15,16]. Myokines on the other 
hand are proteins produced by skeletal muscle, that are not necessarily induced upon 
exercise nor do they have to have a systemic function [16]. Accordingly, a subset of 
myokines may be classified as exercise factors. A potential additional criteria for myokines 
is that they are exclusively produced by skeletal muscle. However, none of the factors 
currently labelled as myokine fulfils that criteria, with the possible but controversial 
exception of irisin [17], and it is questionable whether any protein will. Indeed, all of 
the known myokines are produced by a wide variety of tissues. For example, IL-6 is a 
well-known pro-inflammatory cytokine produced by many different organs and cells 
[18]. It should be emphasized that none of the proteins presently labelled as adipokine 
are exclusively produced by adipose tissue, with the exception of adiponectin. For this 
reason we support the following definition of a myokine: a myokine is any protein that 
is secreted by skeletal muscle that plays a signalling role in an autocrine, paracrine and/
or endocrine manner. The classification as a myokine is irrespective of the proteins also 
being produced by other tissues.  
Having defined the term myokine and exercise factor, it is important to make the 
distinction between exercise factors that are acutely induced by a single exercise bout 
and exercise factors that are chronically induced upon exercise training. In general, 
acute exercise and exercise training have very different effects on skeletal muscle, with 
acute exercise eliciting a more stress-like response compared to a chronic adaptive 
response following exercise training, likely resulting in production of a different set of 
myokines. 
WhICh myOkINeS ARe exeRCISe fACTORS?
As discussed above, not all myokines are exercise factors and not all exercise factors are 
myokines, but in general most potential exercise factors are likely myokines. A variety 
of approaches have been used to find new myokines and explore their function. A 
possible approach is to perform myokine screenings in different types of models. Cell 
culture models are often used to perform screenings, since screenings in cell culture 
models are relatively easy to perform and give a ‘clean’ overview of the secretome of 
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skeletal muscle cells. The screenings in cell culture models resulted in lists of myokines 
that are produced by myocytes in vitro in rest [19], during differentiation [20] and with 
electrical pulse stimulation [21,22]. Another screening approach used human muscle 
biopsies collected before and after acute exercise as starting material, and was able to 
generate a list of potential myokines [23]. Other studies first performed a screening, 
followed by further experimentation to functionally characterize the newly identified 
myokine. This approach has been pursued for Angptl4 [24], IL-7 [25], Apelin [26], Irisin [17] 
and SPARC [27]. SPARC, IL-7, Apelin and Irisin were identified using exercise training as a 
model, whereas Angptl4 was identified using acute exercise as a model. Complementing 
the screenings to identify new myokines, many studies have followed a targeted 
approach assessing mRNA and proteins levels of one particular protein, resulting in the 
identification of several myokines such as IL-6 [28], IL-8 [29], IL-15 [30], BDNF [31] and 
FGF21 [32]. All these myokines were initially investigated in the context of acute exercise, 
except for FGF21 which was initially linked to fasting [32]. 
Adding up all myokines identified in the different studies performed so far results in a 
list of more than 100 myokines induced at the mRNA and/or protein level by exercise, 
electrical pulse stimulation, fasting and differentiation. Many of these myokines have 
only been identified in cell models and have not been studied in humans, making the 
relevance of those myokines uncertain. This review will focus on myokines identified in 
humans in the past 15 years. The list of myokines fulfilling these criteria is shown in table 
2.1. The table indicates whether a myokine is an (potential) exercise factor, and whether 
levels are increased upon acute exercise and/or exercise training. 
From table 2.1 it is evident that a considerable fraction of the myokines cannot be 
classified as exercise factors. So far there is no evidence that Apelin, BDNF, FGF21, IL-7 
and LIF, despite their regulation by exercise, are actually secreted into the circulation. 
For other myokines, including IL-8, IL-15 and especially Irisin, it is not clear if plasma 
levels are increased by exercise. Currently, due to conflicting results, there is a lot of 
controversy surrounding Irisin and its role during exercise. Promising exercise factors 
include Angptl4, CX3CL1, IL-6, CCL2 (MCP-1) and SPARC. All exhibit increased muscle 
gene expression and increased circulating levels upon acute exercise. Expression and 
circulating levels of SPARC are increased upon exercise training, while levels of IL-6 and 
CCL2 decrease after exercise training. Few data are available for CX3CL1, SPARC and to 
a lesser extent CCL2. In the following section all myokines included in table 2.1 will be 
discussed in more detail separately.
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Table 2.1 Myokines identified in humans
Myokines References Exercise factor? Acute Training
Angptl4 [22-24,33] Yes Yes No
Apelin [26] No, not in plasma ? (no data) Yes
BDNF [31,34-36] No, not in plasma Yes Yes
BAIBA [37] Yes ? (no data) Yes
FGF21 [23,32,38] No, not in plasma Yes No
CX3CL1 [23] Yes Yes No
IL-6 [8,9,22,23,28,39-60] Yes Yes Yes, reduced
IL-7 [25] No, not in plasma ? (no data) Yes
IL-8 [22,49,52,58,59,61-63] Yes, only in plasma after 
extreme conditions
Yes ? (no data)
IL-15 [30,64-68] Yes, but very limited proof Yes Yes 
Irisin [17,69-76] Yes, but contradictory 
results and protein might 
not be functional
Yes?, 
contradictory 
results
Yes?, 
contradictory 
results
LIF [77,78] No, not in plasma Yes ? (no data)
CCL2 [23,50,79-85] Yes Yes Yes, reduced
SPARC [23,27,86] Yes Yes Yes
Metrnl [87] Yes, only in mice Yes ? (no data)
exeRCISe fACTORS
IL-6
IL-6 is the most studied and discussed of all myokines. The reason for this attention is 
that IL-6 was the first identified myokine and is also a very well-known cytokine. Indeed, 
more than 99% of the literature on IL-6 pertains to its non-myokine actions. IL-6 is mainly 
characterized as a pro-inflammatory cytokine involved in T cell differentiation and 
activation, and is involved in many (auto)immune diseases such as rheumatoid arthritis, 
inflammatory bowel disease, and diabetes type 1 [88]. IL-6 has also been connected with 
development of insulin resistance in adipose tissue and liver [89-91]. In 1998, Ostrowski et 
al. first showed that mRNA levels and circulating levels of IL-6 are increased during acute 
exercise [54]. Many other studies have confirmed and have further elaborated on these 
finding in the years that followed. The increases in IL-6 mRNA and plasma levels were 
found to be dependent on blood glucose levels and glycogen levels [40,45]. Whereas 
low glycogen levels were associated with increased IL-6 mRNA and plasma levels [45,57], 
glucose ingestion led to lower IL-6 plasma levels, although without any corresponding 
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changes at the gene expression level [40,52]. These results indicate that low glycogen 
and blood glucose levels trigger IL-6 production and secretion during acute exercise, 
suggesting that the direct stimulus for increased IL-6 production may not be muscle 
activity perse but depletion of muscle glycogen. 
Despite many different studies showing increased IL-6 levels after acute exercise, some 
controversy surrounding IL-6 as a myokine remains. To gain more insight in the IL-6 
response upon acute exercise and exercise training, we made an inventory of the studies 
that measured local or plasma IL-6 levels during exercise (see table 2.2). Most studies 
only assessed IL-6 levels in plasma, and almost all studies found increased plasma levels 
of IL-6 in response to a variety of acute exercise types. The studies that did not find an 
increase in plasma IL-6 levels generally involved more moderate exercise that was not 
weight-baring (such as cycling). When IL-6 mRNA and plasma levels were both assessed, 
in almost all cases corresponding increases for both IL-6 plasma and mRNA levels were 
observed. The only discrepant results were described by Catoire et al. and Langsberg 
et al. Langsberg et al. found an increase in IL-6 plasma level, but not mRNA levels, after 
a 36 km run [47]. Catoire et al. showed increased mRNA levels but not plasma levels in 
subjects that performed one-legged cycling exercise [23]. Integrating the results of the 
different studies, it appears that lack of induction of IL-6 by exercise is confined to acute 
exercise studies of limited duration and those that employed a relatively moderate type 
of exercise. Accordingly, the emerging message is that intense weight baring exercise and 
long exercise session that deplete glycogen storages are needed to change IL-6 levels, 
which suggest that increased plasma IL-6 levels may be partly driven by muscle damage. 
In this regard the study of Langsberg et al. is extremely interesting, since they used a 
long and weight baring type of acute exercise, and found increased IL-6 mRNA levels 
only in the tendons of the muscle and not in the muscle itself. Remarkably, the increase 
in IL-6 mRNA in tendons was associated with elevated plasma IL-6 levels. In addition, 
several studies showed that acute exercise also increased IL-6 mRNA levels in adipose 
tissue [43,92,93], suggesting that part of the elevation in IL-6 plasma levels during acute 
exercise might originate from tissues other than skeletal muscle. 
A considerable number of papers have focussed on the effect of exercise training on 
IL-6 levels. Surprisingly, exercise training seems to have the opposite effect on IL-6 as 
compared with acute exercise. Indeed, studies indicate that exercise training reduces 
IL-6 gene expression and plasma levels [41,48]. These findings raise questions about the 
proposed role of IL-6 as mediator of the stimulatory effect of acute exercise on insulin 
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sensitivity. IL-6 produced during contraction positively affected insulin signalling and 
improved insulin sensitivity in muscle [94]. These effects were opposite to the effects of 
increased IL-6 levels in adipose tissue and liver on insulin signalling [89-91]. IL-6 induced 
insulin resistance in hepatocytes [90]. In vivo, IL-6 induced insulin resistance in liver [91], 
while in adipose tissue high IL-6 levels are associated to insulin resistance [89]. In literature 
it was suggested that the effects of IL-6 on insulin sensitivity are very tissue specific and 
also depend on chronically elevated levels or only short-term increased levels [95]. 
In conclusion, acute exercise stimulates production and secretion of IL-6 by skeletal 
muscle, while exercise training reduces IL-6 levels. IL-6 secretion seems to be especially 
activated by high intensity and long duration exercise, suggesting that some form of 
muscle damage may be needed to trigger IL-6 release and raising questions about the 
potential role of IL-6 in mediating the effects of moderate exercise. Finally, it is doubtful 
that the increase in plasma IL-6 after acute exercise originates solely from skeletal muscle. 
Other organs such as adipose tissue likely contribute as well .
CCL2
Similar to IL-6, CCL2 is a very well-known inflammatory marker. During inflammation 
caused by injury or infection, CCL2 recruits monocytes, T cells and dendritic cells. In 
skeletal muscle CCL2 is involved in macrophage infiltration after tissue damage [96,97]. 
Recently it was discovered that skeletal muscle CCL2 mRNA levels are elevated during 
acute exercise, resulting in increased plasma levels [23]. Based on these data, CCL2 can 
be classified as a myokine and exercise factor. Previous studies already showed that 
acute moderate intensity cycling, marathon running, and resistance exercise increased 
CCL2 gene expression levels in skeletal muscle [50,79-81]. CCL2 protein was found to 
be increased in skeletal muscle after eccentric exercise, but not after concentric exercise 
[82]. Furthermore there was a clear co-localization of CCL2 with satellite cells and 
macrophages after the acute eccentric exercise bouts, which could not be observed after 
concentric acute exercise [82]. Given the role of CCL2 in macrophage infiltration upon 
muscle damage and a clear co-localization of CCL2 with macrophages, it appears that 
the local increase in CCL2 might partly originate from immune cells. The induction of 
CCL2 by trauma or acute exercise and subsequent infiltration of macrophages and other 
immune cells appears to be crucial for muscle repair and adaptation [96,98]. Infiltration of 
immune cells was also found to be important for skeletal muscle hypertrophy following 
exercise [99]. Secretion of CCL2 into the blood is also indicative of a systemic role during 
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acute exercise, although concrete evidence is lacking. Interestingly, long-term training 
results in a decrease in plasma CCL2 levels [83,85], which is analogous to the effects of 
exercise training on IL-6 levels. Furthermore, similar to IL-6, CCL2 is produced by adipose 
tissue during obesity as part of a chronic low grade inflammation and promotes insulin 
resistance [100-102]. Evidence suggests that both acute exercise and exercise training 
cause a shift in adipose tissue macrophages from inflammatory M1 to anti-inflammatory 
M2 macrophages [103,104]. It can be hypothesized that CCL2 produced in skeletal 
muscle plays a role in this shift, but more research is necessary to better understand the 
functional consequences of CCL2 release during exercise. In conclusion, CCL2 is a very 
interesting exercise factor that may have an important function in mediating (part of ) 
the inflammatory and metabolic responses following an acute exercise bout.
Angptl4
Angptl4 is a secreted protein that regulates the influx of plasma triglyceride-derived 
fatty acids into tissues by inhibiting the enzyme lipoprotein lipase [105]. Angptl4 is 
produced by a variety of tissues including adipose tissue, liver, heart, intestine and 
skeletal muscle. Expression of Angptl4 in skeletal muscle is activated by plasma free 
fatty acid via the Peroxisome Proliferator–Activated Receptor (PPAR)-δ [106]. Kersten et 
al. showed that acute exercise increased Angptl4 levels in plasma, but only when the 
exercise was performed in the fasted condition [33]. Co-ingestion of glucose, which blocks 
the elevation in plasma free fatty acids during exercise, prevented the exercise-induced 
increase in plasma Angptl4, suggesting that induction of plasma Angptl4 by exercise is 
mediated by elevated free fatty acids. 
Recently we found that acute exercise also increased Angptl4 gene expression levels 
in human skeletal muscle, most likely via elevated plasma free fatty acids. Surprisingly, 
the magnitude of the increase in Angptl4 mRNA was much higher in non-exercising 
muscle as compared with exercising muscle [23,24]. The selective induction of Angptl4 
in non-exercising muscle may serve to prevent local fat overload, while directing fatty 
acids to the active skeletal muscle as fuel, thus pointing to Angptl4 as a key regulator of 
lipid homeostasis during exercise. Increased Angptl4 gene expression during exercise 
was accompanied by increased plasma levels, implying that Angptl4 is a myokine and 
an exercise factor. However, whether Angptl4 produced by skeletal muscle acts at a 
distance and impacts other tissues remains unclear [24]. In contrast to acute exercise, 
exercise training did not change Angptl4 plasma levels [24]. In conclusion, Angptl4 is a 
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very interesting potential exercise factor. Whether skeletal muscle-derived Angptl4 also 
has a systemic role requires further study. 
Cx3CL1
CX3CL1 has been involved in acute skeletal muscle injury and regeneration via its ability 
to attract macrophages and other immune cells, which is thought to be crucial for 
hypertrophy [99]. As an inflammatory marker, CX3CL1 is involved in leukocyte adhesion 
[107], and macrophage-directed rescuing of skeletal muscle cells from apoptosis [108]. 
Because CX3CL1 was only recently identified as a myokine, there is limited literature on 
CX3CL1 in the context of exercise and skeletal muscle. Catoire et al. showed that acute 
exercise induced gene expression and plasma levels of CX3CL1 [23]. Furthermore, it 
was shown that CX3CL1 is part of the secretome of skeletal muscle [20], supporting the 
status of CX3CL1 as a myokine. Besides a local role in muscle regeneration, it is unclear 
whether the increased plasma CX3CL1 may have any systemic effects. Interestingly, 
plasma levels of CX3CL1 were found to be elevated in subjects with type 2 diabetes [109]. 
Furthermore, decreased CX3CL1 signalling was suggested to be one of the mechanism 
underlying β cell dysfunction in type 2 diabetes [110]. Taken together, CX3CL1 is a highly 
interesting myokine and exercise factor, which may be involved in mediating specific 
effects of exercise.
SPARC
SPARC was identified as a myokine in a screening study in mice using microarrays. The 
study revealed that SPARC gene expression levels are increased after acute exercise and 
exercise training [27]. Acute exercise also significantly increased SPARC plasma levels and 
this result was reproduced in humans, suggesting a potential systemic role of SPARC 
during exercise [27]. Plasma levels of SPARC tended to increase in mice following exercise 
training. The increase in SPARC mRNA levels after acute exercise and exercise training in 
humans was corroborated in another study. Unfortunately, plasma levels of SPARC were 
not measured [23]. Locally produced SPARC has been connected to muscle development 
[86,111] and glucose metabolism [112]. Furthermore, it was shown that SPARC has an 
inhibitory effect on tumorgenesis in colon during exercise [27]. An intriguing aspect of 
SPARC is that it is induced during both acute exercise and exercise training, raising the 
possibility that it may function as general exercise factor.
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POSSIBLe exeRCISe fACTORS
Irisin
Irisin was presented as a very promising myokine by Bostrom et al. [17]. Irisin was 
transcribed and translated from the FCNC5 gene and was induced by exercise training. 
Data showed that irisin promotes browning of white adipose tissue. Browning of white 
adipose tissue implicates that white adipose tissue cells develop the properties of brown 
adipose tissue cells, allowing them to generate heat and increase whole body energy 
expenditure [17]. Since the identification of irisin, many studies have tried to confirm 
and further elaborate on the role of irisin in exercise. In general, results of those studies 
have not been able to consistently reproduce the original findings of Bostrom et al. 
Indeed, several studies found that irisin levels in plasma and skeletal muscle were not 
influenced by exercise training [69,70,72,73]. Whereas Bostrom et al. reported no change 
in plasma irisin following acute exercise [17], other studies found that plasma irisin goes 
up during acute exercise [72,75,76]. One of the major concerns is that almost all ELISA’s 
used for quantification of plasma irisin have not been properly validated, casting doubt 
on the reliability of the findings. Another major concern is that irisin levels in human 
plasma are likely very low, since the rate of translation of the FDNC5 gene is much 
lower in humans as compared with mice, due to the fact that human FNDC5 misses the 
usual start codon [74]. Interestingly, a recent study was able to detect irisin protein in 
human plasma using highly sensitive mass spectrometric analysis [71]. In conclusion, 
the role of irisin as a myokine remains controversial. The results in mice are encouraging 
[17,75], but there are serious reservations about the relevance of plasma irisin 
in humans.
IL-8 & IL-15
IL-8 and IL-15 were both identified as myokines shortly after IL-6 was bestowed with 
the same label. IL-8 and IL-15 are well-known pro-inflammatory cytokines. IL-8 induces 
chemotaxis in activated immune cells, and also induces phagocytosis [113]. IL-15 
regulates T and natural killer cell activation and proliferation [114]. A number of studies 
have shown induction of IL-8 and IL-15 by acute exercise [30,49,52,61,68]. IL-15 gene 
expression levels also went up after exercise training [66]. There are no recent studies 
on IL-8 and IL-15 as myokines. Plasma levels of IL-8 were found to be increased by 
strenuous exercise, including 24-h ultra-endurance exercise and 3 hours of running/
cycling [52,59,63]. Only one study showed increased plasma levels of IL-15 after exercise, 
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which consisted of 30 minutes of running at 70% VO2max [67]. This exercise protocol 
seems relatively modest but nevertheless was associated with considerable muscle 
damage, as illustrated by increased plasma creatine kinase levels [67]. The above results 
suggest that only strenuous exercise associated with severe muscle causes plasma levels 
of IL-8 and IL-15 to go up. IL-8 has been suggested to be involved in angiogenesis in 
skeletal muscle [115], while IL-15 is may play a role in glucose metabolism and muscle 
development [116,117]. In conclusion, IL-8 and IL-15 are myokines that likely serve a local 
role in response to exercise. Their identity as exercise factors is uncertain.
AUTOCRINe AND PARACRINe myOkINeS
fGf21
FGF21 is a member of the fibroblast growth factor family which now comprises 22 
members in man. It is produced by a number of tissues, including liver, white adipose 
tissue and pancreas. Metabolically, FGF21 is probably one of the most promising 
myokines, since it influences lipid and glucose metabolism, as well as insulin signalling 
[118-120]. It has been shown that FGF21 is also expressed in skeletal muscle and that 
expression is increased upon fasting [32]. So far only one study has shown a stimulatory 
effect of acute exercise on FGF21 mRNA [23]. Other studies on FGF21 in skeletal muscle 
mainly focussed on the role in insulin signalling. In vitro, in skeletal muscle FGF21 
protected against palmatite-induced insulin resistance [121] and was induced by insulin 
via the Akt/PI-3 kinase pathway [32,122]. Systemically, FGF21 is working as an endocrine 
factor increasing for example lipolysis in white adipose tissue and gluconeogenesis in 
liver [123]. In monkeys and rodents, FGF21 administration causes a marked decrease in 
fasting plasma glucose , insulin, glucagon, and triglycerides [118]. Additionally, FGF21 
administration lowered plasma LDL and raised HDL [118]. A recent study indicates that 
part of the metabolic effects of FGF21 are relayed by the brain [124]. Due to its favourable 
properties, FGF21 has become a highly promising pharmaceutical target for metabolic 
diseases, including diabetes type 2. Taken together, FGF21 is a highly interesting 
putative myokine. Considering the scarce data available, the secretion of FGF21 by 
muscle into the blood needs experimental confirmation, Furthermore, the possible 
effect of acute exercise and exercise training on plasma FGF21 needs to be explored 
further. 
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BDNf
BDNF was found to be increased in plasma upon acute exercise [125,126]. BDNF is mainly 
expressed in various parts of the brain where it functions as a regulator of neuron growth 
and survival [127]. In addition, BDNF is expressed in skeletal muscle, where it is induced 
by acute exercise [31] and exercise training [34]. Current evidence suggests that skeletal 
muscle-derived BDNF is not released into the circulation [31]. The increased plasma levels 
therefore likely originate from the brain, suggesting that muscle-derived BDNF might 
only serve a local role. Skeletal muscle BDNF has been shown to be involved in satellite 
differentiation, muscle regeneration and AMPK signalling [31,36,128]. In conclusion, 
BDNF is a probably myokine but is not released from the muscle into the circulation, 
indicating it is not an exercise factor.
OTheR myOkINeS/exeRCISe fACTORS
Apelin, BAIBA, IL-7, Metrnl and LIF have all been proposed as myokines in humans, 
although evidence for all of them is currently limited [25,26,34,37,87]. Since data in humans 
is so limited for these myokines, we will not extensively address them in this review. 
Interestingly, BIABA is not a protein but a metabolite released from skeletal muscle during 
acute exercise and in vitro during electrical pulse stimulation [37]. BAIBA is likely involved 
in browning of white adipose tissue, making it an interesting potential exercise factor. Very 
recently a paper on Metrnl was published, adding Mertnl to the myokine family. Mertnl 
has been linked to increased energy expenditure and improved glucose tolerance [87].
CONCLUSIONS 
A considerable number of human myokines have been identified throughout the years, 
yet limited information is available about the function of most of those myokines. The 
majority of the myokines identified probably has a local role and is unlikely to carry a 
systemic function as exercise factor. So far the only well-established myokine and exercise 
factor is IL-6. Promising exercise factors and myokines include SPARC, CCL2, CX3CL1 
and Angptl4. For all the other putative myokines, more evidence is needed that they 
are actually secreted into the plasma, and that production is increased in response to 
exercise. In the coming years, emphasis should be placed on better characterizing the 
functional role of the existing and newly identified myokines in the acute and chronic 
response to exercise, and explore their potential as target for metabolic diseases.
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ABSTRACT
There is very limited knowledge on molecular changes induced by endurance, 
resistance and combined (or concurrent) exercise training. This knowledge is 
important for the use of different types of exercise training in the context of health 
and disease. 
The aim of this study was to assess the effect of combined exercise training on gene 
expression profiles, and compare this with the gene expression profiles of endurance 
and resistance exercise training. Microarray dataset from three human intervention 
studies were included (combined exercise training, resistance exercise training and 
endurance exercise training). Microarray analysis was performed on muscle biopsies of 
the vastus lateralis muscle for all three studies. The endurance and resistance exercise 
training dataset were extracted from GEO. 
Our results showed that despite a substantial overlap between the three training 
types, each of the training types had an own specific gene expression signature. The 
combined exercise training gene expression print lacked some specific oxidative and 
PPAR related components compared to endurance exercise training. 
In conclusion, the gene expression profile of combined exercise training has a less 
oxidative signature compared to endurance exercise training. This gene expression 
profile might have implications for the use of combined exercise training in the 
context of metabolic disease and sports.
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INTRODUCTION
The number of people affected by obesity and diabetes type 2 continues to increase, 
putting a growing burden on healthcare and society. Research has shown that exercise 
is one of the most effective ways to prevent and treat metabolic diseases such as type 2 
diabetes. Exercise training increases insulin sensitivity[1], restores mitochondrial function 
[1] and reduces liver fat [2]. The exact mechanisms behind the positive effects of exercise 
on health remain largely unknown. Better understanding of these mechanisms is crucial 
to effectively apply exercise for treatment of metabolic disease. 
Different types of exercise are beneficial in the treatment of metabolic disease. Endurance 
and resistance exercise training are the types of exercise that are most often used. 
Combined (or concurrent) exercise training combines resistance and endurance exercise 
training and is also frequently used in the treatment of metabolic disease. Combined 
exercise training has been suggested to be more favourable to treat metabolic disease 
than endurance or resistance exercise training alone [3]. Currently there is very limited 
knowledge on the similarities and differences in molecular changes induced by the 
different types of exercise training. This knowledge is relevant to determine what type 
exercise should be recommended in disease and as training strategy for a particular 
sport. Indeed, many athletes use resistance exercise training as support training for their 
principal endurance sport. 
Resistance and endurance exercise training cause profound alterations in gene 
expression [4,5], which are at the basis of the adaptive changes in exercise capacity. 
Until now research only assessed the gene expression changes induced by resistance or 
endurance exercise training separately [6,7]. The molecular effects of combined exercise 
training were never assessed, nor was a comparison made between the different types 
of exercise training. Whole genome gene expression profiling by microarray has been 
shown to be a very effective and valuable way to get information on expression of 
all genes in the human genome [8]. Therefore the aim of this study was to assess the 
effect of combined exercise training on gene expression profiles, and compare this 
profile with the gene expression profiles of endurance and resistance exercise training. 
For this purpose we utilized whole genome gene expression data from three types of 
exercise training (resistance, endurance, combined) and compared the gene expression 
profiles of the three types of exercise training using several bioinformatics tools. The 
microarray datasets from the resistance and endurance exercise training study were 
extracted from the Gene Expression Omnibus (GEO). The results show distinct gene 
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expression profiles for each type of exercise training. The gene expression profile of 
combined exercise training has a less pronounced oxidative signature compared to 
endurance exercise training.
meThODS
human intervention studies
Three human intervention studies were included: a combined exercise training study, a 
resistance exercise training study, and an endurance exercise training study. Studies were 
chosen based on the following criteria: supervised and controlled exercise intervention, 
between 6 weeks and 12 weeks of training and healthy male participants. In addition, 
whole genome expression data had to be available.
Combined exercise training
Results of this training intervention were previously published in Meex et al. and 
Catoire et al. [1,9]. In short, 18 healthy middle-aged male subjects performed 12 weeks 
of combined exercise training. Combined exercise training consisted of 2 endurance 
exercise sessions and 1 resistance exercise session per week. More details about the 
training is provided in table 3.1. 
Table 3.1 Overview of the exercise training interventions
Training 
type
Number 
weeks
Number 
of sessions 
per week Type of training
# of 
subjects
Type of 
subjects
Endurance 6 4 45 min cycling on 70% VO2max 24 Healthy young
Resistance 12 3 bilateral knee extensions with 
3x10 reps at 70% of 1-RM
8 Healthy young
Combined 12 3 2x cycling 30 min at 55% of 
Wmax, 1x 1x8 reps at 55% of MVC 
+ 2x 8 reps at 75% MVC for all 
large muscle groups
18 Healthy 
middle-aged
endurance exercise training
The microarray dataset of this study was extracted from the Gene Expression Omnibus 
(GEO; http://www.ncbi.nlm.nih.gov/geo/; GSE35659) and previously published in Keller et 
al. and Timmons et al. [6,10]. The study contained 24 healthy young subjects participating 
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in 6 weeks of endurance exercise training (4 sessions per week). More details about the 
exercise training performed is provided in table 3.1.
Resistance exercise training
The microarray dataset of this study was extracted from GEO (GSE28422). The results were 
previously published in Raue et al. [7]. 8 healthy young subjects performed 3 resistance 
exercise sessions per week for 12 week. More details about the training regimen are 
provided in table 3.1.
microarray analysis
For the three studies the biopsies were taken from the vastus lateralis muscle under 
resting conditions. For the endurance exercise training intervention at least 24 hours had 
elapsed between the last exercise session and collection of the muscle biopsy. For the 
resistance and combined exercise training intervention 48 hours had elapsed between 
the last exercise session and the muscle biopsy. Processing of the biopsies for microarray 
analysis for the endurance and resistance exercise training studies is described in the 
published articles [6,7,10]. The Affymetrix Human Genome U133 Plus 2.0 microarray was 
used for the endurance and resistance exercise training studies. For the combined exercise 
training study, RNA was isolated using Trizol (Invitrogen, Breda, NL) and purified using 
RNeasy columns (Qiagen, Venlo, NL), after which RNA was labelled and hybridized to 
human whole genome Genechip Human Gene 1.1 ST arrays (Affymetrix, Santa Clara, CA). 
All three microarray datasets were normalized using median polish and probesets were 
combined for the three datasets, leaving only the probesets present on both types of 
Affymetrix microarrays. This reduced the number of genes to 17,309. Statistical differences 
between baseline and post-training samples were assessed using Intensity-Based 
Moderated T-statistic (IBMT [11]) for each intervention and considered to be statically 
significant if p < 0.01. For a graphical representation of the workflow, see figure 3.1. 
Pathway analysis 
Geneset enrichment analysis (GSEA; http://www.broad.mit.edu/gsea/) was performed 
for the three datasets and genesets with p < 0.05 were considered significantly enriched 
or depleted. The Enrichment plugin in Cytoscape was used to visualize GSEA output, cut 
offs of p < 0.01, q < 0.02 and overlap coefficient < 0.5 were used. 
Comparing gene expression profiles of three exercise training typesChapter 3
54
Figure 3.1 Flow chart of the work flow of the microarray analysis. The Venn diagram represents the 
overlapping genes for the three training types. Combined N = 18, Endurance N = 24, Resistance N = 8.
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ReSULTS
After combining the three microarray datasets, 17,309 common genes remained. Of these 
17,309 genes, 547 genes were significantly changed by resistance exercise training, 3047 
genes were significantly changed by endurance exercise training and 760 genes were 
significantly changed in combined exercise training (figure 3.1; p < 0.01). For all three 
types of exercise training, the majority of the genes was upregulated, which was most 
pronounced for the combined exercise training. 
Comparative analysis showed an overlap of 63 genes significantly induced by all three 
training types (figure 3.1), representing 8.3%, 2.1% and 11.5% of the total number of 
significant genes for combined, endurance, resistance exercise training, respectively 
(figure 3.2). Interestingly, a large portion of the genes altered by combined exercise 
training overlapped with the genes altered by endurance exercise training (307 genes, 
40.4% of the total number of genes altered by combined training). The overlap between 
the genes altered by combined exercise training and resistance exercise training was 
limited to 3.4%.
Next, the significantly induced genes for each type of training were ranked based on fold 
change. The top 30 for each type of training is depicted in figure 3.3. The top 20 of the 
Figure 3.2 Relative overlap of the three exercise training types for genes (left Venn diagram) and 
GSEA genesets (right Venn diagram). Underlined represents combined exercise training, bold resistance 
exercise training and italic endurance exercise training.
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Figure 3.3 Top 30 genes of combined (A), resistance (B) and endurance (C) exercise training (p < 0.01). 
Individual expression levels of subjects are showed in the colums. Red is a signal log ratio of 2, blue of 
-2. Overlap between the top 30s are indicated with dark grey (present in 3 training types) or light grey 
(present in 2 training types).
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combined exercise training study shown in figure 3.3A deviates from a top 20 that was 
previously published based on the same dataset [9]. The explanation for this is that two 
types of microarrays were combined. Our analysis only took into account probes that 
were present on both types of microarrays. This selection of genes resulted in a difference 
in number of probes for the combined microarrays compared to the number of probes 
per gene for the two types of microarrays separately. A difference in number of probes 
can results in subtle changes in expression levels. Close inspection of the top 30 of the 
three different training types revealed overall higher fold changes following endurance 
exercise training and more limited variation between the subjects, as compared with 
combined and resistance exercise training (figure 3.3). Comparison of the top 30 genes 
for the three training types yielded 2 common genes: COL4A1 and MXRA5. Of the top 
30 genes induced by combined exercise training, 9 genes overlapped with endurance 
exercise training and 5 genes with resistance exercise training. 
To gain more insight into the processes changed by the different types of exercise 
training, geneset enrichment analysis (GSEA) was performed. GSEA examines if certain 
processes or pathways (genesets) are over- or underrepresented in the dataset. In the 
GSEA expression levels of all genes are taken into account, not only the genes that are 
significantly induced. The analysis resulted in 162 enriched genesets for combined 
exercise training, 202 enriched genesets for endurance exercise training and only 51 
enriched genesets for resistance exercise training (p < 0.05). Taking into account the 
relatively limited overlap in significantly altered genes between the different training 
types, the overlap in enriched genesets between the three types of training was 
surprisingly large: 41 genesets (69.5% of resistance exercise training, 25.3% of combined 
exercise training and 20.3% of endurance exercise training genesets; figure 3.2). Eighty-
four genesets were overlapping between combined and endurance exercise training 
(40.4% of combined exercise training and 41.6% of endurance exercise training). 
To obtain a better overview of the results, the GSEA output was loaded into the 
Enrichment tool of Cytoscape and a very strict cut-off was used to visualize the most 
enriched genesets (p < 0.01, q < 0.02). A very strict cut-off was used to be able to generate 
a clear overview of the most enriched (or depleted) genesets. Results of the GSEA of the 
combined exercise training were consecutively compared with GSEA results of endurance 
and resistance exercise training (supplemental figure S3.1). The comparison between 
combined and resistance exercise training showed that the overlap is relatively limited 
(supplemental figure S3.1B). Overlapping geneset were related to immune response 
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and homeostasis. Only one overlapping geneset was related to metabolism: Reactome 
geneset “Respiratory electron transport, ATP synthesis by chemi-osmotic coupling 
and heat production by uncoupling proteins”. The comparison between combined 
and endurance exercise training revealed a more substantial overlap (supplemental 
figure S3.1A). A clear difference in enrichment of genesets involved in metabolism was 
observed between combined and endurance exercise training. Genesets involved in fatty 
Figure 3.4 Results of the Geneset Enrichment Analysis (GSEA) of the three types of exercise training. (A) 
Venn diagram overlapping the enriched geneset of the three exercise types (p < 0.05), (B) selection of the 
enrichment  map showing the genesets different between combined and endurance exercise training. Red 
is enriched, blue is depleted. The inner parts of the circles represent combined exercise training, the outer 
parts endurance exercise training., (C)-(F) heatmaps showing 25 most representative individual genes for 
4 selected genesets: TCA cycle (WIP, sign. enriched in resistance + endurance), fatty acid oxidation (WIP, 
sign. enriched in endurance), electron transport chain (WIP, sign. enriched in resistance, endurance & 
combined), PPAR signalling (KEGG, sign. enriched in endurance). Red is a signal log ratio of 0.25, blue -0.25.
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acid metabolism, citrate cycle and glycolysis were not enriched in combined exercise 
training, but strongly enriched in endurance exercise training (figure 3.4B). Other genesets 
related to oxidative phosphorylation and electron transport chain were enriched in both 
combined and endurance exercise training, but the enrichment in endurance exercise 
training was again more pronounced (figure 3.4B). 
Four representative metabolic genesets are displayed in figure 3.4C-F. The electron 
transport chain geneset was enriched in all three training types (figure 3.4E). Interestingly, 
genes within this geneset showed larger variation and more modest induction by 
combined exercise training as compared with resistance and endurance exercise training. 
The PPAR signalling pathway was only significantly enriched in endurance exercise 
training. This enrichment is caused by a small set of highly induced PPAR targets (figure 
3.4F). Some of those PPAR targets were also induced by combined exercise training alone 
or by both resistance and combined exercise training (PPARG, FABP4, CPT1C, ACSL5, PLTP, 
ILK). The induction of those genes was in almost all cases lower in combined exercise 
training as compared with endurance exercise training. Genes within genesets of the 
TCA cycle (figure 3.4C) and fatty acid oxidation (figure 3.4D) showed a clear induction 
by endurance exercise training. The TCA cycle geneset was also significantly enriched in 
resistance exercise training. Genesets of the TCA cycle and fatty acid oxidation were not 
significantly enriched in combined exercise training, and genes within these genesets 
showed minor and variable changes in expression.  
DISCUSSION
We are the first to compare gene expression profiles of combined exercise training with 
expression profiles of resistance and endurance exercise training. Our results showed 
a substantial overlap between gene expression profiles of combined and endurance 
exercise training, whereas the overlap between combined and resistance exercise training 
was less pronounced. Despite the substantial overlap between the three training types, 
each of the training types had a specific gene expression signature. The expression 
signature of combined exercise training was characterized by fewer and smaller changes 
in oxidative metabolism as compared with endurance exercise training.
In this study we showed that the gene expression profile of combined exercise training 
overlapped more with the profile of endurance exercise training then with the profile of 
resistance exercise training. A similar pattern is seen in literature for other physiological 
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adaptations induced by exercise training [12]. For example, combined exercise training 
increased VO2max and time to exhaustion and these increases were comparable to 
adaptations induced by endurance exercise training [13]. Combined exercise training 
increased strength, however to a lesser extent then in resistance exercise training [14]. 
The predominance of endurance exercise training effects in combined exercise training 
effects was probably caused by a relatively larger fraction of endurance sessions over 
resistance sessions [13]. In this study combined exercise training also consisted of two 
endurance exercise sessions and one resistance exercise session per week, explaining 
why the gene expression profile of combined exercise training overlapped more with 
the profile of endurance exercise training. 
Despite an substantial overlap between the three training types, each of the training 
types had a specific gene expression profile. The distinct gene expression profiles of the 
three different training types indicate that each type of exercise training elicits unique 
molecular adaptions. Interestingly, the genes MXRA5 and COL4A1 were the only genes 
present in the top 30 of all three training types. This presence can indicate that these 
genes can be markers of exercise training. Currently there is very limited data on the 
function of MRXA5 besides it being linked to and serving as potential biomarker for 
colorectal cancer [15,16]. Inspection of BioGPS (www.biogps.org) showed that MXRA5 
is weakly expressed in skeletal muscle under baseline conditions, when compared with 
small intestine and colon. MRXA5 was linked to Duchenne muscular dystrophy in a large 
scale genetic screening study [17], suggesting an potential role in muscle development. 
COL4A1 is a certain type of collagen that is in cooperated into the membrane of cells 
and is linked to angiopathy and haemorrhagic stroke [18]. Mutations in the COL4A1 
gene are thought to play a role in the HANAC syndrome (hereditary angiopathy with 
nephropathy, aneurysm, and muscle cramps[19]). In skeletal muscle COL4A1 is linked 
to myopathy [20]. Similar to MRXA4, baseline expression of COL4A1 in skeletal muscle 
is low (www.biogps.org). 
To gain more insight in the processes changed by the different types of exercise 
training, we performed a GSEA. This GSEA showed that in resistance exercise training 
many oxidative genesets were enriched. This finding is not completely in line with 
expectations based on literature. In general it is suggested that resistance exercise 
training induces changes in genes involved in protein degradation, angiogenesis and 
growth [4,21]. Gordon et al. [4] showed that genes involved in glucose metabolism and 
oxidative phosphorylation were downregulated after resistance exercise training [4], 
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while we showed a clear enrichment in genes involved in oxidative phosphorylation. The 
differences in outcome can be explained by the timing of the muscle biopsies. Gordon 
et al. performed the biopsies 4h after an acute exercise bout, while in the study we 
performed the biopsies were taken at least 48h after the last acute exercise bout. Both 
studies thus assessed a different type of response. Gordon et al. assessed the effect of 
training on the acute exercise gene expression response. This response was reduced for 
gene expression of genes involved in oxidative phosphorylation. This finding does not 
give any information about the effect of resistance exercise training on baseline levels, 
it can even be hypothesized that the reduced response size is caused by increased 
baseline levels. We assessed the effect of training on baseline gene expression levels and 
found that baseline levels of gene involved in oxidative phosphorylation were increased. 
Another interesting finding was that genesets involved in neuronal adaptations were 
enriched in resistance exercise training. This would explain many of the neuronal 
adaptations after resistance exercise training.
The analysis performed in this study were limited to gene expression changes. Health 
or physiological parameters were not measured. We concluded from the results that 
PPAR signalling and fatty acid oxidation were only weakly activated by combined 
exercise training when compared with endurance exercise training. It is known that 
PPAR signalling plays a crucial role in the improvements in dyslipidaemia and insulin 
sensitivity after exercise in skeletal muscle [22-24]. The limited induction of PPAR 
targets might therefore have important implications for the positive health effects 
of combined exercise training. Also the reduced enrichment of genesets involved in 
oxidation hold an important message, namely that oxidative capacity in skeletal muscle 
might show reduced adaption in combined exercise training compared to endurance 
exercise training. This is important in a context of health, since Sparks et al. [25] showed 
that combined exercise training increased mitochondrial capacity in diabetes type 2. 
For future research it is therefore important to assess the adaptive consequences for 
exercise-induced improvements in metabolic disease of a gene expression signature that 
is less oxidative in combined exercise training compared to the signature of endurance 
exercise training. This remark is supported by the literature assessing the muscle fibre 
type – fiber size paradox showing that there is an inverse relation between the size of a 
muscle and its oxidative capacity [26]. Muscle fibres stimulated to induce hypertrophy 
and increase oxidative capacity increased these properties to a lesser extent compared 
to fibres stimulated to induce hypertrophy or increased oxidative capacity alone.
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Combined exercise training is advised and performed based on research showing a more 
beneficial effect on metabolic diseases compared to endurance and resistance exercise 
training alone [27]. In addition, many endurance athletes perform complement their usual 
training schedule with additional resistance exercise training to gain better performance. 
Several studies assessing the addition of resistance exercise training to the training 
program of (elite) endurance athletes showed increased endurance performance [28-30]. 
This increased performance was characterized by increased cycling economy, but not 
increased VO2max [28-31]. Furthermore training power and muscle size were increased by 
the added resistance exercise [28,29]. The increased cycling economy points to neuronal 
optimization as one of the most important factors that result increased performance. As 
stated previously, in this study we showed that combined exercise training had a clearly 
less oxidative signature compared to endurance exercise training. These findings might 
hold an important message for sports practice, namely that combining resistance and 
endurance exercise training might interfere with the oxidative adaptations induced by 
endurance exercise training alone. Important here to note is that the subject populations 
of studies on combined exercise training in sport sciences are very different from the 
subject populations used in studies related to health.
There are some factors that might have influenced the results of the study. Our analysis 
included three studies that differed in other parameters besides the type of exercise. 
First, the number of subjects differed between the studies. Second, subjects participating 
in the combined exercise training intervention were middle-aged, while the subjects 
in the other exercise training interventions were relatively young. Third, the subjects of 
the combined exercise training study were healthy but overweight while subjects in the 
other studies had normal weights. Finally, the timing of the muscle biopsies after the 
last exercise session differed across the studies. All these factors can have influenced 
the outcomes of this study. This study is performed as a first pilot and clearly shows the 
importance of a comparison between the three types of exercise training. The limitations 
of this study implicate that no strong conclusions can be made from the results of this 
study, but give direction for future research. 
We conclude that despite the large overlap in gene expression between combined, 
endurance and resistance exercise training, each of the training types had an unique 
gene expression signature, indicating that each training type induced specific molecular 
changes. The minimal activation of oxidative and PPAR related pathways by combined 
exercise training might have implications for the use of combined exercise training in 
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the context of metabolic disease and sports. It can be hypothesized that addition of 
resistance exercise training potentially interferes with the positive effects of endurance 
exercise training on the gene expression profile of skeletal muscle. This hypothesis is an 
interesting topic for future research.
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Supplemental figure S3.1 GSEA enrichment maps of combined exercise training compared with 
endurance (A) and resistance (B) exercise training. Red is enriched, blue is depleted. The inner parts 
of the circles represent combined exercise training, the outer parts endurance (A) or resistance (B) 
exercise training.
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ABSTRACT
Regular physical activity positively influences whole body energy metabolism and 
substrate handling in exercising muscle. While it is recognized that the effects of 
exercise extend beyond exercising muscle, it is unclear to what extent exercise impacts 
non-exercising muscles. Here we investigated the effects of an acute endurance 
exercise bout on gene expression in exercising and non-exercising human muscle. 
To that end, 12 male subjects aged 44-56 performed one hour of one-legged cycling 
at 50% Wmax. Muscle biopsies were taken from the exercising and non-exercising 
leg before and immediately after exercise and analyzed by microarray. One-legged 
cycling raised plasma lactate, free fatty acids, cortisol, noradrenalin, and adrenalin 
levels. Surprisingly, acute endurance exercise not only caused pronounced gene 
expression changes in exercising muscle but also in non-exercising muscle. In the 
exercising leg the three most highly induced genes were all part of the NR4A family. 
Remarkably, many genes induced in non-exercising muscle were PPAR targets or 
related to PPAR signalling, including PDK4, Angptl4 and SLC22A5. Pathway analysis 
confirmed this finding. 
In conclusion, our data indicate that acute endurance exercise elicits pronounced 
changes in gene expression in non-exercising muscle, which are likely mediated by 
changes in circulating factors such as free fatty acids. The study points to a major 
influence of exercise beyond the contracting muscle. 
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INTRODUCTION
Regular exercise training is generally recognized as a powerful preventive and therapeutic 
strategy for diseases such as type 2 diabetes, obesity and cardiovascular disease. At 
a systemic level, regular exercise training improves cardiac and lung function [1,2,3], 
reduces the amount of adipose tissue [4], increases muscle mass [5,6,7], and decreases 
liver fat [8,9], representing chronic adaptations to repeated exercise bouts. Interestingly, 
the observation that unilateral training also improves strength in the immobilized or 
untrained limb indicates that the beneficial effects of exercise are not limited to the 
tissues directly engaged in exercise [10,11,12].
Immediately upon initiation of exercise, local demand for ATP, oxygen, glucose and fatty 
acids increases dramatically. These demands are accommodated by rapid changes in 
skeletal muscle activity of key enzymes and transporters involved in glucose and fatty 
acid oxidation via allosteric regulation and phosphorylation of rate-limiting enzymes. 
In addition, regulation at the mRNA level importantly contributes to the acute response 
and chronic adaptations to exercise. A large number of studies have shown that acute 
exercise induces genes involved in a variety of processes, including energy metabolism, 
hypertrophy and signalling [13,14,15,16,17,18,19,20,21]. Whole genome mRNA profiling 
has confirmed these findings, revealing major changes in skeletal muscle gene expression 
from 1 hour to even 48 hours after cessation of exercise [22,23,24,25]. All efforts to 
characterize exercise-induced changes in mRNA have so far focused on the exercising 
muscle. To what extent exercise influences gene expression in non-exercising muscles 
remains completely unclear. Conceivably, exercise may elicit changes in gene expression 
in non-exercising muscle via circulating mediators and metabolites. Such a mechanism 
may provide a conceptual framework for the impact of exercise on non-contractile tissues 
such as liver. In the present study, we have employed the one-legged exercise model and 
pre- and post-exercise muscle biopsies to study the acute effects of exercise on whole 
genome gene expression in exercising and resting human skeletal muscle. The results 
reveal that acute endurance exercise elicits pronounced changes in gene expression in 
non-exercising muscle, which are likely mediated by changes in circulating factors such 
as free fatty acids (FFA).
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SUBjeCTS AND meThODS
Subjects
Twelve healthy middle-aged men (age 51.5 ± 5.1 years, body weight 88 ± 17 kg, body 
mass index 26 ± 4) participated in the study. All subjects exercised less than 4 hours per 
week. Anthropometric parameters, VO2max and Wmax (1 and 2 legged) values can be found 
in table 4.1. The study was approved by the medical ethical committee of Wageningen 
University and all subjects received oral and written information about the experimental 
procedures and provided written informed consent.
Table 4.1 Subject characteristics (n = 12)
Age (years) 52 ± 5
Length (cm) 184 ± 5
Weight (kg) 88 ± 17
BMI (kg/m2) 26 ± 4
Rest HR (bpm) 60 ± 11
Maximum HR (bpm) 170 ± 17
VO2max (ml/min/kg) 35 ± 10
VO2peak 1 leg (ml/min/kg) 28 ± 10
Wmax 1 leg (watts) 164 ± 37
Wmax 2 legs (watts) 260 ± 64
HR = heart rate, BMI = body mass index, VO2max = maximum oxygen uptake, VO2peak = peak oxygen uptake, 
Wmax = maximum work load.
experimental design
All subjects performed a single 60 minutes experimental endurance exercise bout, which 
was preceded by two preliminary exercise tests and two familiarization trials (figure 4.1A). 
During the endurance exercise bout subjects had to perform one-legged cycling on a 
cycle ergometer (Excalibur Sport, Lode, Groningen NL) adapted with a custom-made 
leg support. Skeletal muscle biopsies were taken from both legs immediately before 
and shortly after exercise.
Preliminary exercise tests
Two graded cycling exercise tests to exhaustion were performed, the first with both legs, 
the second with one leg (Excalibur Sport, Lode, Groningen NL). The first two-legged 
exercise test was used to determine the subjects’ maximum aerobic capacity (VO2max; 
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table 4.1), while the second test was used to determine maximum workload of the 
dominant experimental leg (Wmax-1-leg; table 4.1). Both tests started at a set workload 
(100 watt 2 legs, 20 watt 1 leg), which increased gradually until exhaustion (15 watts per 
minute 2 legs, 10 watts per minute 1 leg), determined as the participant not being able to 
continue cycling at 60 rounds per minute for longer than 15 seconds. Respiratory quotient 
(RQ) was above 1 at the end of the test in all subjects. During the tests oxygen uptake 
(VO2) and heart rate (HR) were measured (Oxycon Pro, Jaeger, Hoechberg, Germany). 
The tests were performed at the same ergometer as the endurance exercise bout and 
familiarization trails and were completed at least 14 days before the endurance exercise 
bout and 3 days apart to avoid a training effect. The day prior to both tests subjects were 
asked to refrain from alcohol and heavy exercise.
Familiarization trials
All participants were unfamiliar with one-legged exercise. Therefore the two familiariza-
tion trials were performed before the endurance exercise bout to make sure that subjects 
became familiar with one-legged cycling (figure 4.1A). The familiarization trials consisted 
of 20 minutes of one-legged cycling at a self-chosen workload. All subjects performed 
the one-legged exercise with the dominant leg, which was determined via a number of 
daily life related questions.
experimental endurance exercise bout
Subject refrained from heavy exercise the last 4 days prior to the experimental day. The 
last day before the experimental exercise bout subjects received a standardized evening 
meal and refrained from alcohol. On the morning (8.15h) of the experimental test subjects 
reported to the research facility, after an overnight fast (>10 hours). The experimental 
exercise bout consisted of 60 min one-legged cycling at 50% of the one-legged Wmax. 
Before (T0) and shortly after (T1) the exercise a venous blood sample was drawn and 
muscle biopsies were taken from both legs (see figure 4.1B). Two hours after cessation 
of the exercise a third blood sample was taken (T3). During the experimental exercise HR 
was recorded continuously. Subjects remained fasted until after the last blood sampling, 
but were allowed to drink water ad libitum. 
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Blood samples
Blood was collected in EDTA containing tubes. The samples were immediately centrifuged 
at 1000g at 4°C for 10 minutes, after which plasma was stored in -80°C until further 
analysis. Blood samples were analysed for free fatty acids (Centre for Medical Diagnostics 
(SHO), Velp, NL), glucose, triglycerides, cortisol, lactate (Gelderse Vallei hospital, Ede, NL), 
catecholamines (laboratory of clinical chemistry, Radboud Medical Center, Nijmegen, 
NL), and insulin (enzyme-linked immunosorbent assay, Mercodia, Uppsala, Sweden).
muscle biopsies
Percutaneous needle biopsies were taken before (T0) and shortly after (T1) exercise 
from the vastus lateralis muscle from both legs (4 biopsies in total), using the Bergström 
technique with suction [26]. Skin was anesthetized with Xylocaine 2% with Adrenaline. 
All biopsies were taken from a separate incisions. There was at least a 2 cm gap between 
the biopsies of T0 and T1 to prevent influence of the earlier biopsy. The second biopsy 
from the same leg was taken from a more proximal position. Pre-exercise biopsies were 
taken just before the exercise; post-exercise biopsies within 30 minutes after termination 
of the exercise bout, on average it took ~15 minutes before the first post-exercise biopsy 
was taken. Biopsies of the exercising leg were taken first, followed shortly afterwards 
Figure 4.1 Experimental design. The timeline of the study (A) and set-up of the endurance exercise 
bout (B). After 2 familiarization trails and 2 exercise tests, subjects performed 1 hour of submaximal 
one-legged endurance exercise. Before and after the exercise bout muscle biopsies and venous blood 
samples were taken, and another blood sample was taken 2 hours after the end of exercise.
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by the biopsy of the non-exercising leg. After each biopsy, the collected tissue sample 
was carefully cleared from visible adipose tissue and blood and divided into four pieces. 
Three pieces were directly frozen into liquid nitrogen and one piece was embedded 
into Tissue-Tek O.C.T. compound (Sakura Tissue Tek, Alphen a/d Rijn, NL) and frozen in 
liquid-nitrogen cooled isopentane, and stored at -80°C for further analysis. We were not 
able to collect muscle biopsies of one of the participants due to hypersensitivity of the 
participant to the biopsy procedure. 
RNA extraction
Total RNA was isolated from the skeletal muscle tissue by using Trizol reagent (Invitrogen, 
Breda, NL). Thereafter RNA was purified using the Qiagen RNeasy Micro kit (Qiagen, 
Venlo, NL) and RNA quality was checked using an Agilent 2100 bioanalyzer (Agilent 
Technologies, Amsterdam, NL). 
microarray processing
Total RNA (100 ng) was labelled using an Ambion WT expression kit (Life Technologies, 
Bleiswijk, The Netherlands) and hybridized to human whole genome Genechip Human 
Gene 1.1 ST arrays coding 19,732 genes, (Affymetrix ,Santa Clara, CA). Sample labelling, 
hybridization to chips and image scanning was performed according manufacturer’s 
instructions.
microarray data analysis
Microarray analysis was performed using MADMAX pipeline for statistical analysis of 
microarray data [27]. Quality control was performed and all arrays met our criteria, 
except arrays from 2 participants that showed a clearly distinct clustering and pattern 
after normalization. Those microarrays were excluded from further analysis. For further 
analysis a custom annotation was used based on reorganized oligonucleotide probes, 
which combines all individual probes for a gene [28]. Expression values were calculated 
using robust multichip average (RMA) method, which includes quantile normalisation 
[29]. Microarray data were filtered, and probe sets with expression values higher than 
20 on more than 5 arrays were considered to be expressed and selected for further 
statistical analysis. In addition, an Inter Quartile Range (IQR) cut-off of 0.2 was used to 
filter out genes that showed no variation between the conditions. Significant differences 
in expression were assessed using Intensity-Based Moderated T-statistic (IBMT [30]). 
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Genes were defined as significantly changed when the p value was < 0.01. Differences 
in gene expression between the legs were determined using a paired IBMT test on the 
difference between T0 and T1 for both legs (p < 0.05). 
Two subjects (4 and 8) were classified as outliers based on their aberrant response to 
exercise in the non-exercising leg. In subject 4 and 8, expression of 6 out of the 10 most 
highly upregulated genes was higher than the average plus two times the standard 
deviation. Accordingly, the analysis was repeated without these two subjects.
All microarray data are MIAME compliant and have been submitted to the Gene 
Expression Omnibus (accession number GSE41769).
Pathway analysis 
Geneset enrichment analysis (GSEA; http://www.broad.mit.edu/gsea/) was performed 
for both legs using MADMAX and genesets with a false discovery rate (FDR) < 0.2 were 
considered significantly enriched. Possible transcription factors playing a role in the 
activation and inhibition of genes were identified using Ingenuity Pathway Analysis (IPA; 
Ingenuity Systems, Redwood City, CA). The ClueGO plugin in Cytoscape was used for 
gaining insight into processes activated during exercise in both legs [31,32].
cDNA synthesis and quantitative real time PCR 
Total RNA was reverse transcribed with a cDNA synthesis kit (Promega, Leiden, NL). 
Standard qPCR was performed using SensiMix real time PCR reagents (Bioline, London, 
UK) and a Bio-Rad CFX384 machine (Bio-Rad laboratories, Veenendaal, NL). Primer 
sequences were based on availability in the PRIMERBANK (http//pga.mgh.harvard.edu/
primerbank/index.html) and can be found in table 4.2. qPCR data were normalized using 
GAPDH as housekeeping gene for the human samples, since it was shown to be stable 
within skeletal muscle during exercise [33], and was stable between the time points 
according to our microarray analysis. 
Statistical analysis
Statistical analysis for the plasma parameters and qPCR results were performed using 
SPSS (version 18, SPSS, Chicago, IL). Differences between the different time points 
for the plasma parameters (TG, glucose, FFA, lactate, insulin, cortisol, adrenaline and 
noradrenaline) were determined using a repeated measure one-way ANOVA. Differences 
between T0 and T1 in qPCR were evaluated using a paired t-test, differences between the 
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legs in qPCR were evaluated using a paired t-test for the changes between T0 and T1 in 
each leg. Data are mean ± standard deviation and p < 0.05 was considered statistically 
significant.
ReSULTS
Systemic effects of one-legged exercise 
Subjects performed one-legged exercise for one hour at 50% of their maximal workload 
with an average heart rate during the last five minutes of 132 ± 18 beats per minute. 
The percentage heart rate reserve (%HRR) during the last 5 minutes was 65 ± 12.5% 
(figure 4.2). Plasma glucose and triglyceride (TG) levels were not altered by one-
legged cycling, while plasma FFA and lactate increased at T3, but mostly returned to 
baseline at T3 (figure 4.2). Insulin, cortisol and noradrenalin increased during exercise, 
with insulin and cortisol returning to baseline at T3 (figure 4.2). Adrenalin tended to 
increase during exercise, although the increase was not statistically significant (p = 0.08; 
figure 4.2). 
Table 4.2 Primer sequences used for qPCR
Gene name Primer sequence
NR4A1-F            ATGCCCTGTATCCAAGCCC
NR4A1-R           GTGTAGCCGTCCATGAAGGT
NR4A2-F      GTTCAGGCGCAGTATGGGTC
NR4A2-R         AGAGTGGTAACTGTAGCTCTGAG
NR4A3-F           CAGCACTGAGATCACGGCTAC
NR4A3-R     CCCTCCACGAAGGTACTGATG
FOS-F         CACTCCAAGCGGAGACAGAC
FOS-R                AGGTCATCAGGGATCTTGCAG
JUNB-F              CCTACCGGAGTCTCAAAGCG
JUNB-R     CGAGCCCTGACCAGAAAAGTA
GAPDH-F GAAGGTGAAGGTCGGAGTC
GAPDH-R GAAGATGGTGATGGGATTTC
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One-legged cycling exercise altered gene expression in skeletal muscle of 
the exercising and non-exercising leg
We first ruled out that there was a significant difference in baseline expression between 
the two legs. Only eight out of 19,732 genes were found to be significantly different 
between the two legs at baseline (p < 0.01; supplemental table S4.1). 
Statistical comparison of the baseline and post-exercise samples revealed that in the 
exercising leg (E) one-legged exercise significantly changed expression of 938 genes (p 
Figure 4.2 Exercise increases heart rate and plasma levels of FFA, insulin, cortisol and noradrenaline. 
Heart rate reserve (%) was calculated based on the heart rate measured during the exercise (n = 12). 
Plasma glucose, triglyceride, free fatty acids, lactate, insulin, cortisol, adrenaline and noradrenaline 
were measured before and after exercise (T0 and T1; n = 12) and after 2 hours of recovery (T3; n = 12). 
a = p <0.05 compared to T0, b = p < 0.5 compared to T3, c = p < 0.1 compared to T0, p < 0.1 compared 
to T3, repeated measures ANOVA. Depicted is mean ± SEM.
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< 0.01), with the majority of genes being upregulated (figure 4.3A and D). The number 
of genes significantly changed by exercise in the non-exercising leg (NE) was lower 
but still remarkably high (p < 0.01; 516 genes), and also here the majority of genes was 
upregulated (figure 4.3A and C). Intriguingly, the majority of genes altered in the non-
exercising leg were also altered in the exercising leg (figure 4.3A). Overall, the data indicate 
that a single exercise bout of exercise caused marked changes in gene expression not 
only in exercising muscle, but also in non-exercising muscle and that exercise mainly 
promotes upregulation of gene expression. 
To gain more insight into the changes induced by exercise, genes were subsequently 
ranked according to mean fold-change in expression in the exercising leg and the 
changes in expression compared between the individual subjects (figure 4.4A, left panel). 
Expression changes of the same set of genes in the non-exercising leg are presented 
in parallel (figure 4.4A, right panel). Remarkably, the most highly induced genes in the 
exercising leg are the three members of the nuclear receptor subfamily NR4A. Of the 20 
most highly induced genes in the exercising leg, 17 were also significantly upregulated 
in the non-exercising leg although to a lesser extent. Figure 4.4A clearly illustrates the 
marked inter-individual variation in response to exercise in the non-exercising leg. 
qPCR of selected genes largely confirmed the results of the microarray (supplemental 
figure S4.1).
To examine the impact of exercise on gene expression in parts of the body not directly 
influenced by exercise, we next focused our attention on genes upregulated in the non-
exercising leg. Similarly to the exercising leg, genes were ranked according to mean fold-
change in the non-exercising leg (supplemental figure S4.2, left panel) and changes in the 
exercising leg are shown in parallel (supplemental figure S4.2, right panel). Many of the 
most highly upregulated genes in the non-exercising leg were also highly induced in the 
exercising leg (supplemental figure S4.2). The two most highly upregulated genes were 
again NR4A2 (FC = 5.3) and NR4A3 (FC = 4.5). Importantly, subject 4 and 8 both showed 
a distinct profile from the other subjects illustrated by marked induction of numerous 
genes in the non-exercising leg that are not shared with other subjects. Based on the 
notion that gene expression was clearly distinctive from other subjects and using specific 
criteria outlined in the methods, we classified them as outliers and repeated statistical 
analysis without subject 4 and 8. We suspect that these subjects engaged in involuntary 
(isometric) contractions or other type of stimulation of the non-exercising leg. Removal 
of both subjects markedly reduced the number of significantly changed genes (209 vs. 
Gene expression in resting and exercising muscleChapter 4
80
Fi
gu
re
 4
.3
 E
xe
rc
ise
 m
ai
nl
y c
au
se
s u
pr
eg
ul
at
io
n 
of
 g
en
e e
xp
re
ss
io
n 
in
 b
ot
h 
th
e e
xe
rc
isi
ng
 a
nd
 n
on
-e
xe
rc
isi
ng
 le
g.
 (A
) V
en
n 
di
ag
ra
m
 o
f s
ig
ni
fic
an
tly
 re
gu
la
te
d 
ge
ne
s a
nd
 th
ei
r o
ve
rla
p.
 (B
) F
lo
w
ch
ar
t o
f m
ic
ro
ar
ra
y 
an
al
ys
is.
 H
ea
tm
ap
s o
f a
ll 
si
gn
ifi
ca
nt
 g
en
es
 in
 th
e 
no
n-
ex
er
ci
si
ng
 (C
) a
nd
 e
xe
rc
is
in
g 
le
g 
(D
) a
nd
 n
um
be
r 
of
 g
en
es
et
s s
ig
ni
fic
an
tly
 re
gu
la
te
d 
by
 e
xe
rc
is
e 
in
 b
ot
h 
le
gs
. n
 =
 9
, I
Q
R 
= 
in
te
rq
ua
rt
ile
 ra
ng
e.
G
ene expression in resting and exercising m
uscle
Chapter 4
81
4516 genes). Furthermore, the overlap in gene regulation between the exercising and 
non-exercising leg decreased from 285 to 85 genes. After removing subject 4 and 8, many 
of the most highly upregulated genes in the non-exercising leg were characterized by 
lower induction in the exercising leg. Other genes showed similar fold-induction in the 
exercising and non-exercising leg, including ZNF750, PDK4, KLF10, and SLC22A5 (figure 
4.4B), which are established or suspected target genes of PPARs [34]. 
Figure 4.4 Top 20 of most highly induced genes in exercising and non-exercising leg. (A) Left panel 
shows the top 20 of upregulated genes in the exercising leg (n = 9), right panel the corresponding genes 
in the non-exercising leg. (B) Left panel shows the top 20 of upregulated genes in the non-exercising 
leg (n = 7), right panel the corresponding genes in the exercising leg. Green is a signal log ratio of -3, 
red a signal log ratio of 3. Values are displayed per subject to visualize inter-individual differences. FC 
= fold change, * = p < 0.05, # = p < 0.1 between exercising and non-exercising leg.
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Processes during one legged cycling in the exercising leg and non-exercising 
leg
We suspected that exercise-induced changes in gene expression were mediated by 
specific transcription factors. To identify these transcription factors and to identify 
pathways regulated by exercise, we performed Ingenuity pathway analysis (IPA) (figure 
4.5 and supplemental table S4.2). IPA uses information from literature combined with 
gene expression changes to predict a role of transcription factors in the dataset. The most 
significant set of target genes in the exercising leg was the set controlled by CREB1. CREB1 
and also ATF4 (lower in the list) are both induced by cAMP and mediate cAMP-dependent 
gene regulation. SREBF1, SREBF2 and NR1H3 (LXR) are all involved in lipid and especially 
cholesterol homeostasis and have extensive cross-talk. Other sets of target genes shown 
in figure 4.5 are involved in growth (sets under control of STAT3, FOXO1, NOTCH1, MYC 
and NR3C1) and inflammation (sets under control of NR3C1 and STAT3). HIF1A is a major 
regulator in the adaptive responses to hypoxia. 
The only significant set of target genes in the non-exercising leg was the set controlled by 
PPARα, which is consistent with the marked upregulation of several existing and putative 
PPARα target genes (supplemental table S4.2). Since PPARα is activated by fatty acids [35], 
these data point to a role of elevated plasma FFA levels in exercise-induced changes in the 
non-exercising leg, and to a lesser extent in the exercising leg, as other processes seem to 
play a more pronounced role there. 
To further determine the biological processes activated during exercise, we used ClueGO 
and GSEA. ClueGO integrates GO categories and creates a functionally organized GO 
category networks based on the overlap between the different GO categories and the 
significance [31]. According to ClueGO analysis, a substantial number of processes was 
induced during exercise in both legs (figure 4.6). In the exercising leg the important 
processes were growth and development of skeletal muscle, neurons and vessels, 
metabolism (mostly basal and protein metabolism) and transcriptional regulation (figure 
4.6A). Also kinase cascade and signalling were induced. GSEA showed an comparable 
picture, with upregulation of genesets involved in growth (hypertrophy model), MAPK 
signalling and stress response (AP1 pathway; supplemental figure S4.3). ClueGO revealed 
that most processes induced by exercise in the non-exercising leg are involved in basal 
metabolism and signalling/transport (figure 4.6B). GSEA showed a clear upregulation of 
PPAR target genes, (cytokine) signalling and growth and stress response (hypertrophy & 
AP1 pathway; supplemental figure S4.3).  
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DISCUSSION
Here we used the one-legged exercise model to study the effect of acute endurance 
exercise on whole genome muscle gene expression and determine the relative 
importance of systemic versus local contraction-related stimuli. We found that acute 
exercise induced immediate and dramatic gene expression changes in the exercising 
leg, with the most dramatic inductions observed for the NR4A family. Strikingly, acute 
exercise also caused substantial gene expression changes in non-exercising leg. Overall, 
our data indicate that the molecular responses to acute exercise are not confined to 
the exercising muscle but also extend to resting muscle. The notion that exercise alters 
gene expression in non-exercising muscles is new. Our data provide a conceptual and 
molecular framework for the observation that immobilized muscle can experience 
Figure 4.5 Induction of transcription factor pathways by exercise. Transcription factor pathways 
related to growth, stress response, cAMP signalling and hypoxia were induced by exercise. Transcription 
factor pathways were identified for the exercising leg using IPA and are displayed in a bar diagram. 
Genes induced by exercise for the different transcription factors can be found in supplemental table S4.1. 
Transcription factors with a z-score above 1.5 (or under -1.5) are considered as biologically relevant.
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favourable metabolic adaptations in response to repeated contractile activity in non-
immobilized muscle [10,11,12]. 
In general, changes in gene expression in non-exercising muscle were less pronounced 
compared to the exercising muscle, both in magnitude of fold-changes and number of 
genes changed. A relatively small number of genes, many of which represent known 
target genes of the PPAR transcription factors including Angptl4, KLF10, SLC22A5, 
ZNF750, PDK4, was induced equally in exercising and non-exercising muscle. PPARs play 
a key role in regulation of lipid metabolism in a variety of tissue, including skeletal muscle 
[36]. Ingenuity pathway analysis and GSEA further indicated significant enrichment 
of PPAR target genes in set of genes upregulated in the non-exercising leg. Induction 
of PPARα targets is expected to lead to enhanced fatty acid oxidation as an acute but 
perhaps also adaptive response to endurance exercise. Inasmuch as plasma FFA levels 
go up during exercise and fatty acids are known ligands of PPARs and Angptl4 and 
PDK4 [37,38], our data may point to an important role of elevated FFAs as systemic 
factor driving gene expression changes in exercising and non-exercising muscle 
during exercise. One gene (Angptl4) was more highly induced in the non-exercising leg 
compared to the exercising leg. Detailed exploration of the regulation and role of Angptl4 
during exercise will be reserved for a future publication. Apart from FFAs, it could be 
hypothesized that other factors including other metabolites and circulating hormones 
may also impact gene expression in non-exercising muscle. NR4A transcription factors 
are known to be regulated via β-adrenergic signalling [39]. Elevated catecholamines 
(via sympathetic innervation or via the circulation) may at least partially account for 
the induction of NR4A genes in the exercising leg, which was supported by Ingenuity 
Pathway Analysis showing the CREB1 pathway as most significant transcription factor 
pathway. However, even though circulating levels of catecholamines were increased, 
expression of NR4A genes was not increased in the non-exercising leg, indicating only a 
minor role of catecholamines in the non-exercising leg. It can be hypothesized that gene 
expression changes in the non-exercising leg may also be elicited by myokines secreted 
from the exercising leg. In a future publication we will address the impact of exercise on 
secretion of myokines using a so called secretome approach followed by measurement 
of numerous potentially novel and existing myokines in plasma. However, this type of 
analysis is beyond the scope of the present manuscript.  
We are the first to use microarray to assess the immediate effect of acute endurance 
exercise on human skeletal muscle gene expression. Prior studies focused on the recovery 
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after exercise [22,24,25], or used animal models [22,23]. Exercise causes immediate 
perturbations of homeostasis that are gradually restored during recovery. Based on this 
notion, it can be suspected that changes in gene expression elicited by exercise gradually 
fade out during post-exercise recovery. In support, in our study a total of 938 genes was 
altered post-exercise in the exercising leg, whereas previously 173 genes were found to 
be increased 3 hours after termination of exercise and 37 genes 48 hours after exercise 
[24]. However, direct comparison is complicated by the use of different array platforms 
and statistical cut-offs. Mahoney et al. [24] used an custom made array, and only signal 
log ratios were available, which did not allow us to use the same statistical cut-off.
Many of the observed exercise-induced changes in gene expression are likely part of an 
acute stress response related to disturbances in homeostasis elicited by exercise. The 
most highly induced genes in the exercising leg were all members of the NR4A family, 
a subgroup of orphan receptors within the nuclear receptor superfamily. NR4A1 and 
NR4A3 have been reported to be upregulated shortly after acute exercise and during 
recovery in rat [40,41], pig [23], and human [24], and this upregulation likely occurs 
locally by contractile stimuli [40]. This finding was confirmed by our study in which we 
observed an upregulation of NR4As in the exercising, but not in the non-exercising leg. 
NR4A transcription factors are also known to be induced by adrenaline and noradrenaline 
[39]. Circulating adrenalin and noradrenalin levels were increased in our study but 
must exert only a minor effect as NR4As were exclusively induced in the exercising leg,. 
Upregulation of NR4A2 has been observed once in human but its role during exercise 
is unknown [24]. NR4A1 and 3 are thought to play a key role in regulating energy 
metabolism and early adaptation [42,43,44]. Combined analysis of our study and the 
study of Mahoney et al. suggests that NR4A2 is induced immediately during exercise 
and decreases relatively quickly after exercise during recovery, whereas NR4A3 shows 
a different pattern characterized by a relative small induction during exercise followed 
by a large induction in the recovery phase (supplemental figure S4.4 [24]). The results 
may imply that NR4A family might play an important role in the regulation of metabolic 
responses after exercise.  
Unlike in other subjects, in two subjects the overall magnitude of gene expression 
changes in the exercising and non-exercising leg were very similar. It is unclear how such 
an extreme response can occur in a resting leg that was not engaged in any concentric 
contractions. We cannot completely exclude these two subjects performed significant 
isometric contractions in the non-exercising leg, although subjects were instructed not 
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to. Alternatively, a potential role for (involuntary) neural stimulation muscles may be 
envisioned. It is known that neural stimulation can induce gene expression changes via 
increased calcium concentrations in the skeletal muscle [45,46,47], as well as via other 
mechanisms [48]. Since energy utilization and metabolic flux must have been much 
lower in the non-exercising leg, which showed gene expression changes comparable 
to the exercising leg, it can be inferred that the majority of gene expression changes are 
unrelated to metabolic flux. The exception are genes induced similarly in the exercising 
and non-exercising leg in all subjects. 
One-legged cycling is frequently used as a model to enable direct comparison between 
exercising and resting muscle. Earlier studies encountered problems with repeated 
biopsies, showing inflammatory gene expression changes induced by repeated biopsies 
[49] . Other studies showed no effect of repeated biopsies on gene expression [50]. 
The main difference between these studies is that the study that did show an effect of 
repeated biopsies on gene expression used one incision for all biopsies [49], whereas the 
other study showing no effect performed new incisions for each biopsies [50], analogous 
to our protocol. This indicates that separate incisions might be crucial for reducing the 
effect of repeated biopsies, which was also verified by the lack of inflammatory genes 
changed in the resting muscle in our study. 
In conclusion, exercise has profound effects on gene expression in human skeletal 
muscle, not only in exercising muscle but also in resting muscle. The latter effects are 
likely mediated by changes in circulating factors such as FFA and may explain why 
muscles not involved in the exercise movement may undergo favourable adaptations 
in response to exercise.
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Supplemental figure S4.1 qPCR confirming microarray results of NR4A family, JUNB and FOS (n = 
11). Fold changes of both legs are displayed, which are calculated by dividing the post-exercise by the 
baseline sample for both legs. Before expression values were normalized by the housekeeping gene 
GAPDH. * = p < 0.01. Depicted is mean ± SEM.
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Supplemental figure S4.3 Acute endurance exercise induces several genesets in both legs related to 
immune response, skeletal muscle hypertrophy and stress. Venn diagram shows the overlap between 
the upregulated genesets in both legs. Next to the circles are the top 5 enriched genesets. Genesets 
depicted in bold are overlapping between exercising and non-exercising leg, whereas geneset with a 
normal font are unique for that leg. FDR = 0.2, exercising leg n = 9, non-exercising leg n = 7.
Supplemental figure S4.4 Combined time course of gene expression of selected genes of Mahoney 
et al. and this study: signal log ratios of selected genes (based on presence in datasets and expression) 
are displayed directly after exercise (this study) and 3 and 48 hours after exercise (Mahoney et al. 2005). 
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Supplemental table S4.1 List of differentially expressed genes at baseline (T0) in exercising and 
non-exercising leg
Gene name Mean FC P value FDR value
XPOT -1.28545 0.0014 0.99962
PROCR 1.17887 0.0038 0.99962
C3orf71 1.191506 0.0049 0.99962
BANP 1.22251 0.0052 0.99962
MALL 1.283441 0.0088 0.99962
SPRR4 1.250174 0.0094 0.99962
LOC100505587 1.150362 0.0096 0.99962
THAP5 1.230518 0.0098 0.99962
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Supplemental table S4.2 Induced transcription factor pathway and the genes contributing to 
this induction
Transcription factor Target genes in dataset
Exercising leg  
CREB1 APOLD1, ATF3, BHLHE40, BTG2, CEBPB, CIITA, CSRNP1, CYR61, DUSP14, EGR1, EGR2, 
ERRFI1, FLT1, FOS, FOSB, GADD45B, IDI1, IRS2, JUNB, LDLR, LSS, MCL1, MIDN, MKNK2, 
MYC, NAB2, NFIL3, NFKBID, NOS2, NR4A1, NR4A2, NR4A3, PDXK, PER1, PPARGC1A, 
PPP1R15A, RGS2, SERTAD1, SIAH2, SIK1, SLC2A3, VEGFA
SMAD3 BCL2L11, CCL2, CDKN1A, CTGF, ESR1, FOS, HEY1, JAM2, JUNB, JUND, MXD1, POR, 
RHOB, SKIL, SMAD1, SMAD7, TGFB1, TGFB3
SREBF1 ACLY, ADH1C, CDKN1A, CFD, FASN, HK2, HMOX1, HSPA1A/HSPA1B, HSPA5, IDI1, 
INSIG1, IRS2, LDLR, LGALS3, LSS, PIK3R3, SREBF1, TGFB1, VEGFA
STAT3 A2M, BCL2L11, BCL3, CCL2, CD9, CDKN1A, CIITA, CXCL2, DLL1, EGR1, FASN, FOS, 
GADD45A, ICAM1, IFI30, IFITM3, IL6R, JUNB, MCL1, MYC, NOS2, PCNT, PIM1, 
PPARGC1A, RORC, SGK1, SOCS3, SREBF1, STAT1, TAP1, TLR3, TNFRSF1B, VEGFA, WARS
HIF1A ADAM17, ADM, AKAP12, AURKA, BIRC2, CDKN1A, CHKA, CXCL12, CYR61, ERO1L, 
FAM13A, FLT1, FOS, HK2, HMOX1, INHBB, IRS2, ITGA5, ITGB3, KDM3A, LIFR, MCL1, 
MYC, NDRG1, NOS2, NOS3, NOTCH1, NRARP, PDGFA, PDGFB, PFKFB3, SLC40A1, 
SMAD7, SOX9, TGFB1, TGFB3, VASP, VEGFA
FOXO1 ACLY, BCL2L11, CDC42EP3, CDKN1A, CTGF, ELOVL5, FASN, FOXO1, GADD45A, 
GADD45B, HSPA5 ,IER3,  IRS1, IRS2, KLF2, LPL, ME1, PPARGC1A, SGK1, SLC25A1, 
SREBF1
EGR1 ATF3, CASP3, CASP9, CCL2, CDKN1A, CXCL2, FOSL1, GADD45A, GDF15, HMOX1, 
ICAM1, JUNB, JUND, ME1, MXD1, MYC, NAB2, NDRG1, PDGFA, PDGFC, TGFB1, 
THBS1, VEGFA
NOTCH1 CDKN1A, CEBPD, CFD, DLL1, FLT1, FOSB, HES1, HEY1, HEY2, ICAM1, MYC, NOS2, 
NR2F2, REL, RORC, TGFB1, TGFBR2, TP63
CLOCK ANGPTL4, ARNT2, BHLHE40, BPHL, CBR1, CCRN4L, CHST3, DBP, DDIT3, DNAJB9, 
DUSP8, FASN, FKBP5, GADD45A, GADD45B, GDNF, GIMAP4, HSPA1A/HSPA1B, HSPH1, 
ICAM1, ID1, JMJD6, JUNB, KLF13, MAP2K3, MKNK2, NFIL3, PER1, PER2, POR, SLC20A1, 
ST3GAL5, TNFAIP1, TOR1B, USP2, WEE1
NR3C1 A2M, ABHD2, ABL1, ACTB, ACTN1, ADH1C, ADM, ANGPTL4, APOL3, AQP1, ARID4B, 
BAG2, BAG3, BCL2L11, BCOR, BHLHE40, BIRC2, BRAF, CASP9, CCL2, CDC42EP3, 
CDKN1A, CLK2, CSRNP1, CSRNP2, DAPK2, DAPK3, DDIT4, DDX5, DEDD2, DUSP1, 
DUSP16, DYNLL1, EGR1, EMP1, ERRFI1, FASTKD1, FKBP5, FOS, FOXO1, GADD45A, 
GADD45B, GLUL, HNRNPU, ICAM1, IER2, IER3, IGF1, ING2, IP6K3, JMJD6, JUND, 
LRRC8A, MCL1, MKNK2, MYC, NFKBIA, PARP4, PDE4B, PDGFA, PDPN, PIK3CB, PIK3R3, 
PLEKHF1, PPP1R13L, PPP1R15A, PPP2CA, PPP2R1B, RELT, RGS2, RHOB, RRAGC, 
SEMA3C, SERINC3, SERPINB9, SERTAD2, SGK1, SIAH1, SIAH2, SLC19A2, SLC38A1, 
SMAD1, SNAI2, STOM, THBD, TLE3, TNFAIP1, TNFAIP3, TNFRSF10B, TNFRSF12A, 
TNFRSF1B, TP53BP2, TSC22D3, UGCG, VGLL2, YWHAH
ATF4 ATF3, CDKN1A, CEBPB, CTH, DDIT3, DDIT4, ERO1L, GDF15, KLF4, LGALS3, MAP1LC3B, 
NDRG1, NID2, OSMR, PMP22, PYCR1, SLC7A5, SNAI2, TNFRSF12A, VEGFA, WARS
NR1H3 ACSL3, ARG2, FASN, LDLR, LPL, MYLIP, NFKBIA, NOS2, PPARGC1A, SREBF1
SREBF2 ACLY, CDKN1A, FASN, IDI1, INSIG1, IRS2, LDLR, LSS, SREBF1
FOXO4 BCL6, CDC42EP3, CDKN1A, CTGF, FASN, GADD45A, GADD45B, IDI1, IER3, SGK1
Supplemental table S4.2 continues on next page
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Supplemental table S4.2 Continued
Transcription factor Target genes in dataset
ELK1 CDKN1A, EGR1, EGR2, FOS, FOSL1, JAM2, JUNB, MCL1
ETS1 CDKN1A, CTGF, DIAPH1, FLT1, HSPA1A/HSPA1B, INSIG1, ITGB3, MCL1, MYC, NPR1, 
PLAU, PVR, SP100, ZNF302
FOXL2 ATF3, CXCL2, FOS, ICAM1, IER3, MAFF, NR4A3, PPARGC1A, PPP1R15A, RGS2, SMAD6, 
TNFAIP3
SMAD4 ANGPT2, CDC42EP3, CDK17, CDKN1A, CTGF, GADD45A, GADD45B, ID2, IER3, IRAK3, 
ITGA6, JAM2, MYC, POR, RASSF1, SERTAD1, SGK1, SLC6A1, SMAD3, SMAD6, SMAD7, 
TGFB1, THBS1, VEGFA
TP73 ABCC1, ADAM17, BHLHE40, CDKN1A, CTH, DBP, DDIT3, FASN, HIVEP1, IL4R, KLHL21, 
MIR22HG, PDGFB, PMP22, PTPN3, SAT1, TCEAL1, TGFB1, THBS1, TNFRSF1B, VEGFA
MYC ADM, AKAP12, AMD1, ANGPT2, BIRC2, CDKN1A, CHKA, CLEC3B, COL15A1, COL4A1, 
COL6A3, COX7A2L, DDIT3, DUSP1, EIF4A1, FABP4, FASN, FBLN2, FBN1, GADD45A, 
GADD45G, GLS, HIST1H4A, HK2, HMOX1, HSP90AA1, HSPH1, ID2, ITGA6, KLF4, KRAS, 
MAT2A, MNT, MYC, MYO1C, ODC1, PFKP, PLAU, PLAUR, PMP22, SDCBP, SERINC3, 
SERPINH1, SGK1, THBS1, THBS2, TIMP2, TXNIP, VEGFA
Non-exercising leg
PPARA ANGPTL4, CES3, CPT1A, MVK, NR1D1, PDK4, PPM1D, RETSAT, SLC25A20, UCP2
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ABSTRACT
Endurance exercise is associated with significant improvements in cardio-metabolic 
risk parameters. A role for myokines has been hypothesized, yet limited information is 
available about myokines induced by acute endurance exercise in humans. Therefore 
the aim of the study was to identify novel exercise-induced myokines in humans. To 
this end, we carried out a one hour one-legged acute endurance exercise intervention 
in 12 male subjects and a 12 week exercise training intervention in 18 male subjects. 
Muscle biopsies were taken before and after acute exercise or exercise training, and 
were subjected to microarray-based analysis of secreted proteins (secretome). For 
acute exercise, secretome analysis resulted in a list of 86 putative myokines, which 
was reduced to 29 by applying a fold-change cut-off of 1.5. Based on that shortlist, a 
selection of putative myokines was measured in the plasma using ELISA or multiplex 
assay. From that selection, CX3CL1 (Fractalkine) and CCL2 (MCP-1) increased at both 
mRNA and plasma level. From the known myokines, only IL-6 and FGF21 changed at 
the mRNA level, whereas none of the known myokines changed at the plasma level. 
Secretome analysis of exercise training intervention resulted in a list of 69 putative 
myokines. Comparing putative myokines altered by acute exercise and exercise 
training revealed a very limited overlap of only 13 genes. 
In conclusion, this study identified CX3CL1 and CCL2 as myokines that were induced 
by acute exercise at the gene expression and plasma level and that may be involved 
in communication between skeletal muscle and other organs.
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INTRODUCTION
Physical exercise can serve as a very powerful tool in the prevention and treatment of 
metabolic diseases, including obesity and type 2 diabetes. In type 2 diabetic patients, 
exercise increases insulin sensitivity in liver and muscle [1], improves cardiorespiratory 
fitness and cardiovascular health [2], and reduces dyslipidaemia [3,4]. While skeletal 
muscle is the predominant organ impacted by acute exercise, specific metabolic 
alterations elicited by exercise may be accounted for by changes at the level of other 
organs such as the liver and adipose tissue. Very little is known about mechanism of 
crosstalk between muscle and other organs that could underlie effects of exercise on 
systemic health. 
One possible mechanism is via secretion of proteins that signal between muscle and 
the rest of the body. A recent publication showed that acute exercise not only changes 
gene expression in the exercising muscle, but also in the non-exercising muscle [5], 
supporting a crosstalk between active skeletal muscle and inactive organs. In recent 
years, it has become clear that skeletal muscle releases a variety of proteins into the 
circulation. These proteins are referred to as myokines and represent putative “exercise 
factors” [6-8]. To serve as exercise factor, production of the myokine should be altered 
upon muscle contraction and/or by chronic exercise training. A number of myokines 
have been shown to be released from muscle during and shortly after exercise, with 
interleukin-6 (IL-6) being the most prominent example [9]. Evidence suggests that IL-6 
released from muscle during exercise may contribute to the exercise-induced increase 
in hepatic glucose production [10]. Other presumed myokines include IL-8, IL-15 [11], 
leukemia inhibitory factor (LIF; [12]), and fibroblast growth factor 21 (FGF-21;[13]). None 
of these factors are solely produced by muscle and all have major functions elsewhere in 
the body. Due to their potential as pharmacological targets, there is an on-going quest 
to find additional myokines and studies are undertaken to determine their role during 
acute exercise and in the adaptive response to chronic exercise training. 
Different approaches towards identification of novel myokines have been pursued, 
mainly focusing on animal models or on cultured myocytes subjected to electrical 
pulse stimulation [14-18]. The studies undertaken in humans focus on specific genes 
and proteins [19-21] or are limited to exercise training [14,22]. So far no untargeted 
screenings have been undertaken to identify novel myokines during acute exercise in 
humans. Furthermore, there are data on myokines commonly regulated by acute exercise 
and exercise training. Myokines increasing in both exercise modalities would be highly 
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interesting targets for development of exercise mimetics and are also prime candidates 
to serve as general exercise (bio)marker. 
Accordingly, in this study we have utilized the one-legged exercise model and performed 
whole genome gene expression analysis in pre- and post-exercise muscle biopsies to 
screen for new putative myokines in humans. Results of the myokine screening of the 
acute one-legged exercise were compared with a myokine screening of a 12-week 
exercise training intervention, to assess the overlap between acutely and chronically 
induced myokines. The overall results of the whole genome gene expression analysis of 
the one-legged cycling have been published elsewhere [5]. The present paper is focused 
specifically on the study of myokines. Our results point to a number of novel myokines 
that may be involved in cross-talk between skeletal muscle and other organs.
meThODS
Acute exercise intervention
Twelve healthy middle-aged men (age 51.5 ± 5.1 years, body weight 88 ± 17 kg, body 
mass index (BMI) 26 ± 4 kg/m2; average±standard deviation) participated in the study. 
Inclusion criteria were: between 40 and 60 years of age, BMI under 30 kg/m2 and male 
gender. Subjects had an average maximal oxygen uptake of 35 ± 10 ml/min/kg and 
were sedentary to moderately active (not more than 3 hours of exercise per week). 
Subjects did not use any medicine, nor did they smoke. More details about the study 
population can be found elsewhere [5]. This age group was chosen because they are part 
of the population mostly affected by diseases such as obesity and diabetes type 2, and 
at the same time are able to perform more intense exercise without causing potential 
health risks. The study was approved by the medical ethical committee of Wageningen 
University and all subjects received oral and written information about the experimental 
procedures and provided written informed consent.
Detailed microarray analysis of this study was published elsewhere [5]. This study is a 
detailed follow up on this article to provide more insight on the myokines induced by 
exercise. All subjects performed a single 60 minute experimental endurance exercise 
bout, which was preceded by two preliminary exercise tests and two familiarization 
trials. During the endurance exercise bout subjects had to perform one-legged cycling 
at 50% of maximal wattage reached during a one-legged maximal exercise test (Wmax) on 
a cycle ergometer (Excalibur Sport, Lode, Groningen NL), adapted with a custom-made 
Identification of hum
an exercise-induced m
yokines
Chapter 5
105
5
leg support. Exercise was reported to be fairly difficult and subjects reached a maximum 
of ~60% of the heart rate reserve after one hour. Skeletal muscle biopsies were taken 
from both legs before and within 15 minutes after exercise. Subjects were fasted during 
the whole experimental exercise bout, in total for approximately 15 hours, and had ad 
libitum access to water. Temperature in the exercise room was ~20° Celcius.
exercise training intervention
18 healthy middle-aged male subjects (at baseline: age 59 ± 3.7 years, weight 95.1 ± 12 
kg, BMI 29.8 ± 6.6 kg/m2, VO2max 28.9 ± 4.4 ml/min/kg; average ± standard deviation) 
performed a 12 week mixed exercise training intervention. The 18 healthy subjects 
participated in a larger study and were matched for age, BMI and maximal oxygen uptake 
with 18 diabetic subjects. The mixed exercise training consisted of 2 endurance exercise 
session and 1 resistance exercise session per week (45 minutes per session). More details 
about the study and participants can be found in Meex et al. [1]. 
Tissue collection
Blood was collected in EDTA containing tubes. The samples were immediately centrifuged 
at 1000g at 4°C for 10 minutes, after which plasma was stored in -80°C until further 
analysis. 
For the acute exercise study, percutaneous needle biopsies were taken before (T0) and 
shortly after exercise (T1) from both legs (4 biopsies in total). For the exercise training 
study, needle biopsies were taken before and 3 days after termination of the training 
period after an overnight fast. Biopsies were collected from the vastus lateralis muscle 
using the Bergström technique with suction [23]. All biopsies were taken from a separate 
incision. After collections biopsies were immediately frozen into liquid nitrogen and 
stored at -80°C for further analysis. We were not able to collect muscle biopsies of one 
of the participants due to hypersensitivity of the participant to the biopsy procedure.
RNA extraction, microarray processing and microarray data analysis
RNA extraction, microarray processing and microarray analysis for the acute exercise study 
are described in detail elsewhere [5]. In short, RNA was isolated using Trizol and purified 
using RNeasy columns, after which RNA was labelled and hybridized to human whole 
genome Genechip Human Gene 1.1 ST arrays coding 19,732 genes (Affymetrix ,Santa 
Clara, CA). Microarray analysis was performed using MADMAX pipeline for statistical 
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analysis of microarray data [24]. Quality control was performed and all arrays met our 
criteria, except arrays from 2 participants that showed a clearly distinct clustering and 
pattern after normalization. Those microarrays were excluded from further analysis. 
Microarray data were filtered (expression values > 20 on more than 5 arrays, interquartile 
range > 0.2). Significant differences in expression were assessed using Intensity-Based 
Moderated T-statistic (IBMT [25]). Genes were defined as significantly changed when the 
p value was < 0.01. Differences in gene expression between the legs were determined 
using a paired IBMT test on the difference between T0 and T1 for both legs (p < 0.05). The 
microarray dataset is MIAME compliant and have been submitted to the Gene Expression 
Omnibus (accession number GSE41769).
Several participants were excluded through the pipeline of the acute exercise study. To 
provide an overview the excluded subjects and reason for exclusion are summed up in 
chronological order. The study started with 12 participants, one participant was excluded 
due to hypersensitivity to the biopsy procedure, two participants were excluded based 
on a distinct clustering in the quality control of the microarray, and two participants were 
excluded solely in the non-exercising leg based on their aberrant response to exercise 
in that leg (rationale in Catoire et al. [5]) , leaving the acute exercise study with N = 9 for 
the exercising leg and N = 7 for the non-exercising leg.
The processing and analysis of the muscle biopsies derived from the exercise training 
study was as described above. All samples passed quality control. The microarray data 
were filtered (expression values > 20 on more than 5 arrays, interquartile range > 0.2) and 
subjected to statistical analysis (p < 0.01). The primary microarray dataset was submitted 
to Gene Expression Omnibus (GSE53598).
cDNA synthesis and quantitative real time PCR 
Total RNA was reverse transcribed with a cDNA synthesis kit (Promega, Leiden, NL). 
Standard qPCR was performed using SensiMix real time PCR reagents (Bioline, London, 
UK) and a Bio-Rad CFX384 machine (Bio-Rad laboratories, Veenendaal, NL). Primer 
sequences were based on availability in the PRIMERBANK (http//pga.mgh.harvard.edu/
primerbank/index.html) and can be found in table 5.1. GAPDH was used as housekeeping 
gene [26], as its expression did not change upon acute exercise or exercise training 
(measured by qPCR and/or microarray)
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Secretome analysis  
Microarray-based secretome analysis was performed on all significantly changed genes 
in the acute exercise and training studies by screening for genes likely encoding secreted 
proteins using Gene Ontology Classification and SignalP predicting tools. Specifically, 
significantly changed genes annotated in Gene Ontology Cellular Component (GO CC) 
as extracellular region or space (GO:0005576/GO:0005615) were selected. Remaining 
genes that were not assigned to a GO category were screened for presence of a signal 
peptide using SignalP [27]. 
Plasma measurement of known and new myokines
IL-6, IL-18, IL-15, BDNF, CCL2 (MCP-1) and VEGF were measured in plasma of the acute 
exercise study using a multiplex immunoassay as described by Schipper et al. [28]. 
CYR61, CXCL2 (USCN Life Science, Houston, TX), and CX3CL1 (fractalkine, R&D Systems, 
Minneapolis, MN) were measured using enzyme-linked immunosorbent assay (ELISA).
Bioinformatics tools used for microarray analysis
Using an interquartile range > 0.5, 821 genes were selected from the acute exercise 
dataset and used for further analysis. Those genes showed the largest variability through 
Table 5.1 Primer sequences used for qPCR
Gene Primer sequence
hIL6-F AAACAACCTGAACCTTCCAAAGA
hIL6-R   GCAAGTCTCCTCATTGAATCCA
hIL15-F TTTCAGTGCAGGGCTTCCTAA
hIL15-R   GGGTGAACATCACTTTCCGTAT
hMCP1-F   CAGCCAGATGCAATCAATGCC
hMCP1-R TGGAATCCTGAACCCACTTCT
hVEGFA-F CGCAGCTACTGCCATCCAAT
hVEGFA-R GTGAGGTTTGATCCGCATAATCT
hCX3CL1-F ACCACGGTGTGACGAAATG
hCX3CL1-R TGGATGAGCAAAGCTACAGGTAT
hFNDC5-F TGGAGGAGGATACGGAGTACA
hFNDC5-R CCACATGAACAGGACCACGA
hADAMTS1-F GAGGCGTATTTCATCCAGCC
hADAMTS1-R GTCCTCGTCTTCGGTCTCC
hCYR61-F CTCGCCTTAGTCGTCACCC
hCYR61-R CGCCGAAGTTGCATTCCAG
GAPDH-F GAAGGTGAAGGTCGGAGTC
GAPDH-R GAAGATGGTGATGGGATTTC
Identification of human exercise-induced myokinesChapter 5
108
the experiment. For the plasma levels, values measured at T0 and T1 were used as input. 
MixOmics, a R package [29], was used to perform sparse partial least square regression 
(sPLS) to assess the relationship between plasma parameters and gene expression. A 
canonical sPLS was used. Furthermore a hierarchical clustering was performed on the 
sPLS results. Clusters were extracted in R and analysed using Ingenuity (www.ingenuity.
com) and ClueGO [30]. Correlation of the top 200 most variable genes were calculated 
using GItools.
Statistical analysis
Statistical analysis for the plasma myokines and qPCR data was performed using SPSS 
(version 18, SPSS, Chicago, IL). Differences between the different time points for the 
plasma parameters were determined using a repeated measure one-way ANOVA. Gene 
expression differences between T0 and T1 were evaluated using a paired t-test. Gene 
expression differences between the legs for the changes from T0 to T1 were evaluated 
using a paired t-test. Data are mean ± SD and p < 0.05 was considered statistically 
significant.
ReSULTS
Acute exercise-induced myokines determined by secretome analysis 
One hour of one-legged cycling significantly changed the expression of 938 genes in the 
exercising leg (p < 0.01, N = 9), compared to 209 genes in the non-exercising leg (p < 0.01, 
N = 7). The overall analysis of the whole genome expression data has been published 
elsewhere [5]. The significantly changed genes were further analysed to identify potential 
candidate myokines by so called secretome analysis, which involved screening of the 
microarray dataset for genes likely encoding secreted proteins using Gene Ontology 
Classification and SignalP predicting tools. We found that 80 genes encoding secreted 
proteins were changed in the exercising leg, 52 of which were upregulated and 28 were 
downregulated (Figure 5.1; p < 0.01). In the non-exercising leg, 17 genes encoding 
secreted proteins were significantly changed (12 up- versus 5 down-regulated; figure 
5.1). Upregulated genes showed an overlap between the exercising and non-exercising 
leg, which was not observed for the down-regulated genes. The complete list of putative 
myokines can be found in supplemental table S5.1. We further reduced the number of 
exercise-induced myokines by applying a fold-change (FC) cut-off of 1.5, resulting in 29 
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Figure 5.1 Secretome analysis reveals a large number of new putative myokines in the acute exercise 
study. Flow chart showing the various steps for identifying new myokines. Genes were considered 
significantly changed when p < 0.01. T0 is before exercise, T1 directly after exercise. Geneset was filtered 
using signal cut-offs > 20 on more than 5 arrays, and an interquartile range of 0.2 was applied. Exercising 
leg N = 9, non-exercising leg N = 7.
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putative myokines. The 1.5 FC cut-off was applied to narrow down our search for new 
systemic myokines, based on the notion that minor changes in gene expression are less 
likely to have physiological consequences. Only 2 putative myokines were significantly 
regulated in both legs, while a further 23 putative myokines were specifically regulated 
in the exercising leg. 4 myokines were specifically regulated in the non-exercising leg 
(figure 5.2). Putative myokines with the highest fold-change were ADAMTS1 (exercising 
leg; FC 4.9), Angptl4 (exercising leg: FC 1.6, non-exercising leg 3.5) and S100A8 (non-
exercising leg: FC 2.5). The set of myokines that was significantly induced in the exercising 
leg included the chemokines CXCL2, CX3CL1 (fractalkine) and CCL2. CCL2 has already 
been reported as a myokine whose mRNA and protein level are increased locally in the 
muscle during exercise [31,32]. Interestingly, only one putative myokine (Angptl4) was 
Figure 5.2 Heatmap of putative myokines induced in the acute exercise study with a fold change 
> 1.5. Heatmap showing the 29 most highly induced genes encoding secreted proteins. Genes were 
divided into three categories: significantly induced in both legs, significantly induced in exercising leg 
and significantly induced in non-exercising leg. Muscle-specific gene expression was verified using 
BioGPS and is indicated for all putative myokines. * = p < 0.05, # = p < 0.1 between the legs, Paired 
t-test was performed for the difference between the legs for N = 7. ** = genes selectively expressed 
in cardiomyocytes and smooth muscle cells (BioGPS), ? = not present in BioGPS. Exercising leg N = 9, 
non-exercising leg N = 7.
Gene name Description E NE FC E FC NE Muscle specific
ANGPTL4 angiopoietin-like 4 1.5* 3.5 NO
SEMA3F sema domain, immunoglobulin domain (Ig), short basic domain, 3F 1.5* 1.2 NO
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 5.2* 1.3 NO
CYR61 cysteine-rich, angiogenic inducer, 61 3.2* -1.5 NO
APOLD1 apolipoprotein L domain containing 1 2.6* 1.3 NO
THBD thrombomodulin 1.9* 1.3 NO
CX3CL1 chemokine (C-X3-C motif) ligand 1 1.9* -1.2 NO
CXCL2 chemokine (C-X-C motif) ligand 2 1.8* 1 NO
LOC100505657 hypothetical protein LOC100505657 1.8* 1.2 ?
FGF6 fibroblast growth factor 6 1.7 1.4 NO
DLL1 delta-like 1 (Drosophila) 1.7* 1.4 NO
SMPDL3A sphingomyelin phosphodiesterase, acid-like 3A 1.6* 1.1 NO
HSPH1 heat shock 105kDa/110kDa protein 1 1.7* 1.0 NO
THBS1 thrombospondin 1 1.6 1.3 **
ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 1.6* 1.1 NO
VEGFA vascular endothelial growth factor A 1.5* 1.3 NO
SDC4 syndecan 4 1.5* 1.2 NO
GDNF glial cell derived neurotrophic factor 1.5* 1.2 NO
CRISPLD2 cysteine-rich secretory protein LCCL domain containing 2 1.5# 1.1 NO
PDGFB platelet-derived growth factor beta polypeptide 1.5* -1.2 NO
DHRS4L2 dehydrogenase/reductase (SDR family) member 4 like 2 -1.6* -1.1 NO
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 -1.8* 1.0 NO
S100A8 S100 calcium binding protein A8 1.7 2.5 NO
LYZ lysozyme 1.4 1.8 NO
SNCA synuclein, alpha 1.2* 2 NO
MSTN myostatin -1.2* -1.5 NO
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more highly induced in the non-exercising compared to the exercising leg. The changes 
in gene expression of selected putative myokines as determined by microarray were 
confirmed by qPCR (figure 5.3A), except for VEGFA.
Figure 5.3 Verification of microarray data by qPCR. Gene expression of selected novel (A) and known 
(B) myokines as determined by qPCR in the acute exercise study. Signal log ratios (SLR) for both legs 
are displayed. Expression values were normalized by the housekeeping gene GAPDH. * = p < 0.05, # = 
p < 0.1. Depicted is mean ± SEM, N = 11.
Identification of human exercise-induced myokinesChapter 5
112
We examined whether any of the 29 exercise-induced genes encoding secreted proteins 
were selectively expressed in muscle, as assessed using BioGPS (http://biogps.org). Only 
2 of the putative myokines were expressed selectively in muscle, THBS1 and CTGF, which 
showed the highest expression in smooth muscle and cardiomyocytes (figure 5.2).
Several known myokines, including IL-6, IL-8, IL-15, and FNDC5 (Irisin) did not appear in 
the total list of 96 significantly changed genes that encoded secreted proteins. Detailed 
analysis revealed that most known myokines were indeed not significantly changed 
in either the exercising or non-exercising leg (table 5.2). IL-6 and FGF21 were both 
significantly induced in the exercising leg, but due to their low expression signal did not 
pass the filtering process. To confirm the microarray results we performed qPCR on a 
selection of known myokines (figure 5.3B), which largely confirmed the microarray results. 
Indeed, IL-15 and FNDC5 were not significantly changed, and a trend was observed for 
increased expression of IL-6 in the exercising leg. 
Table 5.2 Microarray results of majority currently known myokines for the exercising (N = 9) and 
non-exercising leg (N = 7)
Gene name FC exercising leg p value FC non-exercising leg p value
IL6 1.6 0.0002 1.2 0.1
IL8 -1.0 0.7 -1.1 0.3
IL15 -1.1 0.2 -1.1 0.2
BDNF 1.1 0.2 1.1 0.2
IL7 -1.1 0.2 1.1 0.3
LIF 1.1 0.5 -1.0 0.9
FGF21 1.1 0.01 -1.0 0.9
Irisin -1.0 0.7 -1.1 0.2
Acute exercise-induced in plasma levels of myokines 
Based on the list of 29 putative myokines altered > 1.5 fold, we created a shortlist 
of promising myokines that we measured in plasma using either ELISA or multiplex 
immunoassay. 
In line with the increased mRNA levels, plasma levels of CCL2 and CX3CL1 increased 
during one legged exercise and during recovery, which was consistently observed in 
all subjects (figure 5.4A). Despite increased mRNA expression, CYR61 and CXCL2 did not 
show any change in plasma levels in response to exercise. Plasma VEGFA levels seemed 
to be slightly increased by exercise but the effect did not reach statistical significance 
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(figure 5.4A). Also, plasma levels of the known myokines IL-6, IL-8, IL-15 and BDNF did 
not change during or after exercise (figure 5.4B). 
Figure 5.4 Plasma levels of myokines. Selected known myokines were measured in plasma of the acute 
exercise study by multiplex immunoassay or ELISA. Black bar between time points 0 and 1 indicates 
exercise period. Depicted is mean ± SEM, * = p < 0.05 compared to baseline, N = 12.
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Relationship between plasma myokine levels and muscle gene expression 
in acute exercise
To better understand the underlying molecular basis for the changes in plasma levels 
of the putative myokines, we determined the correlation between plasma levels of 
myokines and genes regulated in the exercising leg using sparse partial least square 
(sPLS) followed by clustering (figure 5.5). This analysis showed that CX3CL1 and CCL2 
are part of one cluster, which also includes BDNF, VEGF, and to a lesser extent IL-15. 
Those 5 myokines are highly correlated with a subset of 242 genes shown in the upper 
left corner of the heatmap in figure 5.5. To gain insight into the function and regulation 
Figure 5.5 Hypertrophy, metabolism and inflammation characterize the extracted set of genes 
resulting from a sPLS regression analysis of exercising leg gene expression and myokine plasma levels. 
sPLS was performed on the most variable genes (IQR > 0.5) and myokine plasma levels of the acute 
exercise study and hierarchically clustered (upper left window). A cluster highly correlating with CCL2 and 
CX3CL1 was extracted and analysed with Ingenuity (right upper window) and ClueGO (lower window).
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of these genes, upstream regulator analysis was performed using Ingenuity, which 
indicates which regulators (transcription factor, cytokine, enzyme complex) might be 
responsible for the observed gene expression changes. The analysis yielded upstream 
regulators mainly involved in metabolism (e.g. CREB1, ERK), growth/hypertrophy (e.g. 
TGFB1, STAT3) and inflammation (IL-1beta, TNFalpha). In addition, a Gene Ontology (GO) 
category analysis was performed using ClueGO, which yielded the specific processes that 
were represented by the genes highly correlated with the five myokines: metabolism, 
inflammation, signalling, growth/tissue development/hypertrophy, cell death. 
We further extended this analysis by correlating gene expression of myokines with gene 
expression of 200 other highly regulated genes in the exercising leg. This resulted in a 
subset of 44 genes having a correlation coefficient > 0.5 with the CX3CL1 or CCL2 gene, 
or both (figure 5.6). 68% of those genes were also present in the subset generated by 
correlating plasma levels and gene expression. Similarly, the upstream regulators for 
the 44 genes largely overlap with the upstream regulators for the genes clustering 
with plasma CX3CL1 and CCL2. To assess the similarities between exercising and non-
exercising leg, sPLS using MixOmics was performed on the non-exercising (figure 5.7). 
Again, a clear cluster was obtained that exhibited a high correlation with CX3CL1, CCL2, 
Figure 5.6 Similar processes also characterize genes with a high correlation with the CX3CL1 and 
CCL2 genes. A correlation analysis was performed using GItools on gene expression of the 200 most 
variable genes and genes coding for myokines of the acute exercise study. 44 genes had a correlation 
coefficient > 0.5 with the CX3CL1 and/or CCL2 gene. Overlap was determined between those 44 genes 
and the subset of genes clustering with CCL2 and CX3CL1, highlighted in the heatmap in figure 5.5 
(middle part) and analysed for upstream regulators with Ingenuity (right part).
Identification of human exercise-induced myokinesChapter 5
116
Figure 5.7 The genes in the non-exercising leg correlating with CX3CL1 and CCL2 plasma levels 
correspond largely to the set of genes of exercising leg. sPLS of both legs is shown, for both legs expression 
values of the most variable genes (IQR > 0.5) and myokine plasma levels were used (upper part). Both 
clusters were extracted and overlapped (middle part). The non-exercising cluster was analysed with 
Ingenuity (lower part).
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BDNF, and VEGF. Genes in this cluster showed marked overlap (68%) with the gene cluster 
from the exercising leg. Also, GO categories determined with ClueGO were highly similar 
between the two gene clusters.
Comparison between secretome analysis of acute exercise versus exercise 
training
Microarray analisys was performed and the 20 highest induced genes are depicted in 
figure 5.8A. Secretome analysis of the exercise training intervention resulted in a list of 
69 genes potentially coding for myokines, which can all be found in supplemental table 
S5.1. A large subset of those 69 genes encoded proteins that play a role in the extracellular 
matrix of the cell and therefore are unlikely to be involved in signalling, In general the 
fold-induction of the putative myokines was much lower in exercise training compared 
with acute exercise (figure 5.8A), and the majority of putative myokines was upregulated 
(figure 5.8C). Although the total number of putative secreted proteins was comparable 
between exercise training and acute exercise, the overlap was relatively small, with only 
12 genes shared between the two exercise modalities (figure 5.8B). All 13 genes exhibited 
a very modest change in expression, which for most genes went in opposite directions 
by acute exercise and exercise training (figure 5.8D). Only SHE, ENG, EFNA1 and ACTN4 
were upregulated by both acute exercise and exercise training.  
DISCUSSION
Here we applied secretome analysis to identify novel myokines induced by acute 
exercise or exercise training. We are unaware of any other unbiased screenings for novel 
myokines that used muscle biopsies from exercising humans as starting material. Our 
results reveal a number of exercise-induced myokines that are secreted into plasma, 
including CX3CL1 and CCL2. In contrast, one-legged exercise had no effect on plasma 
levels of several known myokines, including IL-6, IL-8 and IL-15. Intriguingly, we observed 
only very minor overlap between the secretome analysis of acute exercise and exercise 
training, reflecting the very different effects of acute exercise and exercise training on 
gene expression in muscle.
CCL2 and the newly discovered myokine CX3CL1 are well-known chemokines. CCL2 is 
a key mediator of macrophage recruitment during the inflammatory response and was 
reported to be increased at the mRNA level by resistance exercise [19,31] and moderately-
intensive cycling [32]. Immunohistochemical studies indicate that CCL2 protein is present 
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Figure 5.8 Overlap between acutely induced and training induced myokines. (A) Top 20 upregulated 
genes during exercise training. (B) Venn diagram of overlap of putative myokines induced in acute 
exercise and exercise training. (C) Number of putative myokines up- or downregulated in acute exercise 
and exercise training. (D) Bar chart of the expression of the overlapping putative myokines. Acute N 
= 9, training N = 18.
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in skeletal muscle, being co-localized with satellite cells and macrophages [33]. CX3CL1 
(also referred to as Fractalkine) plays a role in leukocyte adhesion [34] and is involved in 
macrophage-directed rescuing of skeletal muscle cells from apoptosis [35]. Both CCL2 
and CX3CL1 are involved in acute skeletal muscle injury and regeneration by attracting 
macrophages and other immune cells recruited for repair and growth of skeletal muscle, 
and may play a role in the adaptive response to exercise [36]. Infiltration of macrophages 
is believed to be crucial for exercise-induced hypertrophy and it is possible that CX3CL1 
and CCL2 play a role in this process [37]. To what extent exercise-induced local changes 
in CX3CL1 and CCL2 influence skeletal muscle insulin sensitivity will be the subject of 
our future investigations. Existing data suggest that CCL2 is negatively related to insulin 
sensitivity [38,39] and increased CCL2 plasma levels are associated with diabetes [40]. 
The influence of CX3CL1 on insulin signalling is not known, but plasma levels of CX3CL1 
were found to be elevated in subjects with type 2 diabetes [41]. 
Since both chemokines are expressed and secreted from a wide variety of tissues, as 
is true for all myokines identified so far, it is unclear whether the changes in plasma 
levels are exclusively driven by increased production in skeletal muscle. Expression 
profiling of human primary myotubes reveals that expression levels of CCL2 in skeletal 
muscle are extremely high (data not shown, GSE18589; ranked 145 out of 19,741 genes), 
which is supported by BioGPS (http://biogps.org). CX3CL1 expression levels in primary 
myotubes are markedly lower . Staining of CCL2 in skeletal muscle biopsies showed CCL2 
to be present in skeletal muscle cells [33]. At the same time, we cannot rule out that 
macrophages or other cell types present in the biopsies play a role in the induction of 
CCL2 and CX3CL1 gene expression upon exercise. It is important to note that the number 
of macrophages in resting skeletal muscle is limited, and that infiltration of macrophages 
reaches its peak 24 hours post-exercise [42]. Accordingly, it can be argued that myocytes 
most likely account for the elevated CCL2 and CX3CL1 mRNA levels after acuter exercise. 
Several studies have shown that IL-6 is increased upon endurance exercise, both at the 
mRNA and plasma level [9,20,43]. We found a significant increase in IL-6 mRNA in the 
exercising leg, which was not associated with any change in plasma IL-6 levels, suggesting 
a more local role of IL-6. It should be emphasized that IL-6 mRNA levels were very low and 
failed to pass the initial filtering of the microarray data. The reason for the discrepancy 
with several published studies is unclear [9,20,43]. One potential explanation is that the 
size of muscle mass used in one-legged cycling was insufficient to elicit any changes in 
IL-6 plasma levels. Another explanation is that the exercise intensity was relatively modest 
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(50% Wmax versus 75% VO2max) compared to other studies with similar exercise duration 
[44,45], although we did observe an increase in IL-6 mRNA. Recent data showed that 
carbohydrate ingestion attenuates the increase in plasma IL-6 but not skeletal muscle 
IL-6 mRNA during exercise in humans [46]. Overall, the degree of correlation between 
muscle IL-6 mRNA expression and plasma IL-6 levels is clearly dependent on the specific 
exercise conditions.
Of all the other proteins that have been suggested to be myokines, only FGF-21 showed 
a significant increase in mRNA levels in response to exercise, although the magnitude 
of induction was very modest. Limited research has been performed on FGF-21 as a 
myokine [13], and there are no reports indicating that exercise increases FGF-21 mRNA 
levels. Limited information is also available on other putative myokines, including IL-
8, IL-15, BDNF, and LIF, and their induction in skeletal muscle during exercise has not 
been consistently demonstrated [21,47,48]. The latter observation may be related to 
differences in type, intensity or duration of exercise. Recently, irisin was discovered as a 
novel muscle specific protein that is induced by exercise-training via the transcriptional 
co-activator PGC1α. Irisin was proposed to be released into the circulation and was 
found to stimulate browning and associated thermogenesis in subcutaneous fat in mice 
[18]. It was demonstrated that plasma levels of irisin are induced specifically by exercise 
training and not upon acute exercise, which is consistent with our observation that acute 
exercise did not alter expression of the gene coding for irisin (FNDC5). However, in the 
meantime serious concerns have arisen about the sequence of human FNDC5 and the 
secretion of irisin into human blood [49]. For this reason we did not attempt to measure 
plasma irisin levels in our study.
The main outcome of the mixomics analysis was the emergence of a clear cluster of genes 
correlating with plasma levels of CCL2 and CX3CL1. Interestingly, only CCL2 and CX3CL1 
correlated with a clear cluster, whereas much weaker correlations were seen for other 
myokines. Combined with the observed induction of CCL2 and CX3CL1 mRNA, these 
data suggest that changes in plasma levels of CCL2 and CX3CL1 are driven by changes 
in muscle gene expression. Additionally, the processes characterizing the genes present 
in the CCL2 and CX3CL1 cluster nicely corresponded with the known role of CX3CL1 
and CCL2 in growth and hypertrophy, inflammation, and apoptosis [35-37], pointing 
to a potential role of CCL2 and CX3CL1 in exercise-induced gene expression changes.
There was only very limited overlap between the putative myokines altered by acute 
exercise compared with myokines altered by exercise training. In general, acute exercise 
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and exercise training have very different effects on gene expression, with acute exercise 
eliciting a more stress-like response compared to a chronic adaptive response to exercise 
training. Whereas the adaptive response causes the improvements in exercise capacity 
and cardiometabolic fitness, it is still unclear which type of response is most important for 
conferring the positive effect of exercise on other parameters, such as insulin sensitivity. 
Based on this notion, it is difficult to define which types of myokines represent the 
best candidates as pharmacological target for metabolic disturbances such as insulin 
resistance. Interestingly a large part of the genes resulting from the secretome analysis 
of the exercise training study encoded extracellular matrix (ECM) proteins. Although 
ECM proteins are secreted out of the cells, they are unlikely to have an effect on distant 
cells or tissues. However, they could play a more indirect role in endocrine signalling by 
influencing the release and activation of other proteins.
One of the major limitations of our approach is that it precludes identification of novel 
myokines that are regulated exclusively at the post-transcriptional level. Another 
limitation is that the microarray datasets used in this article are derived from two separate 
relatively small sets of subjects. Subjects participating in both studies would have made 
the analysis more powerful. Despite the relatively small sample sizes, in both studies the 
changes identified were very consistent between the subjects. 
In conclusion, we identified several myokines that may be involved in cross-talk between 
skeletal muscle and other organs. The most promising candidates were CX3CL1 and 
CCL2 (MCP-1), which were increased at the gene expression level and in blood plasma. 
Furthermore, there was no substantial overlap of genes encoding potentially secreted 
proteins induced by acute exercise and exercise training, emphasizing the difference in 
response to acute exercise or exercise training.
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Supplemental table S5.1 Results secretome analysis acute exercise and exercise training
  Acute exericse study    
  Gene name Description FC E FC NE
Bo
th
 le
gs
ANGPTL4 angiopoietin-like 4 1.6 3.5
SEMA3F sema domain, immunoglobulin domain (Ig), short basic 
domain, secreted, 3F
1.5 1.2
ENG endoglin 1.4 1.3
SRGN serglycin 1.3 1.4
NOTCH1 notch 1 1.3 1.2
B4GALT1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, 
polypeptide 1
1.2 1.3
O
nl
y 
ex
er
ci
si
ng
 le
g
ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 
1
4.9 1.3
CYR61 cysteine-rich, angiogenic inducer, 61 3.0 -1.5
APOLD1 apolipoprotein L domain containing 1 2.5 1.3
THBD thrombomodulin 2.0 1.3
FGF6 fibroblast growth factor 6 1.9 1.4
CXCL2 chemokine (C-X-C motif ) ligand 2 1.9 1.0
CX3CL1 chemokine (C-X3-C motif ) ligand 1 1.8 -1.2
DLL1 delta-like 1 (Drosophila) 1.8 1.2
THBS1 thrombospondin 1 1.8 1.3
LOC100505657 hypothetical protein LOC100505657 1.8 1.2
SMPDL3A sphingomyelin phosphodiesterase, acid-like 3A 1.7 1.1
CCL2 chemokine (C-C motif ) ligand 2 1.7 1.0
HSPH1 heat shock 105kDa/110kDa protein 1 1.6 1.0
VEGFA vascular endothelial growth factor A 1.6 1.3
ADAMTS9 ADAM metallopeptidase with thrombospondin type 1 motif, 
9
1.6 1.1
GDNF glial cell derived neurotrophic factor 1.6 1.2
CTGF connective tissue growth factor 1.5 -1.2
SDC4 syndecan 4 1.5 1.2
CRISPLD2 cysteine-rich secretory protein LCCL domain containing 2 1.5 1.1
PDGFB platelet-derived growth factor beta polypeptide 1.5 -1.2
PLAU plasminogen activator, urokinase 1.5 1.3
PDGFA platelet-derived growth factor alpha polypeptide 1.4 1.3
LPL lipoprotein lipase 1.4 1.2
SERPINB9 serpin peptidase inhibitor, clade B (ovalbumin), member 9 1.4 1.2
FLT1 fms-related tyrosine kinase 1 1.4 1.1
IFFO2 intermediate filament family orphan 2 1.4 1.3
ANGPTL2 angiopoietin-like 2 1.3 1.2
INHBB inhibin, beta B 1.3 1.1
SEMA3G sema domain, immunoglobulin domain (Ig), short basic 
domain, secreted, (semaphorin) 3G
1.3 1.1
C8G complement component 8, gamma polypeptide 1.3 -1.1
Supplemental table S5.1 continues on next page
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Supplemental table S5.1 Continued
  Gene name Description FC E FC NE
O
nl
y 
ex
er
ci
si
ng
 le
g
ICAM1 intercellular adhesion molecule 1 1.3 1.1
GLA galactosidase, alpha 1.3 1.0
CHSY1 chondroitin sulfate synthase 1 1.2 1.1
TINAGL1 tubulointerstitial nephritis antigen-like 1 1.2 1.0
CD55 CD55 molecule, decay accelerating factor for complement 1.2 1.0
ACTN4 actinin, alpha 4 1.2 1.1
MGAT4A mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-
acetylglucosaminyltransferase, isozyme A
1.2 1.1
TGFB3 transforming growth factor, beta 3 1.2 1.1
MMRN2 multimerin 2 1.2 1.1
C2orf69 chromosome 2 open reading frame 69 1.2 -1.0
SHE Src homology 2 domain containing E 1.2 1.1
C3orf64 chromosome 3 open reading frame 64 1.2 1.2
HSPA5 heat shock 70kDa protein 5 1.2 -1.0
C1orf170 chromosome 1 open reading frame 170 1.2 1.0
VCL vinculin 1.2 1.0
TXLNA taxilin alpha 1.1 1.0
CXCL12 chemokine (C-X-C motif ) ligand 12 -1.1 -1.1
A2M alpha-2-macroglobulin -1.1 -1.0
ASB14 ankyrin repeat and SOCS box containing 14 -1.1 -1.3
APOL6 apolipoprotein L, 6 -1.2 -1.0
COL15A1 collagen, type XV, alpha 1 -1.2 1.1
LAMA4 laminin, alpha 4 -1.2 -1.1
PCOLCE procollagen C-endopeptidase enhancer -1.2 -1.0
LY6G5B lymphocyte antigen 6 complex, locus G5B -1.2 1.1
HMCN1 hemicentin 1 -1.2 -1.1
GPX7 glutathione peroxidase 7 -1.2 -1.1
THBS2 thrombospondin 2 -1.2 -1.1
ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 -1.2 -1.0
OLFML3 olfactomedin-like 3 -1.2 -1.1
C3 complement component 3 -1.2 -1.0
COL6A3 collagen, type VI, alpha 3 -1.2 -1.0
HSD17B11 hydroxysteroid (17-beta) dehydrogenase 11 -1.2 -1.0
APOL3 apolipoprotein L, 3 -1.2 1.1
RNASE1 ribonuclease, RNase A family, 1 (pancreatic) -1.2 -1.1
MAMDC2 MAM domain containing 2 -1.2 -1.2
C1RL complement component 1, r subcomponent-like -1.2 1.0
CTSW cathepsin W -1.2 -1.0
LCN12 lipocalin 12 -1.2 -1.2
IGF1 insulin-like growth factor 1 (somatomedin C) -1.3 -1.1
ADM adrenomedullin -1.3 -1.1
MMP28 matrix metallopeptidase 28 -1.3 1.1
DHRS4L2 dehydrogenase/reductase (SDR family) member 4 like 2 -1.5 -1.2
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 -1.7 1.0
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Exercise training study   
Gene name Description FC Average
IGF2 insulin-like growth factor 2 (somatomedin A) 1.6
COL3A1 collagen, type III, alpha 1 1.6
COL4A1 collagen, type IV, alpha 1 1.6
COL1A1 collagen, type I, alpha 1 1.6
THBS4 thrombospondin 4 1.6
ASPN asporin 1.5
BGN biglycan 1.5
MXRA5 matrix-remodelling associated 5 1.5
PXDN peroxidasin homolog (Drosophila) 1.5
COL4A2 collagen, type IV, alpha 2 1.4
FRZB frizzled-related protein 1.4
LOXL2 lysyl oxidase-like 2 1.4
PECAM1 platelet/endothelial cell adhesion molecule 1 1.4
SPARC secreted protein, acidic, cysteine-rich (osteonectin) 1.4
KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 1.4
LAMA4 laminin, alpha 4 1.4
F2R coagulation factor II (thrombin) receptor 1.3
NOV nephroblastoma overexpressed 1.3
KDR kinase insert domain receptor (a type III receptor tyrosine kinase) 1.3
LAMB1 laminin, beta 1 1.3
NID2 nidogen 2 (osteonidogen) 1.3
COL15A1 collagen, type XV, alpha 1 1.3
SULF2 sulfatase 2 1.3
A2M alpha-2-macroglobulin 1.3
PAMR1 peptidase domain containing associated with muscle regeneration 1 1.3
TNFSF10 tumor necrosis factor (ligand) superfamily, member 10 1.3
COL5A2 collagen, type V, alpha 2 1.3
HSPG2 heparan sulfate proteoglycan 2 1.3
ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 1.3
CECR1 cat eye syndrome chromosome region, candidate 1 1.2
IGFBP7 insulin-like growth factor binding protein 7 1.2
Supplemental table S5.1 Continued
  Gene name Description FC E FC NE
O
nl
y 
no
n-
ex
er
ci
si
ng
 le
g S100A8 S100 calcium binding protein A8 1.5 2.5
SNCA synuclein, alpha (non A4 component of amyloid precursor) 1.2 2.0
LYZ lysozyme 1.2 1.8
EFNA1 ephrin-A1 1.0 1.2
PPT1 palmitoyl-protein thioesterase 1 1.0 1.2
EDN1 endothelin 1 1.0 -1.3
MSTN myostatin -1.2 -1.5
Supplemental table S5.1 continues on next page
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Supplemental table S5.1 Continued
Gene name Description FC Average
NID1 nidogen 1 1.2
SERPINE2 serpin peptidase inhibitor, clade E , member 2 1.2
CTHRC1 collagen triple helix repeat containing 1 1.2
HMCN1 hemicentin 1 1.2
GLIPR1 GLI pathogenesis-related 1 1.2
FAP fibroblast activation protein, alpha 1.2
ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 1.2
ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1.2
IGFBP2 insulin-like growth factor binding protein 2, 36kDa 1.2
IGFBP4 insulin-like growth factor binding protein 4 1.2
TCN2 transcobalamin II 1.2
IL34 interleukin 34 1.2
CPE carboxypeptidase E 1.2
IGFBP3 insulin-like growth factor binding protein 3 1.2
TGFBI transforming growth factor, beta-induced, 68kDa 1.2
CXorf36 chromosome X open reading frame 36 1.2
ENG endoglin 1.2
VWF von Willebrand factor 1.2
RNASE1 ribonuclease, RNase A family, 1 (pancreatic) 1.2
LAMA3 laminin, alpha 3 1.2
TGFB1 transforming growth factor, beta 1 1.2
CD109 CD109 molecule 1.2
ELMO1 engulfment and cell motility 1 1.2
THSD1 thrombospondin, type I, domain containing 1 1.2
PDGFB platelet-derived growth factor beta polypeptide 1.2
ACTN4 actinin, alpha 4 1.2
F8 coagulation factor VIII, procoagulant component 1.1
BMP1 bone morphogenetic protein 1 1.1
LAMC1 laminin, gamma 1 (formerly LAMB2) 1.1
SHE Src homology 2 domain containing E 1.1
EFNA1 ephrin-A1 1.1
HLA-C major histocompatibility complex, class I, C 1.1
NRP1 neuropilin 1 1.1
LGALS8 lectin, galactoside-binding, soluble, 8 1.1
GRN granulin 1.1
PDGFA platelet-derived growth factor alpha polypeptide -1.2
IGFBP6 insulin-like growth factor binding protein 6 -1.2
IGHG3 immunoglobulin heavy constant gamma 3 (G3m marker) -1.3
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ABSTRACT
Physical activity increases energy metabolism in exercising muscle. Whether acute 
exercise elicits metabolic changes in non-exercising muscles remains unclear. We 
show that one of the very few genes that during acute exercise is more highly 
induced in non-exercising muscle compared to exercising human muscle encodes 
Angiopoietin-like 4 (Angptl4), an inhibitor of lipoprotein lipase-mediated plasma 
triglyceride clearance. Using a combination of human, animal and in-vitro data, we 
show that induction of Angptl4 in non-exercising muscle is mediated by elevated 
plasma free fatty acids via PPARδ, presumably leading to reduced local uptake of 
plasma triglyceride-derived fatty acids and their sparing for use by exercising muscle. 
In contrast, in exercising muscle induction of Angptl4 is counteracted likely via AMPK-
mediated downregulation, promoting use of plasma triglycerides as fuel for active 
muscles. Our data suggest a key role of non-exercising muscle and local regulation 
of Angptl4 via AMPK and FFA in governing lipid homeostasis during exercise.
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INTRODUCTION
Acute exercise greatly increases cellular demand for ATP, oxygen, glucose and fatty acids. 
To meet these demands, acute exercise is associated with marked changes in skeletal 
muscle activity of key transporters and enzymes involved in glucose and fatty acid 
transport and oxidation [1]. Much of the regulation occurs via allosteric regulation and 
covalent modification of rate-limiting enzymes. In addition, alterations at the level of 
mRNA are increasingly believed to represent an important regulatory mechanism in the 
acute response to exercise [2]. Indeed, acute exercise induces mRNA expression of many 
genes involved in a variety of processes, including energy metabolism, hypertrophy and 
signaling [3-6]. Not surprisingly, most studies have focused on the events occurring in 
exercising muscle. In contrast, much less is known about the exercise-induced changes 
in non-exercising muscle. Studies have shown that resting skeletal muscle is crucial in 
the removal of lactate from the circulation during high-intensity exercise [7], and also 
plays a role in adrenaline and noradrenaline production during exercise [8]. In addition, 
similar to exercising muscle, resting muscle exhibits enhanced phosphorylation of mTOR 
following resistance exercise [9]. Overall, however, the impact of exercise on metabolic 
processes and gene expression in non-exercising muscles remains ill-defined. It can 
be envisioned that exercise may elicit changes in gene expression in non-exercising 
muscle via circulating mediators including muscle-derived myokines and metabolites 
[10]. The present study was undertaken to try to elucidate the role of inactive muscle in 
the metabolic response to acute exercise.
ExpERImENTAl pROCEDURES
Human intervention studies
Twelve healthy men (age 51.5 ± 5.1 years, body weight 88 ± 17 kg, body mass index 26 
± 4) participated in the study, referred to as study A [4]. Subjects were asked to follow 
healthy eating guidelines the day before the experiment and to refrain from alcohol 
consumption. Subjects fasted from 10 p.m. the prior evening until the end of the 
intervention. During the exercise session subjects were allowed to drink water ad libitum. 
All subjects performed a single endurance exercise bout, consisting of 60 minutes one-
legged cycling at 50% of one-legged Wmax (determined by graded one-legged cycling 
test). One-legged cycling was performed on a cycle ergometer (Excalibur Sport, Lode, 
Groningen NL) adapted with a custom-made leg support. Skeletal muscle biopsies were 
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taken from 11 subjects from both legs, before and after exercise, with the average time 
of collection at approximately 15 minutes pre- or post-exercise. One subject became 
apprehensive about the needle biopsy immediately prior to the first biopsy collection. 
Two subjects were later excluded from the microarray analysis because the microarrays 
failed to meet quality control criteria. In addition, a venous blood sample was taken before 
and shortly after exercise. Other human intervention studies included in this manuscript 
have been previously published and are briefly outlined below.
Study B: 8 young untrained and healthy male subjects (age: 23.3 ± 3.2 years) performed 
3h of cycling on an electromagnetically braked ergometer at an intensity of 40% of the
predetermined Wmax [11]. To facilitate completion of the exercise test, subjects received 
two 125 mL servings of a maltodextrine drink during the second half of the test. Subjects 
were allowed to drink water ad libitum during the entire test. Plasma was collected before 
and after 3h cycling exercise and used for measurement of Angptl4.
Study C: 8 young untrained and healthy male subjects (age: 23.3 ± 3.2 years) followed 
a two week exercise training program on a cycling ergometer [11]. Training consisted 
of alternating days of interval and endurance training and always started with 7.5 
min of warming up at 40% Wmax and ended with 7.5 min of cooling down at 40% Wmax. 
Fasting plasma was collected before and after the 2 week training program and used 
for measurement of Angptl4. Plasma was collected 3 days after the last training session.
Study D: 6 healthy non-obese male subjects (age: 42.7 ± 2.0 years) followed a 12 week 
exercise training program on a cycling ergometer [12]. Subjects trained three times per 
week for 12 weeks for 47.5 ± 2.5 min at 40% of predetermined VO2max. Fasting plasma 
was collected before and after the 12 week training program and used for measurement 
of Angptl4. Plasma was collected 3 days after the last training session.
Study E: seven healthy, untrained male volunteers participated in the study (age: 22.7 ± 
0.6 years). After an overnight fast, a Teflon cannula was inserted in an antecubital vein 
for sampling of blood. Subjects rested on a bed, and a baseline blood sample was taken. 
Immediately thereafter, subjects ingested 1.4 g/kg bodyweight glucose or water. Subject 
exercised at 50% VO2max for 2h and then rested for 4h. At regular intervals subjects 
ingested 0.35 g/kg bodyweight glucose or water. Muscle biopsies were collected before 
exercise and after the 4h rest period. All subjects underwent the experimental protocol 
two times, once with glucose ingestion and once while fasting [13].
Study F: twelve healthy lean male volunteers participated in the study (age: 23.6 ± 1.0 
years). Subjects stayed in the respiration chamber for 60h in the normal fed condition 
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or while being completely fasted, according to a randomized crossover design with a 
2-week washout period. Blood samples were collected at the end of the study after an 
overnight fast (fed condition), or after a cumulative 60h fast. Around the same time, a 
muscle biopsy was taken [14]. 
Study G: nine healthy lean male volunteers participated in the study (age: 24.4 ± 1.3 years). 
After an overnight fast, two Teflon cannulas were inserted into an antecubital vein of each 
arm. One cannula was used for the infusion of Salbutamol and one cannula for sampling 
of blood. A first blood sample and muscle biopsy was taken, followed by a continuous 
infusion of salbutamol for 3h. In addition, two doses of 250 mg acipimox or placebo 
were given orally at -120 min and time 0. Blood samples were taken at regular intervals 
throughout the study [15]. A second muscle biopsy was taken after the 3h infusion.
The studies were approved by the medical ethical committee of the institute involved 
(Wageningen University or Maastricht University).
Blood samples
Blood was collected in EDTA containing tubes and immediately centrifuged for 10 minutes 
(1000g, 4°C). Blood samples were analyzed for FFA levels (Centre for Medical Diagnostics, 
Velp, NL) and Angptl4 levels (see below).
Skeletal muscle biopsies
Percutaneous needle biopsies were taken before and shortly after exercise from the 
vastus lateralis muscle from both legs, using the Bergström technique with suction. All 
biopsies were taken from separate incisions, with the second biopsy in the leg located 
2 cm more proximal to the first. Biopsies were taken on average 10-15 minutes before 
and after the exercise bout. All biopsies were collected, processed, and frozen within 30 
minutes post-exercise. After each biopsy, the collected tissue sample was carefully cleared 
from adipose tissue and blood and directly frozen into liquid nitrogen or embedded 
into Tissue-Tek O.C.T. compound (Sakura Tissue Tek, Alphen a/d Rijn, NL) and frozen in 
liquid-nitrogen cooled isopentane.
Muscle biopsy lysates were prepared using a lysis buffer consisting of 50 mM Tris HCl (pH 
7.5), 150 mM NaCL, 1 mM EGTA, 1 mM EDTA, 0.27 M sucrose and 2% Triton X-100. Protease 
and phosphatase inhibitor were added to the buffer (Complete and PhosSTOP, Roch 
diagnostics GmbH, Mannheim, Germany). Buffer was added to a 1:15 ratio (tissue:buffer) 
and the tissue was lysed using TissueLyser II (Qiagen, Venlo, NL).
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Immunofluorescence 
5-μm thick frozen muscle sections were treated with 0.1% Triton X-100 in PBS and 
incubated for 45 min at room temperature (RT) with the primary antibody mix diluted in 
0.05% Tween20 in PBS: a polyclonal rabbit hAngptl4, a mouse monoclonal IgM antibody 
directed to MHC1 (type 1 muscle fibers; Developmental Studies Hybridoma Bank, Iowa 
City, Iowa, USA) and a mouse monoclonal IgG1 antibody to caveolin-3 (BD Biosciences, 
Breda, NL). After three washing steps with PBS sections were incubated for 45 min at RT 
with the appropriate fluorescent-labeled secondary antibodies. The specificity of the 
antibody for Angptl4 was previously demonstrated via immunoblot of human plasma 
and use of appropriate peptide controls and corroborated by immunochemical and 
immunofluorescence staining of Angptl4 in human heart, intestine, and skin wounds, 
using appropriate negative controls [16-18].
Animal experiments
Exercise studies were carried out using the TSE PhenoMaster treadmill module (TSE 
Systems, Bad Homburg, Germany), allowing four mice to run simultaneously. Four to 
five month old male Wildtype (WT) and Angptl4-transgenic (Angptl4-Tg) mice on C57Bl/6 
background were used for the exercise experiments. The Angptl4-Tg mice used for the 
experiments had been bred on C57Bl/6 background for 15 generations. Mice were 
littermates. Number of mice per group varied between 6 and 9. All mice were acclimatized 
to the treadmill (10 m/min for 10 minutes) on three consecutive days. On the day of 
exercise, mice were fasted (4 hours) and were subjected to either a moderate exercise 
protocol (12 m/min at 0% incline for 90 minutes) or ran until exhaustion (30 minutes at 
12m/min, then every 5 minutes an increase of 2.5m/min and 2 degrees until exhaustion). 
A mouse was considered exhausted if it failed to run after 3 times prompting within 1 
minute with a slider with plastic bristles. The moment of exhaustion was determined by 
an investigator unaware of the genotype of the mice. A control group of non-exercising 
mice from each genotype remained sedentary inside the treadmill. Upon cessation of 
exercise mice were immediately anaesthetized using isoflurane and blood was collected 
by orbital puncture. Mice were then sacrificed by cervical dislocation and tissues were 
quickly excised and immediately frozen in liquid nitrogen.
The horizontal wire test was performed by placing a steel wire between a gray PVC 
stand at a height of 30 cm. Mice were hung on the wire with their forepaws and time 
measurements started at the moment that the researcher judged there was a good grip. 
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Time measurement was ended as the animal grasped the wire with at least one hind paw. 
If the animal fell, it was placed back in its cage for a 3 minutes rest, and measurements 
were repeated.
Animals experiment were approved by the animals ethics committee of Wageningen 
University. 
plasma triglyceride and free fatty acid clearance
After a 6 hour fast, 6-month old male WT and Angptl4-Tg mice were put on a treadmill at 
a speed of 14m/min. After 30 minutes of running, mice were injected with a single bolus 
of [14C]-oleate and glycerol tri[3H]oleate-labeled VLDL-like particles and continued to run 
for another 15 minutes. After 15 minutes, blood was collected, followed by immediate 
sacrifice of the mice and collection of tissues. Tissues and serum were processed 
for determination of 3H-activity and 14C-activity. Preparation of VLDL-like particles, 
complexing of [14C]-oleate with BSA, infusion protocol, and calculations were carried 
out as described previously [19-21].
Cell culture and treatment
C2C12 myoblasts were maintained in DMEM (Lonza, Breda, NL) supplemented with 10% 
fetal calf serum (FCS), 1% penicillin/streptomycin/ amphotericin (PSA) under 5% CO2 
at 37°C. At ∼70-90% confluency, myoblasts were either treated or full growth medium 
was replaced with alphaMEM supplemented with 2% FCS and 1% PSA to promote 
differentiation into myotubes. Differentiation medium was changed every 2-3 days. 
C2C12 myotubes were used for treatment after 1 week of differentiation. All experiments 
with C2C12 myotubes were performed in differentiation medium. 
C2C12 myotubes were treated with human serum by replacing FCS with human 
serum and incubated for 3h to 6h. For siRNA-mediated knock-down, C2C12 cells were 
transfected with siRNA sequences using Lipofectamin RNAiMax the day before starting 
the differentiation. ON-TARGETplus SMARTpool for PPARδ, AMPKα1, AMPKα2 and non-
targeting was used (Dharmacon/Thermo-Fisher Scientific, Etten-Leur, NL) at 100 pmol/
mL. The medium was replaced by differentiation medium (DMEM supplemented with 
2% horse serum, 100 µg/ml penicillin and 100 µg/ml streptomycin) after 24h. After 4 
days of differentiation, cells were treated with oleic acid and AICAR as indicated below. 
Differentiated human primary myotubes were prepared as described previously [22]. 
Oleic acid (200 µM) was added to cells complexed with BSA (2.5:1). AICAR and metformin 
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were used at 1 mM. The AMPK inhibitor compound C was used at concentrations indicated 
in the legend. Cells were treated for 12h unless indicated otherwise. 
RNA isolation and qpCR
Total RNA was isolated using Trizol reagent (Invitrogen, Breda, NL) and purified for 
microarray analysis using the Qiagen RNeasy Micro kit (Qiagen, Venlo, NL). 
RNA was reverse transcribed using a First Strand cDNA Synthesis Kit (Fermentas, St. Leon-
Rot, Germany). Real-time PCR was carried out using SensiMiX (Bioline, London, UK) on 
a CFX 384 Bio-Rad thermal cycler (Bio-Rad, Veenendaal, NL). Cyclophilin, GADPH and/
or 36B4 were used as housekeeping genes. Primer sequences can be found in table 6.1.
RESUlTS
To investigate the molecular events occurring during exercise in non-exercising muscle, 
we carried out an acute exercise trial in which 12 human subjects performed moderate-
high intensity cycling exercise with one leg, and muscle biopsies were taken before and 
Table 6.1 Primer sequences
Forward primer Reverse primer
m36B4 ATGGGTACAAGCGCGTCCTG GCCTTGACCTTTTCAGTAAG
Cyclophilin CAGACGCCACTGTCGCTTT TGTCTTTGGAACTTTGTCTGCAA
PGC1-a AGACGGATTGCCCTCATTTGA TGTAGCTGAGCTGAGTGTTGG
Cpt1b ATCATGTATCGCCGCAAACT CCATCTGGTAGGAGCACATGG
Lpl CAGCTGGGCCTAACTTTGAG GACCCCCTGGTAAATGTGTG
Angptl4 GTTTGCAGACTCAGCTCAAGG CCAAGAGGTCTATCTGGCTCTG
Ppard TTGAGCCCAAGTTCGAGTTTG CGGTCTCCACACAGAATGATG
Cd36 TCCAGCCAATGCCTTTGC TGGAGATTACTTTTCAGTGCAGAA
Plin2 GGATGTGGTGACGACTACCAT ACAGACTTGGTCCTTTCCACG
Pdk4 TCTACAAACTCTGACAGGGCTTT CCGCTTAGTGAACACTCCTTC
Ppara TATTCGGCTGAAGCTGGTGTAC CTGGCATTTGTTCCGGTTCT
Pparg CACAATGCCATCAGGTTTGG GCTGGTCGATATCACTGGAGATC
Prkaa1 TTCGGGAAAGTGAAGGTGGG TCTTCTGCCGGTTGAGTATCT
Prkaa2 CAGGCCATAAAGTGGCAGTTA AAAAGTCTGTCGGAGTGCTGA
Cs GGACAATTTTCCAACCAATCTGC TCGGTTCATTCCCTCTGCATA
Klf10 ATGCTCAACTTCGGCGCTT CGCTTCCACCGCTTCAAAG
Angptl4 CACAGCCTGCAGACACAACTC GGAGGCCAAACTGGCTTTGC
GAPDH CATGTTCCAGTATGACTCCACTC GGCCTCACCCCATTTGATGT
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after exercise from the exercising and non-exercising (resting) leg. One legged cycling 
allows for direct analysis of the effects of acute exercise in exercising muscle, with the non-
exercising leg serving as control leg. Microarray analysis was performed on all 4 muscle 
biopsies of 9 subjects [4]. Microarrays from two subjects failed to meet quality control 
criteria and were excluded from analysis, and one subjects refused to have biopsies taken.
Surprisingly, the most significantly induced gene in the non-exercising leg was Angptl4 
(figure 6.1A), a sensitive target of the PPAR transcription factors that encodes a secreted 
Figure 6.1 Exercise induces Angptl4 gene expression in non-exercising human muscle. (A) Heatmap 
showing genes altered by exercise in the non-exercising leg muscle ranked according to statistical 
significance. Values are displayed per subject (P1 to P9). Fold-change (FC) in gene expression is indicated. 
(B) mRNA expression profile of Angptl4 in exercising and non-exercising leg according to microarray. 
(C) qPCR analysis of Angptl4 mRNA expression. (D) mRNA expression of PPARδ targets KLF10, PDK4, 
SLC22A5, as well as LPL. (E) Angptl4 protein levels in post-exercise muscle biopsies as determined by 
ELISA. Error bars represent SEM. *Significantly different according to paired Student’s t test (p < 0.01).
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inhibitor of the enzyme lipoprotein lipase [23-25]. Lipoprotein lipase (LPL) catalyzes 
hydrolysis of circulating triglycerides and therefore plays a key role in uptake of fatty 
acids in skeletal muscle [26]. Paired individual gene expression profiles in muscle biopsies 
from both legs clearly showed that Angptl4 was much more strongly induced in the 
non-exercising leg compared with the exercising leg (figure 6.1B), which was confirmed 
by qPCR analysis (figure 6.1C). In fact, the microarray analysis indicated that Angptl4 
was one of the very few genes that was more highly induced in the non-exercising leg 
compared with the exercising leg, whereas other PPAR targets such as PDK4, SLC22A5 and 
KLF10 were induced to the same extent in both legs (figure 6.1D). The same was true for 
LPL mRNA levels (figure 6.1D). In parallel with changes in Angptl4 mRNA, the content of 
Angptl4 protein in muscle after exercise was significantly higher in the non-exercising 
leg compared to the exercising leg, as determined by ELISA (figure 6.1E). 
To localize Angptl4 protein in human muscle, immunohistochemical staining was 
performed, which revealed substantial staining of Angptl4 in human muscle fibers, 
with a slight preference for type 1 slow oxidative fibers (figure 6.2). Consistent with the 
function of Angptl4 as inhibitor of endothelial-bound lipoprotein lipase, most intense 
Angptl4 protein staining was observed in the capillaries (figure 6.2).
Figure 6.2 Angptl4 protein is detected in human muscle in myocytes and endothelial cells. Immuno-
fluorescent staining of Angptl4 in a biopsy from human vastus lateralis muscle. Angptl4 in green. Myosin 
heavy chain 1 (MHC1, marker type I fiber) in red. Caveolin in blue. Representative image is shown.
Induction of Angptl4 mRNA in skeletal muscle during one-legged exercise was associated 
with a significant increase in plasma Angptl4 concentration (figure 6.3A). Cycling with two 
legs for a more extended period (3 hours) caused an even more significant increase in 
plasma Angptl4 concentration (figure 6.3B). In contrast, the plasma Angptl4 concentration 
was not altered by two weeks of intense endurance exercise training (figure 6.3C), or 
by a twelve week endurance exercise program (figure 6.3D), indicating that Angptl4 is 
specifically induced by acute exercise. 
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Since the non-exercising leg was inactive, changes in gene expression in the resting leg 
muscle cannot be caused by local contractile activity but must be related to systemic 
factors, including circulating metabolites. To verify this notion, serum from fasted 
human subjects collected before and after 2h of cycling exercise was added to mouse 
C2C12 myotubes and Angptl4 mRNA expression was determined by qPCR. Post-exercise 
serum markedly increased Angptl4 mRNA compared to pre-exercise serum (figure 
6.4A). Intriguingly, no such effect was observed using pre- and post-exercise plasma 
from subjects that received repeated glucose drinks during the cycling exercise (figure 
6.4A). Angptl4 expression in C2C12 myotubes was also more strongly induced by plasma 
collected from subjects in fasted state compared with fed state (figure 6.4B). In those 
subjects, skeletal muscle Angptl4 expression was also markedly higher in the fasted state 
compared with the fed state (figure 6.4C). Together, these data suggest that Angptl4 is 
induced by a circulating factor that is specifically induced by exercise in the fasted state 
but is not elevated when glucose is consumed during exercise, and is also enriched in 
Figure 6.3 Plasma Angptl4 are increased by acute exercise but not by exercise training. (A) Plasma 
Angptl4 levels before and after 1 hour of one-legged cycling exercise at 50% of one-legged Wmax (Study 
A, n = 12). (B) Plasma Angptl4 levels before and after 3 hour cycling exercise at 40% Wmax (Study B, n = 
8). (C) Fasting plasma Angptl4 levels before and after an intense 2 week endurance training program 
on a cycling ergometer (Study C, n = 8). (D) Fasting plasma Angptl4 levels before and after a moderate 
intensity 12 week endurance training program on a cycling ergometer (Study D, n = 6).
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the fasted state compared with fed state. One such parameter is plasma free fatty acids 
(FFA) (figure 6.4A,B, right panel), levels of which also increased during one-legged cycling 
(figure 6.4D), and which were previously shown to potently induce Angptl4 mRNA in 
Figure 6.4 Sensitive induction of Angptl4 gene by FFAs in human and mouse myocytes. (A) C2C12 
myotubes were incubated for 6h with 10% serum from subjects (n = 5) before and after exercise 
performed in fasted state or with provision of glucose (Study E). Angptl4 mRNA in left panel. Serum 
FFA levels in right panel. (B) C2C12 myotubes were incubated for 3h with 10% serum from subjects 
(n = 12) at the end of 60h fast or a 60h normal fed condition (Study F). Angptl4 mRNA in left panel. 
Serum FFA levels in right panel. (C) Angptl4 mRNA in muscle biopsies collected at the end of 60h fast 
or a 60h normal fed condition (Study F). (D) Plasma FFA levels before and after one-legged exercise 
(n = 12). (E) Left panel: pooled mRNA expression of selected genes in muscle biopsies collected before 
and after Salbutamol infusion with and without prior Acipimox administration (Study G, n = 9). Right 
panel: Plasma FFA levels during salbutamol infusion. Error bars represent SEM. Angptl4 mRNA (F) 
and Angptl4 concentration in medium (G) in primary human myotubes treated with oleic acid. (H) 
Angptl4 and Pppard mRNA in C2C12 myotubes transfected with control (non-targeting) or PPARδ 
siRNA and treated with oleic acid. *Significantly different according to Student’s t test (p < 0.05). Error 
bars represent SD unless indicated otherwise. Cells were treated for 12h unless indicated otherwise.
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various cell types, including in cultured myocytes [27-30]. In support of a role of plasma 
FFA in induction of Angptl4 gene expression in human muscle, raising plasma FFA 
levels by salbutamol treatment markedly increased muscle Angptl4 expression, which 
was largely blunted when salbutamol was co-administered with the lipolysis inhibitor 
Acipimox (figure 6.4E). This expression pattern was not found for other relevant genes 
such as PPARGC1A and PDK4. 
To further study Angptl4 gene regulation by fatty acids, we used cultured myocytes. 
Oleic acid markedly induced Angptl4 mRNA in human primary myotubes (figure 6.4F), 
which was accompanied by a similar increase in Angptl4 protein secretion (figure 
6.4G). Oleic acid also markedly induced Angptl4 expression in C2C12 myotubes, which 
was significantly blunted upon siRNA-mediated knock-down of PPARδ (figure 6.4H). 
Consistent with high sensitivity of Angptl4 gene regulation to stimulation by fatty acids, 
microarray analysis indicated that the (second) most highly induced gene by oleic acid 
in human primary myotubes and mouse C2C12 myotubes corresponded to Angptl4 
(supplemental figure S6.1). Taken together, these data strongly suggest that the marked 
induction of Angptl4 mRNA in the non-exercising human muscle is caused by increased 
plasma FFA levels associated with exercise.
Despite being exposed to elevated plasma FFA as well, exercising human muscle shows 
only a very minor increase in Angptl4 expression. Accordingly, we hypothesized that 
induction of Angptl4 mRNA in exercising muscle by FFA is mitigated by a contraction-
related factor. If that is true, expression of Angptl4 should go up strongly after cessation 
of exercise when performed in the fasted state, since plasma FFA remain high for hours 
after such exercise. Indeed, Angptl4 mRNA in exercising human muscle is increased 20-fold 
four hours post-exercise in the continued fasted state compared to baseline, concurrent 
with sustained elevation of plasma FFA (supplemental figure S6.2).
A candidate factor that may suppress Angptl4 in exercising muscle is adenosine 
monophosphate-activated protein kinase (AMPK), which has been demonstrated to be 
activated specifically in exercising muscle but not non-exercising muscle during one-
legged exercise [31,32]. In our study, despite the fact that muscle biopsies were collected 
approximately 10-15 minutes post-exercise, we found enhanced AMPK phosphorylation 
in some subjects (figure 6.5A), although not in all subjects. To study the impact of AMPK 
activation on Angptl4 expression, we treated mouse C2C12 myotubes with the AMPK 
activator AICAR, leading to phosphorylation of AMPK (supplemental figure S6.3A). 
Strikingly, AICAR treatment markedly reduced Angptl4 mRNA (figure 6.5B) and protein 
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Figure 6.5 AMPK activation suppresses Angptl4 mRNA. (A) Immunoblot for AMPK and phospo-
AMPK in skeletal muscle biopsies from two selected subjects before (= t0) and after exercise (= t1) (B) 
Expression of Angptl4 mRNA in C2C12 myotubes treated with oleic acid (200 μM) and/or AICAR (1 mM) 
for 3 hours. (C) Immunoblot for Angptl4 in C2C12 myotubes treated with oleic acid and/or AICAR. (D) 
Time-course of the effect of AICAR on Angptl4 mRNA in C2C12 myotubes. (E) Comparison effect AICAR 
(1 mM) and metformin (0.5 mM) on Angptl4 mRNA in C2C12 myotubes. (F) Effect of AICAR (1 mM) and 
compound C (concentration indicated in mM) co-treatment on Angptl4 mRNA in C2C12 myotubes. 
(G) Angptl4 mRNA in C2C12 myotubes transfected with control (non-targeting) or AMPKα1/AMPKα2 
siRNA and treated with AICAR. (H) Effective knock-down of AMPKα1 and AMPKα2 by AMPKα1/AMPKα2 
siRNA. (I) Angptl4 levels in medium of human primary myotubes treated with oleic acid and AICAR. 
(J) Expression of PPARs and PPAR targets in C2C12 myotubes treated with AICAR. (K) Angptl4 mRNA 
in C2C12 myotubes pre-incubated with 50 μg/mL α-Amanitin for 1h and treated with AICAR for 3h 
and 6h. (L) Angptl4 mRNA in gastrocnemius of mice that overexpress an activating mutant of the 
muscle-specific isoform of the AMPKγ-subunit. Error bars represent SEM. Data were extracted from 
GSE4065 [34]. (M) Angptl4 mRNA in gastrocnemius of mice that overexpress a dominant negative 
mutant of the AMPKα2 subunit. Cells were treated for 12h unless indicated otherwise. Error bars 
represent SEM. *Significantly different according to Student’s t test (p < 0.05). Error bars represent SD 
unless indicated otherwise.
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(figure 6.5C) in C2C12 myotubes and blunted the induction of Angptl4 expression by oleic 
acid. The suppressive effect of AICAR on Angptl4 mRNA was very fast (figure 6.5D), was 
mimicked by the alternative AMPK activator metformin (figure 6.5E), could be partially 
abolished by the AMPK inhibitor compound C (figure 6.5F, supplemental figure S6.3B), 
and was modestly relieved upon combined knock-down of the AMPK α1 and α2 subunit 
(figure 6.5G,H). AICAR also modestly but significantly reduced the oleic acid-induced 
upregulation of Angptl4 secretion in primary human myotubes (figure 6.5I). The reduction 
of Angptl4 mRNA in C2C12 myotubes was not mediated by downregulation of PPARδ, 
PPARα, or PPARγ, as expression of all three PPARs was increased rather than decreased by 
AICAR treatment (figure 6.5J). Target genes of PPARδ, the main PPAR isotype in muscle, 
were also either increased or remained unchanged by AICAR including Plin2, Pdk4, Klf10 
and Cpt1b, as was the glucocorticoid receptor Nr3c1, another transcriptional inducer 
of Angptl4 [33] (figure 6.5J). These data suggest that downregulation of Angptl4 mRNA 
by AMPK activation is not mediated by any of the known transcriptional regulators of 
Angptl4. Time course studies in C2C12 myotubes indicated that AICAR reduces Angptl4 
gene expression with nearly the same speed as the transcriptional inhibitor α-amanitin, 
and no additive effect between the α-amanitin and AICAR was observed, suggesting 
that AMPK activation almost completely blocks Angptl4 gene transcription (figure 6.5K). 
In vivo overexpression of an activating mutant of the muscle-specific isoform of the 
AMPKγ-subunit supported the suppressive effect of AMPK on Angptl4 gene expression 
(figure 6.5L) [34]. Conversely, in vivo overexpression of a dominant negative mutant of 
the AMPKα2 subunit led a significant induction of Angptl4 mRNA (figure 6.5M) [35]. The 
data suggest that the stimulatory effect of plasma FFA on skeletal muscle Angptl4 mRNA 
is counteracted by AMPK activation in exercising muscle. 
As previously observed for the PPARδ agonist GW501516 [29], induction of Angptl4 mRNA 
in C2C12 myotubes by oleic acid was associated with a pronounced decrease in heparin 
releasable LPL activity (figure 6.6A), while inducing Lpl mRNA (figure 6.6B). To study the 
impact of Angptl4 upregulation on skeletal muscle lipid uptake in vivo, we used Angptl4-
transgenic mice characterized by overexpression of Angptl4 mRNA and protein in a variety 
of tissues including skeletal muscle (figure 6.6C) [36]. Transgenic Angptl4 overexpression 
did not affect muscle weights or percentage lean body mass (supplemental figure S6.4). 
To assess the functional effect of Angptl4 overexpression during exercise, we subjected 
WT and Angptl4-Tg mice to an acute moderate exercise bout on a motorized treadmill. 
Total LPL protein in skeletal muscle (gastrocnemius) after exercise were not different 
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Figure 6.6 Angptl4 upregulation impairs LPL activity and uptake of plasma TG-derived fatty acids in 
muscle. Heparin releasable LPL activity (A) and LPL mRNA (B) in mouse C2C12 myotubes treated with 
oleic acid (400 µM) for 24h. (C) Angptl4 protein abundance and mRNA expression in mouse skeletal 
muscle. (D) Total LPL activity in skeletal muscle (gastrocnemius) of WT and Angptl4-Tg mice at rest 
and after 90 minutes of moderate running exercise (12 m/min). (E) Serum 3H-activity after 15 minutes 
of running in WT and Angptl4-Tg mice injected with [14C]-oleate together with glycerol tri[3H]oleate-
labeled VLDL-like particles. (F) 3H-activity in subcutaneous adipose tissue and gastrocnemius after 15 
minutes of running. (G) Serum 14C-activity after 15 minutes of running in WT and Angptl4-Tg mice 
injected with [14C]-oleate together with glycerol tri[3H]oleate-labeled VLDL-like particles. (H) 14C-activity 
in subcutaneous adipose tissue and gastrocnemius after 15 minutes of running. (I) Distance covered 
excluding warm-up by WT and Angptl4-Tg mice subjected to an incremental exercise test to exhaustion. 
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between WT and Angptl4-Tg mice (figure 6.6D). However, Angptl4-Tg mice showed 
markedly reduced plasma clearance of [3H]triolein-labeled very-low-density lipoprotein 
(VLDL)-like particles during exercise (figure 6.6E) and reduced fatty acid uptake from the 
labeled VLDL-like particles into skeletal muscle, but not into subcutaneous adipose tissue 
(figure 6.6F). Plasma clearance of [14C]-oleic acid and uptake into skeletal muscle and 
subcutaneous adipose tissue was unaffected in Angptl4-Tg mice (figure 6.6G,H). Plasma 
levels of FFA, glucose, glycerol and β-hydroxybutyrate were not different between WT 
and Angptl4-Tg mice in exercised or resting state (supplemental figure S6.5A). To assess 
whether reduced muscle uptake of plasma TG-derived fatty acids in Angptl4-Tg mice had 
any influence on muscle performance, we determined the maximal endurance capacity 
using an incremental treadmill protocol until exhaustion, characterized by a gradual 
increase in speed and slope of the treadmill. Strikingly, Angptl4-Tg mice ran significantly 
less far compared to WT mice (figure 6.6I). Strength as determined using the horizontal 
wire test was not different between the two sets of animals (supplemental figure S6.5B). 
Depletion of muscle glycogen stores during exhaustive exercise was comparable between 
WT and Angptl4-Tg mice (figure 6.6J), whereas liver glycogen levels remained higher in 
Angptl4-Tg mice after exhaustive exercise, which reached statistical significance (figure 
6.6K). Intramuscular triglycerides were lower in Angptl4-Tg mice, which also reached 
significance after exhaustive exercise (figure 6.6L). No differences in baseline expression 
of markers of oxidative capacity were observed between the two genotypes suggesting 
that Angptl4 does not influence oxidative capacity (figure 6.6M). Finally, we determined 
the relative decrease in plasma TG in exercised state compared to resting state in WT, 
Angptl4-Tg and Angptl4-/- mice, as a measure of relative plasma TG utilization. The 
relative decrease in plasma TG in exercised vs. resting state was much more pronounced 
in Angptl4-/- compared to WT and especially Angptl4-Tg mice (figure 6.6N), likely due 
to preferential use of plasma TG in Angptl4-/- mice. Conversely, the relative increase in 
plasma FFA in exercised vs. resting state was more pronounced in Angptl4-/- mice, likely 
Muscle glycogen (J), liver glycogen (K) and muscle triglyceride (L) levels in WT and Angptl4-Tg mice 
at rest or after exhaustive running exercise. (M) mRNA expression of selected genes in skeletal muscle 
(gastrocnemius) of WT and Angptl4-Tg mice at rest. (N) the relative level of plasma TG (left panel) and 
FFA (right panel) in exercised state (90 minutes of moderate running exercise) compared to resting 
state (90 minutes rest) in WT, Angptl4-Tg and Angptl4-/- mice. *Significantly different from WT mice 
according to Student’s t test (p < 0.05). #Significantly different from resting mice according to Student’s 
t test (p < 0.05). Error bars represent SEM. N = 6-10 mice per group.
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due to sparing of plasma FFA in favor of use of TG-derived fatty acids. Overall, these 
data indicate that upregulation of Angptl4 impairs skeletal muscle uptake of fatty acids 
from circulating TG-rich lipoproteins and reduces liver glycogen utilization, leading to 
decreased exhaustive exercise performance.  
DISCUSSION
The activity of LPL and associated tissue uptake of plasma TG-derived fatty acids is 
under control of different physiological stimuli in different tissues [26]. In white adipose 
tissue LPL activity is decreased by fasting, which was unequivocally demonstrated to be 
mediated by upregulation of Angptl4 [37]. In brown adipose tissue LPL activity is increased 
by cold exposure, which is associated with a decrease in Angptl4 mRNA [38], hinting at 
a potential role of Angptl4. Our data suggest that Angptl4 also plays an important role 
in LPL-dependent plasma TG clearance in skeletal muscle and particularly during acute 
exercise by coordinating lipid uptake between exercising and non-exercising muscles.
Acute exercise increases adipose tissue lipolysis and raises plasma levels of FFA. Whereas 
the abundant plasma FFA are efficiently oxidized in exercising muscle, their increase 
leads to elevated intramuscular fat storage in non-exercising muscle, possibly leading 
to lipotoxicity [39]. Previously, we found that Angptl4 functions as a fatty acid-inducible 
anti-lipotoxic factor in cardiomyocytes and macrophages [27,40]. The present paper 
suggests that the exercise-induced increase in plasma FFA stimulates Angptl4 synthesis in 
non-exercising human muscle, leading to local inhibition of LPL activity and diminished 
uptake of plasma TG-derived fatty acids in compensation for elevated uptake of plasma 
FFA, presumably to mitigate lipid overload and associated lipotoxicity in non-exercising 
muscle during prolonged exercise. In contrast, in exercising muscle the stimulatory effect 
of FFA on Angptl4 is counteracted by AMPK-mediated suppression of Angptl4 mRNA, 
thereby maintaining LPL activity and supporting the use of plasma TG as fuel for the 
exercising muscle (figure 6.7).
Previously, in vivo AMPK activation by AICAR was found to lower plasma TG levels [41,42]. 
Suggesting a role for LPL in plasma TG lowering by AMPK, AMPK activation by AICAR or 
metformin increased intralipid clearance and increased heparin-releasable LPL activity 
in rat hearts, without causing any change in LPL mRNA [43,44]. Furthermore, AICAR and 
metformin enhanced LPL activity in rat L6 muscle cells [45]. Based on the data presented 
here, it is plausible that the stimulatory effect of AICAR and metformin on LPL activity and 
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concomitant lowering of plasma TG is mediated by suppression of Angptl4 in muscle and 
possibly other tissues. Future studies will have to address this question in more detail.
Our data indicate that overexpression of Angptl4 reduces maximal endurance exercise 
performance, most likely by limiting the provision of plasma TG-derived fatty acids to 
the muscle and by limiting utilization of liver glycogen, which is an important fuel for 
Figure 6.7 Schematic representation of the proposed role of Angptl4 in lipid provision to exercising 
muscle. During exercise, circulating FFAs and VLDL particles are directed to exercising and non-exercising 
muscle. In the non-exercising leg, increased FFA levels provoke an increase in Angptl4 expression via 
PPARδ, leading to inhibition of LPL activity and consequent reduction in uptake of fatty acids derived 
from VLDL, which is likely aimed at preventing lipid overload. In contrast, in the exercising leg the 
stimulatory effect of FFA on Angptl4 mRNA is counteracted by AMPK-mediated suppression of Angptl4 
mRNA. As a result, LPL activity remains high, allowing full exploitation of fatty acids derived from VLDL 
as substrate for fatty acid oxidation to meet the energetic needs of exercising muscle.
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exercising mice. Until recently, due to a number of methodological issues, the role of 
plasma TG as source of fatty acids for oxidation in exercising muscle and thereby its 
overall importance as fuel during endurance exercise has likely been underestimated 
(reviewed in [1]). Indeed, during leg exercise plasma TG uptake and clearance are 
increased manifold compared to the resting situation [46]. The relevance of plasma TG 
during exercise is further suggested by the adaptive increase in muscle LPL mRNA and 
activity in response to an acute exercise bout and following exercise training [47,48]. In 
contrast to Angptl4, expression of LPL is induced to the same extent in exercising and 
non-exercising muscle. Enhanced activity of LPL in skeletal muscle is believed to account 
for the low plasma TG concentrations in trained individuals [49,50].  
Angptl4 adds to a growing list of secreted proteins whose production in muscle is 
increased by acute exercise [51,52]. For many of these proteins it is unclear whether the 
change in production mainly impacts the muscle locally, or whether the proteins also 
exert an endocrine effect and thus function as a myokine. With respect to Angptl4, even 
though acute exercise leads to elevated Angptl4 levels in the circulation, it is unclear 
whether this increase mainly stems from increased mRNA and production of Angptl4 in 
skeletal muscle, or whether other tissues contribute as well. Overall, the co-expression 
of Angptl4 with LPL in tissues such as (cardiac) muscle and adipose tissue combined 
with the tissue-specific regulation of Angptl4 expression suggests that Angptl4 may 
mainly act via local inhibition of LPL, perhaps already in the sub-endothelial space via 
co-secretion with LPL [29,53].
In conclusion, our data indicate that in addition to the responses in exercising muscle, 
molecular changes in non-exercising muscle likely play a key role in regulation of fuel 
supply during exercise. It can be speculated that the beneficial effects of exercise on 
various health parameters are conveyed by adaptive changes in non-exercising muscles. 
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SUpplEmENTAl ExpERImENTAl pROCEDURES
plasma and tissue metabolites
Plasma metabolites and liver and muscle glycogen were determined as previously 
described [1]. Skeletal muscle total lipids were extracted by Folch and triglyceride levels 
were measured using colorimetric assay kit (INstruchemie) [2].  
lpl activity 
Oleic acid (400 µM) was added to cells complexed with BSA. After 24h, the medium was 
aspirated and the cells were washed twice with PBS. LPL was released from the myotubes 
by addition of 0.5mL PBS per well containing 100IU/ml heparin (LEO, Ballerup, Denmark). 
Heparin releasable LPL was collected after 5 minutes of incubation. LPL activity was 
measured with an LPL activity assay kit (Roar Biomedical, New York, USA) on a Fluoroskan 
Ascent FL Microplate Fluorometer (Thermo Fisher Scientific, Massachusetts, USA). 
LPL activities in homogenates of mouse skeletal muscle was measured as previously 
described [3].
western blot
Protein lysates (20-30 μg protein/lane) were loaded on a denaturing gel and separated 
by SDS gel electrophoresis. Protein were transferred to a PDVF membrane. The primary 
antibody (rabbit anti-Phospho-AMPKα antibody (Thr172) (40H9), rabbit anti-AMPKα 
antibody, Cell Signalling; rat anti mouse Angptl4 antibody (Kairos 142-2), AG-20A-
0054-C100 Adipogen) was used at a 1:1000 and 1:2000 ratio, and the secondary antibody 
(HRP-labelled goat anti-rabbit or anti-rat IgG, Sigma) at 1:5000. All incubations were 
performed in Tris-buffered saline, pH 7.5, with 0.1% Tween-20 and 5% dry milk, except 
for the final washings when dry milk was omitted.
Angptl4 elisa
Angptl4 levels in cell culture medium and in muscle homogenates were measured by 
ELISA as detailed previously [4]. Briefly, 96-well plates were coated with anti-human 
Angptl4 polyclonal goat IgG antibody (AF3485, R&D Systems) and incubated overnight at 
4°C. Plates were washed extensively between each step. After blocking, 100 μL of medium 
of cells was applied, followed by 2 hour incubation at room temperature. A standard 
curve was prepared using recombinant human Angptl4 (3485-AN, R&D Systems) at 0.3 
to 2.1 ng/well. Next, 100 μL of diluted biotinylated anti-human Angptl4 polyclonal goat 
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IgG antibody (BAF3485, R&D Systems) was added for 2 hour, followed by addition of 
streptavidin-conjugated horseradish peroxidase for 20 min, and tetramethyl benzidine 
substrate reagent for 6 min. The reaction was stopped by addition of 50 μL of 10% H2SO4, 
and the absorbance was measured at 450 nm.
microarray processing
Total RNA (100 ng) was labeled using an Ambion WT expression kit (Life Technologies, 
Bleiswijk, NL) and hybridized to human whole genome Genechip Human Gene 1.1 ST 
arrays coding 19,732 genes (Affymetrix ,Santa Clara, CA). 
Microarray analysis was performed using MADMAX pipeline for statistical analysis of 
microarray data [5]. Quality control was performed and all arrays met our criteria. For 
further analysis a custom annotation was used [6] and expression values were calculated 
using robust multichip average (RMA) method [7]. Microarray data was filtered, probe 
sets with expression values > 20, located at > 5 arrays and with an Inter Quartile Range 
(IQR) value > 0.2 were stated to be expressed and selected for further statistical analysis. 
Significant differences in expression were assessed using Intensity-Based Moderated 
T-statistic (IBMT) [8]. Genes were defined as significantly changed when the p value was 
< 0.01. The microarray dataset has been deposited to the NCBI Gene expression omnibus, 
accession number GSE41769.
Microarray analysis of human myotubes from three subjects treated with oleic acid 
has been previously described [9]. Microarray analysis of C2C12 myotubes treated with 
oleic acid has also been previously described [10]. The microarray datasets have been 
deposited to the NCBI Gene expression omnibus, accession numbers GSE18589 and 
GSE38590.
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Supplemental figure S6.1 The top 20 of genes most highly induced by oleic acid in primary human 
myotubes (left panel) or mouse C2C12 myotubes (right panel) ranked according to fold-change, as 
determined by Affymetrix microarray.
Supplemental figure S6.2 (A) Angptl4 mRNA in human vastus lateralis muscle collected before a 
2h cycling exercise bout and after 4 hours of post-exercise recovery, all in fasted state. (B) Plasma free 
fatty acid concentrations during the entire exercise trial [11]. Error bars represent SEM.
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Supplemental figure S6.3 (A) Immunblot for AMPK and phospho-AMPK in C2C12 myotubes treated 
with AICAR (1 mM) for 12h. (B) Immunoblot for phospho-AMPK in C2C12 myotubes treated with AICAR 
(0.5 mM) and compound C (20 μM) for 12h.
Supplemental figure S6.4 Weight of soleus, gastrocnemius, tibialis anterior and lean body mass 
in WT and Angptl4-Tg mice.
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Supplemental figure S6.5 (A) plasma metabolic parameters in WT and Angptl4-Tg mice at rest or 
after 90 minutes of moderate running exercise (12 m/min). (B) Horizontal wire test: average time until 
mice grasped wire with both hind legs. *Significantly different according to Student’s t test (p < 0.05). 
Error bars represent SEM.
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General discussion
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The primary aim of this thesis was to study the signalling role of skeletal muscle during 
exercise. To accomplish this, first an overview was given of the current knowledge 
on myokines produced by skeletal muscle. Second, the local effect of exercise on 
gene expression changes in skeletal muscle was assessed using high through-put 
transcriptomics tools. Third, the effect of exercise on gene expression in a non-active 
organ, in this case non-exercising skeletal muscle, was assessed. Finally, we identified 
myokines produced during acute exercise and exercise training using secretome analysis 
and assessed the role of one of the newly identified myokines Angptl4 in skeletal muscle.
Acute exercise versus exercise trAining
The effects on gene expression of acute exercise and exercise training are studied in 
chapter 3 and 4. In chapter 4 we show that acute exercise has a large impact on gene 
expression of active skeletal muscle, illustrated by the number of genes changed and the 
large fold changes. The effect of exercise training on gene expression as studied in chapter 
3 is more modest. The fold changes are smaller and fewer genes changed. The results 
of chapter 3 and 4 illustrate the different effects of acute exercise and exercise training. 
The existing literature supports the differential effects of acute exercise and exercise 
training, since it is shown that acute exercise and exercise training change different sets 
of genes and that genes change in an opposite manner [1]. In theory, exercise training is 
nothing more than a series of acute exercise sessions resulting in adaptation. In practice, 
the interaction between the acute exercise response and the adaptation induced by 
exercise training is complex and sophisticated. Therefore in the following paragraphs 
the interaction between acute exercise and exercise training will be discussed. 
stress-like response during acute exercise
Every single acute exercise bout increases the demand for ATP, oxygen and fuel substrates. 
Also the clearance of lactate, CO2 and other compounds is increased. This remodelling 
and restructuring is accompanied by the activation of many biological pathways. Many 
of the remodelling and restructuring in response to acute exercise occurs at the protein 
and enzymatic level. In chapter 4 we show that changes in gene expression also play 
a role in this response. Other studies show that responses to acute exercise are further 
characterized by increased binding activity of several transcription factors and DNA 
hypomethylation [2-5]. 
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The instant remodelling and restructuring in biological pathways illustrates that acute 
exercise can be characterized as a stress-like response, that is often accompanied by 
muscle damage [6,7]. Up to now it remains unclear whether this damage is favourable 
or unfavourable for recovery and adaptation. In the past muscle damage was seen as 
an unfavourable side effect of strenuous exercise, causing an very pronounced stress 
response which interfered with the adaptive response [8]. Since the 1980s evidence is 
growing that muscle damage plays a crucial role in the adaptive response during exercise 
training and might even be essential for adaptation [6]. Examples of stress responses 
during exercise-induced muscle damage that are important for adaptation are infiltration 
of immune cells and reactive oxygen species production in skeletal muscle. After muscle 
damage in mice, immune cells such as macrophages and neutrophils infiltrate the 
muscle tissue [9]. This infiltration is shown to play an important role in hypertrophy, since 
hypertrophy is blunted when there is impaired infiltration [10]. Production of reactive 
oxygen species is the another example of the stress response induced by acute exercise 
[11]. Production of reactive oxygen species was shown to be crucial in the metabolic 
signalling pathways that result in adaptation after exercise [12,13]. Recent studies indicate 
that antioxidant supplementation blunts the adaptive response to exercise training, 
supporting the importance of the stress response upon acute exercise in the adaptive 
response of exercise training [14,15].  
Immune cell infiltration might not only play a role in hypertrophy during the adaptive 
response of exercise training. Chapter 5 shows that CCL2 and CX3CL1 increase mRNA and 
plasma levels after acute exercise. Both myokines are well known attractors of immune 
cells and are extensively linked to metabolism [9,16-18]. These links to metabolism and 
immune cell infiltration suggest that the stress-like response of acute exercise in the form 
of immune cell infiltration can play a role in metabolic remodelling of skeletal muscle. In 
future research this question could be partially addressed via a human study in which 
participants are administered with a placebo or non-steroidal anti-inflammatory drug 
such as ibuprofen shortly before an endurance exercise session. If inflammation and 
associated immune cel infiltration is important in the metabolic remodelling after acute 
exercise, the metabolic remodelling will be blunted in the group receiving ibuprofen. 
Adaptive response during exercise training
As stated before, in theory exercise training is nothing more than a series of acute exercise 
sessions resulting in adaptation. In practice, the training effect of exercise is complicated 
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and not straightforward at all. During acute exercise the majority of the changes occur 
via allosteric regulation and covalent modification of rate-limiting enzymes. In exercise 
training the role of gene expression changes is very important [19]. In the next paragraphs 
we will therefore focus on the responses in gene expression changes induced by exercise 
training.
Gene expression response curves
Each exercise-reactive gene has a unique response curve during acute exercise. These 
response curves are the cornerstone of the adaptive training effect on gene expression. 
Expression of all induced genes eventually returns back to baseline [20,21]. The speed of 
this decline (or increase) to baseline varies per gene and the form of the response curve 
varies per gene [21]. Some genes are characterized as early response genes and their 
expression changes shortly after onset of exercise and returns back to baseline shortly 
after termination [21]. Other genes change expression after termination of exercise and 
are restored very slowly during recovery. Some genes do not return to baseline levels until 
48 hours into recovery. Since every gene has an unique response curve, the integration 
of acute gene expression response curves into the chronic exercise training adaptation 
response is complicated and different for every gene. 
Chronic adaptation 
Consecutive gene expression response curves as described in the previous paragraph 
will result in chronic adaptation. The adaptive gene expression response during exercise 
training can be simplified by dividing it into two types of adaptation outcomes. The first 
type of adaptation outcome is chronically changed mRNA levels of genes important 
in the adaptive response. This first type of adaptation outcome of exercise training is 
illustrated in chapter 3. The second type of adaptation outcome of exercise training is 
characterized by changed response sizes after exercise. Specifically, the amplitude of the 
response curves of genes can be increased or decreased in amplitude by exercise training. 
Whether acute gene expression changes result in chronic adaptation depends on many 
factors, such as timing, intensity and duration of consecutive exercise sessions [20]. 
Also the nutritional status before, during and after exercise is an important factor in the 
adaptive response after exercise [20,22]. Since acute exercise is a stress-like response, 
multiple acute exercise bouts performed with very limited recovery between each bout 
might not result in actual adaptation, since during repair and adaptation new damage 
G
eneral discussion
Chapter 7
167
7
is induced. On the other hand, when exercise sessions are performed with a very long 
intervals of rest, adaptations might also not occur. Too much time between sessions 
will results in discontinuation of adaptations initiated by exercise. Besides timing, the 
intensity of the exercise and the amount of muscle damage induced is important for 
which and how much adaptation occurs. 
Types of adaptive responses
The adaptations during exercise training can be characterized by four different adaptive 
responses (see also figure 7.1). The responses illustrated in figure 7.1 depict genes 
showing increased expression. A similar but opposite figure can be made for genes 
showing decreased expression. The first response (A) represents consecutive bouts of 
acute exercise separated by a long recovery period. These exercise sessions only elicit an 
Figure 7.1 Adaptive response on exercise training. Response A represents consecutive bouts of acute 
exercise that only elicit an acute effect, but do not result in any training effect, since recovery periods 
are too long. Response B represents consecutive bouts of exercise that are separated by appropriate 
recovery, which will result in overall increased basal levels. Response C represents consecutive bouts 
that are also separated by appropriate recovery and result in a higher response. Response D represent 
the opposite of response C, every bout results in a lower response. Based on Haskell [20].
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acute effect, but do not result in any training effect. The second response (B) represents 
consecutive bouts of exercise that are separated by appropriate recovery time. Such a 
response will induce an overall improvement after the training period: the basal levels 
will be increased, as is shown in this thesis. The third response (C) represents consecutive 
bouts that are also separated by appropriate recovery, but results in a higher response 
and not in higher baseline levels. Finally, the opposite of effect C can occur, where every 
exercise bout will give a lower response than the previous one (D). Response D can 
result in overtraining, but also beneficial adaptations can be characterized by a lower 
response. In chapter 3 it is likely that for some genes not (only) response B occurred, but 
response C. The limiting factor here is the designs used, which do not allow us to show 
differences in response. It is important to keep in mind that every response will result in 
levelling off of the training effect, since the adapted muscle will experience less stress 
with every training session. Every adaptation will reach a plateau at a certain point in 
time. Another important remark is that the net training effect can differ between genes, 
proteins and activity levels. Appropriate recovery for one factor might be not optimal 
for another factor. 
How does acute exercise contribute to the exercise training effect? 
Acute exercise can directly or indirectly contribute to the adaptations observed after 
exercise training. Acute exercise contributes directly to adaptation via gene expression 
changes induced by acute exercise bouts. Those gene expression changes result in 
adaptation in several ways as depicted in figure 7.1. Final adaptation outcomes will be 
changed basal levels or changed response curves of genes. The acute changes in mRNA 
levels direct the gene expression adaptations seen at the end of an exercise training 
period. 
An indirect contribution is via the stress induced by increased demands for ATP, oxygen 
and fuel substrates during acute exercise. This stress causes a lot of changes and 
disturbances and results in for example immune cells infiltration and reactive oxygen 
species production. These changes are shown to be crucial for adaptation and therefore 
characterize the indirect influence of acute exercise on the adaption during exercise 
training. 
In conclusion, acute exercise and the stress-like response characterizing acute exercise 
are important in the adaptations induced by exercise training. Furthermore acute exercise 
determines the magnitude of the adaptations induced by exercise training. Timing, 
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intensity,  duration and the amount of stress induced are important factors influencing 
the adaptations.
Myokines: wHAt is in it For tHe Future?
The background and motivation for the research described in this thesis was the growing 
interest in myokines and the impact of the identification of IL-6 as the first myokine. 
IL-6 produced during contraction has a positive effect on insulin resistance [18]. These 
findings are in contrast with earlier findings pinpointing IL-6 as a pro-inflammatory 
cytokine that induces insulin resistance [23,24]. Based on the identification of IL-6 as 
a myokine and the systemic role of IL-6, myokines are classified as the long-searched 
‘exercise factors’. Exercise factors circulate in the blood and are produced during exercise 
to communicate with organs not directly affected by exercise. Muscle contractions cause 
changes in skeletal muscle and these changes also demand changes in other organs of 
the body. Myokines are potentially the missing link between contracting muscle and 
other organs such as adipose tissue. Furthermore, there is a potential large impact of 
myokines on health, since they are the link that explains the positive health effects of 
exercise on relatively passive organs. 
the evolvement of the myokine field
In 1998 IL-6 was identified as the first myokine, and surprisingly 16 years later IL-6 is 
still the best characterized myokine. The field did not evolve much further, despite that 
many studies were performed to identify new myokines and to assess their role during 
exercise. This conclusion can also be drawn from the review in chapter 2. A myokine that 
was recently discovered and received a lot of attention was irisin [25]. Irisin is discussed 
in detail in chapter 2 of this thesis. In short, a lot of controversy surrounds this myokine, 
since the induction during exercise cannot be replicated in humans and functionalityof 
irisin in humans is questionable [26]. Irisin is one of the few myokines for which a potential 
systemic role has been studied. Another example is SPARC [27]. For many other newly 
identified myokines data on their production by skeletal muscle and induction by 
exercise are limited [28,29]. Studies on the function of myokines and the mechanisms 
behind their induction are scarce. If the mechanism was assessed in previous studies, 
often the focus was on the local role. An example of a study assessing the local role of a 
myokine in exercise is presented in chapter 6. Also in this chapter the systemic role of the 
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myokine remains unrevealed. For the myokines identified in chapter 5 it was shown that 
their levels increase during exercise, but the function of this increase was not explored. 
From chapter 2 it can be concluded that myokines have received a lot of attention in the 
past years. Many studies only identified new myokines and only a small subset of those 
studies generated more knowledge on the systemic role of myokines. This knowledge 
gap raises questions on the systemic relevance of myokines. Two explanations can be 
given for the knowledge gap in the myokine field. On the one hand it is possible that 
the systemic role of myokine is complicated and therefore relatively hard to reveal. On 
the other hand, there is the possibility that the systemic role of myokines is limited. If the 
last explanation is true, it implies that myokines potentially only serve a local role during 
exercise. This has no implications for the importance of myokines locally, but it could 
mean that systemically those myokines are not important in the adaptations observed 
in other tissues such as adipose tissue or the liver.
only a local role for myokines?
Not only the current status of literature raises questions on the systemic relevance of 
myokines, also several findings presented in this thesis contribute to the doubt regarding 
the systemic role of myokines. We show that CCL2, CX3CL1 and Angptl4 plasma increase 
levels during exercise, but that these increases are relatively modest. The increased 
plasma levels can just be a spill-over from the increased local levels. Furthermore it can 
be imagined that to have an impact on other organs via the circulation considerable 
increases in plasma levels are needed, which are clearly not observed for these myokines. 
It is important to note that we used one-legged cycling, a model in which the muscle 
mass used is relatively limited.
Furthermore we show that there is an important role for circulating free fatty acids. In 
chapter 4 we show that free fatty acids induce gene expression changes in non-exercising 
skeletal muscle. This role for free fatty acids indicates that not only myokines but also other 
circulating factors can induce gene expression changes in the non-exercising muscle. 
Exercise factors might therefore not only be myokines but also other circulating factors 
whose plasma levels change during exercise. The identification of BAIBA as an exercise 
factor is very interesting [30], since this confirms that metabolite can indeed serve a 
signalling role upon exercise. The limited role for myokines in gene expression changes 
in the non-exercising leg is somewhat contradicted by our analysis in chapter 5 that 
shows a strong similarity in genes correlating with CCL2 and CX3CL1 in the exercising 
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and non-exercising skeletal muscle, which do support some role for myokines in the 
gene expression changes in the non-exercising muscle. It remains unclear whether the 
overlap in genes in the exercising and non-exercise skeletal muscle is systemically or 
locally driven. 
role for immune cells in production myokines
In chapter 2 the current myokine field is extensively reviewed and several myokines are 
described. For IL-6 the literature was searched for studies assessing IL-6 levels during 
exercise. After careful examination it appears that to achieve increased IL-6 mRNA and/
or plasma levels intensive exercise was needed. The type of exercise used was weight-
baring, a type of exercise that often induces muscle damage [11]. Based on these findings 
it appears that some degree of muscle damage is needed to increase IL-6 plasma levels. 
This role for muscle damage in IL-6 production is confirmed in the literature [31]. In 
chapter 5 IL-6 only increases at the mRNA level, but not at the plasma level. The type of 
exercise used in chapter 5 is very modest and does not induce muscle damage, since 
inflammatory gene expression is only moderately induced. Interestingly, the myokines 
IL-8 and IL-15 also need (very) intense exercise to increase plasma levels [32,33]. Based 
on these conclusions and findings, the role of muscle damage in myokine production 
becomes very interesting. The role of muscle damage in the adaptations after acute 
exercise is previously discussed in this discussion, and there it is concluded that infiltration 
of immune cells induced by exercise-induced muscle damage likely plays an important 
role in the adaptations after endurance and resistance exercise training [34-37]. Given 
that intense exercise is needed to produce myokines, exercise-induced immune cell 
infiltration might play an important role in the production of myokines. 
During injury immune cell infiltration follows a specific time course [9]. Whether the order 
of infiltration is identical in acute exercise in unclear. During injury first neutrophils infiltrate 
that promote more damage in skeletal muscle [9,38]. Next, pro-inflammatory M1-like 
macrophages and anti-inflammatory M2-like macrophages infiltrate in skeletal muscle 
[9,37]. Macrophages have a clear role in repair, especially M2-like macrophages that have 
as main function repair and regeneration [37,39,40]. Interestingly, macrophages are known 
to secrete a large subset of pro- and anti-inflammatory cytokines during an inflammatory 
response to initiate other immune cells and influence surrounding tissues [9,39]. Many 
of the cytokines produced by macrophages are similar to the known myokines. Immune 
cells could therefore contribute to the increased myokine levels measured.
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Since most macrophages infiltrate after the initial infiltration of neutrophils, these 
macrophages cannot play a role in the initial secretion of inflammatory-linked myokines. 
Secretion of these myokines starts during exercise, while macrophages infiltrate during 
recovery [37]. Interestingly, a group of macrophages resides permanently in skeletal 
muscle near the connective tissue [41]. This group of macrophages can be activated 
immediately when damage is induced by for example exercise. Exercise could thus cause 
secretion of pro- and anti-inflammatory cytokines by those residing macrophages. It is 
interesting that many of the chemokines involved in macrophage infiltration after injury 
are also increased after acute exercise, as described in chapter 5 [9]. Also peritendonous 
tissue can produce cytokines during exercise as was shown by Langsberg et al. [42]. The 
cytokines produced are similar to the known myokines. This production suggests that 
also connective tissue plays a role in the increased myokine levels measured in plasma 
after exercise.
In conclusion, the myokine field is currently characterized by an expanding list of 
myokines, and large knowledge gaps remain concerning the systemic relevance of the 
known myokines. Furthermore, we conclude from the literature and findings presented 
in this thesis that other cell types residing in skeletal muscle, such as immune cells and 
connective tissue, can have a role in the myokine production during exercise. 
Angptl4 And skeletAl Muscle
In a review by Raschke et al. [43], Angptl4 is for the first time classified as a myokine. 
Raschke et al. base the classification of Angptl4 as a myokine on previously shown 
increases in Angptl4 plasma levels during acute exercise and production of Angptl4 
by skeletal muscle cells in vitro [44,45]. In chapter 6 we show that Angptl4 is not only 
increased in plasma during exercise, but that local mRNA and protein levels in skeletal 
muscle increase as well during acute exercise. Furthermore we show in chapter 6 a role 
for PPARs in the induction of Angptl4. This finding is supported by the findings of a 
study that used an in vitro skeletal muscle model and shows that PPARδ is responsible 
for regulation of Angptl4 levels [46]. The most important finding presented in chapter 6 
is that Angptl4 is crucial in the direction of triglyceride-derived free fatty acids to active 
skeletal muscle. Angptl4 prevents via lipoprotein lipase (LPL) inhibition a lipid overload in 
the passive skeletal muscle and assures supply of free fatty acids to active skeletal muscle. 
It is interesting to compare this novel role of Angptl4 in skeletal muscle to the roles 
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of Angptl4 in other tissues. Angptl4 is generally known as a crucial regulator of lipid 
metabolism. In adipose tissue, Angptl4 is thought to play a local key role in increasing 
fat liberation and decreasing fat storage [47]. In liver, the role of Angptl4 is thought to be 
more systemically, since Angptl4 produced by the liver is secreted into the circulation. 
Liver-derived Angptl4 serves as an endocrine factor that inhibits LPL in peripheral tissues 
[48]. In heart, Angptl4 serves an important role by preventing a lipid overload in the heart 
that can have an toxic effect [49]. In intestine, Angptl4 not only regulates LPL activity, but 
also pancreatic lipase activity. Functionally, Angptl4 in intestine reduces fat absorption 
[50]. Finally, in macrophages Angptl4 reduces excessive fat uptake from chylomicrons to 
prevent an uncontrolled fat-induced inflammation [51]. The role of Angptl4 in skeletal 
muscle matches very well with the role of Angptl4 in all other tissues. In muscle Angptl4 
prevents for lipid overload in the resting skeletal muscle, which is comparable to the 
functioning of Angptl4 in heart and macrophages. 
What is interesting is that hepatic Angptl4 serves a systemic role and Angptl4 is thus 
released into the circulation [52]. Also for intestinal Angptl4 a systemic role was suggested 
[53]. We showed that during exercise Angptl4 plasma levels increased together with 
increased local Angptl4 levels, suggesting that these increased levels originate from the 
increased skeletal muscle Angptl4 levels. Norheim et al. [54] showed that during exercise 
Angptl4 levels also increased in liver and adipose tissue in mice. They suggest that the 
increased Angptl4 levels therefore mainly originate from liver and adipose tissue, and 
not from skeletal muscle [54]. If increased plasma levels do not originate from skeletal 
muscle, this implies that Angptl4 as a myokine does not have a systemic role. This 
conclusion does not change the importance of Angptl4 as a local myokine, but it does 
hold an important message for other myokines that exhibit increaseedg plasma levels 
during exercise, which is that other tissues can contribute to the increased plasma levels.
Norheim et al. also show that gene expression levels of Angptl4 are relatively low 
compared to adipose tissue and liver gene expression levels [54]. Also the increases during 
exercise are larger in liver compared to skeletal muscle. In chapter 6 we do not compare 
Angptl4 skeletal muscle gene expression levels to other tissue gene expression levels. 
Furthermore, western blot comparison between tissues shows that Angptl4 protein levels 
in skeletal muscle in mice are comparable to protein levels in liver and brown adipose 
tissue (data not shown). Hence despite lower gene expression levels in skeletal muscle, 
protein levels are comparable. This observation suggests that Angptl4 gene expression 
levels are a relatively poor predictor of Angptl4 protein levels. 
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In conclusion, Angptl4 is likely a myokine that serves a local role in skeletal muscle. This 
local role is partly comparable to the role of Angptl4 in other tissues. A major novel 
finding is that induction of Angptl4 directs triglyceride-derived fatty acids to tissues 
where the fatty acids are needed. 
Future directions
In the past 15 years many myokines were identified using several approaches. Most 
studies identifying myokines used an untargeted approach, resulting in an extensive 
list of myokines. As stated previously in this discussion, these untargeted approaches 
did not result in knowledge about the physiological and systemic function of these 
myokines. Therefore in future research it is important that the myokine field shifts from 
the now popular untargeted approach to a targeted approach. In this targeted approach 
an in-depth analysis of one identified myokine should be performed to gain more 
insight in the mechanisms that induced the myokine during exercise and to determine 
the local and systemic function during exercise. A good example of a study using such 
an approach is chapter 6, where the mechanism behind the induction of new myokine 
Angptl4 is assessed and the local functional role is addressed. To apply such a targeted 
approach on other myokines, use of cell culture and animal models is preferred and 
is even compulsory. Cell culture models can give more insight in the local function 
and mechanisms behind the induction, for example by treatment with agonists and 
antagonists of specific pathways and transcriptional regulators. Also administration of 
the recombinant myokine to cell culture systems can provide valuable insights into the 
functioning of a myokine. Knockout and (muscle-specific) transgenic mouse models 
can give very relevant information about the local function of a specific myokine. More 
importantly knockout and transgenic mouse models can give very valuable information 
about the systemic function of a specific myokine. Regular exercise is partly comparable 
with a muscle-specific transgenic model, since they both result in chronically elevated 
systemic levels. Therefore such an model provides insight in the phenotype induced by 
increased levels of that specific myokine. Knockout mice models can provide insight in 
the role of a myokine during exercise (training). If the myokine plays an important role 
in the exercise response, the lack of that specific myokine in a (tissue specific) knockout 
model will influence the exercise response. 
Once the mechanism and the local and systemic function for several myokines are clear, 
research can shift to the effect of those myokines in the context of health. Resolving the 
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function of myokines will furthermore provide more insight into one of the concerns 
raised in the discussion, namely whether myokines are systemically relevant. If myokines 
turn out to serve a metabolically relevant systemic role, the role of myokines in metabolic 
disease and insulin signalling would be a very interesting topic for future research.
FinAl conclusions
In this thesis we studied the signalling role of skeletal muscle during exercise. Taking 
all the chapters together, we conclude that skeletal muscle has an important signalling 
role during exercise. However, it remains unclear how important this signalling role is 
systemically. 
This conclusion is based on several observations. We show that exercise not only 
elicits molecular changes in active or trained skeletal muscle, but also in non-active 
organs (non-exercising skeletal muscle). After providing an overview of literature, we 
conclude that a subset of 14 myokines is currently identified in humans, playing a role 
in the (local) signalling function of skeletal muscle. Furthermore, we are able to identify 
several myokines produced by skeletal muscle during exercise in our studies, of which 
some are known and some are new myokines. CX3CL1 and Angptl4 are added to the list 
of myokines. We confirm CCL2 as a myokine with a potential systemic function, while 
other known myokines (IL-6, IL-8, IL-15, FGF-21) cannot or can only partly be confirmed 
as myokines. For Angptl4 we are able to provide more insight in the mechanism and 
functioning during exercise, concluding that Angptl4 is important in the substrate 
distribution during exercise. CCL2, CX3CL1 and Angptl4 all increase plasma levels during 
acute exercise, but based on the research presented in this thesis we cannot conclude 
that skeletal muscle serves a significant systemic signalling role.
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Tijdens inspanning wordt er veel gevraagd van de skeletspieren. De spieren zijn 
verantwoordelijk voor de uitvoering van de bewegingen die worden gemaakt 
tijdens inspanning. Om dit te bewerkstelligen vinden er veel lokale veranderingen 
en aanpassingen plaats in de spieren. Andere organen zoals de lever worden minder 
beïnvloed door inspanning, maar laten desondanks na inspanning ook lokale 
veranderingen en aanpassingen zien. De veranderingen in deze ‘passieve’ organen 
suggereren dat de spieren misschien met andere organen kunnen communiceren. In 
het afgelopen decennia zijn er vele onderzoeken uitgevoerd die hebben onderzocht 
hoe spieren met andere organen zouden kunnen communiceren. Eind jaren ’90 werd er 
ontdekt dat spieren hormoonachtige stoffen kunnen uitscheiden, deze stoffen werden 
myokines genoemd. De myokines kunnen via de bloedbaan naar andere (passieve) 
organen reizen en hiermee de veranderingen initiëren die worden geobserveerd tijdens 
inspanning. Er is nog maar weinig bekend over welke myokines spieren precies aanmaken 
en wat de functies van deze myokines zijn. Daarom hebben we in dit proefschrift 
onderzocht welke myokines aangemaakt worden door de spieren tijdens inspanning 
en wat de rol zou kunnen zijn van deze myokines. Verder hebben we ook gekeken naar 
de lokale veranderingen die plaatsvinden in de spier tijdens inspanning, zodat we de 
aanmaak van myokines beter kunnen begrijpen. 
In hoofdstuk 2 hebben we een overzicht gemaakt van de gepubliceerde literatuur over 
myokines. Daaruit bleek dat er relatief veel myokines bekend zijn, maar dat er nog maar 
weinig bekend is over hun functie. Verder zijn er weinig myokines waarvan is aangetoond 
dat ze daadwerkelijk tijdens inspanning aangemaakt worden. Vervolgens hebben we in 
hoofdstuk 3 gekeken naar de effecten van training op genexpressieveranderingen in de 
spier. Er zijn drie verschillende types training met elkaar vergeleken, namelijk duurtraining, 
krachtraining en een combinatie van kracht- en duurtraining. Bij de proefpersonen werd 
een spierbiopt afgenomen voor en na de trainingsperiode. Met een microarray-analyse 
is vervolgens een compleet profiel gemaakt van de genexpressies van alle genen. 
Uit de microarray-analyse bleek dat de genexpressieprofielen van de verschillende 
trainingtypes op elkaar leken, maar dat er ook een aantal belangrijke verschillen waren. 
Het belangrijkste verschil was dat vergeleken met de genexpressieveranderingen 
veroorzaakt door duurtraining de genexpressieveranderingen veroorzaakt door 
gecombineerde training minder gerelateerd zijn aan het aanmaken van energie met 
behulp van zuurstof of vetten. Veranderingen in de expressie van deze genen spelen een 
belangrijke rol in de trainingseffecten veroorzaakt door inspanning en zijn daarom een 
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zeer belangrijk onderdeel van de aanpassingen veroorzaakt door training. In hoofdstuk 
4 is er gekeken naar de genexpressieveranderingen veroorzaakt door acute inspanning. 
Proefpersonen hebben een uur met één been gefietst. Vooraf en direct na afloop van het 
uur fietsen zijn er spierbiopten afgenomen. Met deze spierbiopten is er een microarray-
analyse gedaan om een compleet beeld te krijgen van de genexpressieveranderingen 
in de actieve en rustende spier. Hieruit bleek dat inspanning genexpressieverandering 
induceert in zowel de rustende als de actieve spier, al zijn de veranderingen in de rustende 
spier wat kleiner dan de veranderingen in de actieve spier. Deze bevinding bewijst dat 
spieren tijdens inspanning met passieve organen kunnen communiceren: de rustende 
spier wordt immers niet gebruikt, maar een relatief groot aantal genen in de rustende 
spier veranderen toch in expressie. Verder bleek uit de resultaten dat de veranderingen 
in de rustende spier deels worden geïnduceerd door vrije vetzuren uit het bloed. 
In hoofdstuk 5 hebben we gekeken welke myokines door de spier worden aangemaakt 
tijdens acute inspanning. Om dit te onderzoeken zijn de resultaten van de eenbenige 
fietsstudie gebruikt die al eerder in hoofdstuk 4 beschreven zijn. De microarray-analyse 
is verder geanalyseerd door middel van een secretoomanalyse, wat inhoudt dat bij alle 
significant veranderde genen werd gekeken of deze uitgescheiden kunnen worden en 
of ze dus mogelijke myokines kunnen zijn. Uit deze analyse kwam een lijst met mogelijke 
myokines en van deze lijst is er een selectie in het bloed gemeten. Twee van de gemeten 
myokines gingen omhoog in het bloed, namelijk de eiwitten CCL2 en CX3CL1. Omdat 
deze twee eiwitten in het bloed te meten zijn, spelen zij mogelijk een rol in de effecten van 
inspanning op de passieve organen. In hoofdstuk 6 is een ander eiwit dat in genexpressie 
omhoog ging tijdens acute inspanning eruit gelicht. Dit eiwit Angptl4 had als enige gen 
een veel hogere expressie in de rustende spier vergeleken met de fietsende spier. Om uit 
te vinden wat de rol van dit verschil in expressie was, hebben wij verschillende muis- en 
celkweekexperimenten uitgevoerd. Uit de experimenten kwam dat de vrije vetzuren uit 
het bloed de verhoogde Angptl4-expressie in de rustende spier veroorzaakten. In de 
fietsende spier hadden de vrije vetzuren dit effect ook, maar werd het effect geremd 
door activatie van het enzym AMPK. Dit enzym is heel belangrijk in het aansturen van 
alle effecten die worden geobserveerd tijdens inspanning. Uit dit onderzoek bleek dat 
AMPK tevens de Angptl4-genexpressie remt. Het verschil in Angptl4-expressie tussen 
de benen reguleert de instroom van vetzuren, omdat deze vetzuren een belangrijke 
energiebron zijn voor de actieve spier tijdens inspanning. Angptl4 zorgt ervoor dat de 
vetzuren de fietsende spier ingaan en niet de rustende spier waar ze toch niet nodig zijn. 
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Uiteindelijk kunnen we concluderen dat de skeletspieren een belangrijke signaal-
overbrengende rol hebben tijdens inspanning. Kanttekeningen zijn echter dat er nog 
steeds slechts beperkte kennis is over de mechanismen achter de werking van de 
myokines. Van veel myokines is bijvoorbeeld niet bekend wat de exacte functie is van 
het eiwit.
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En dan, na 4 jaar, zet ik de eerste zinnen van mijn dankwoord op papier. Het voelt echt 
raar om mijn promotieperiode af te sluiten. Toen ik vier jaar geleden naar Wageningen 
kwam had ik me niet kunnen voorstellen hoe ik me hier op mijn plek zou gaan voelen en 
hoeveel ik in deze periode zou leren. Daarom ben ik bijzonder trots op dit proefschrift, 
het is een mooie afsluiting van een geweldige periode. Dit proefschrift heb ik natuurlijk 
niet alleen geschreven, een groot aantal mensen heeft er, allemaal op hun eigen manier, 
een bijdrage aan geleverd.
De persoon die ik als eerste wil bedanken is mijn promotor Sander. Allereerst bedankt 
voor het vertrouwen dat je 4 jaar geleden in me had en de gok die je nam om iemand 
zonder enige labervaring aan te nemen voor dit project. Ik denk dat we terugkijkend 
kunnen zeggen dat het goed heeft uitgepakt . Ik ben je dankbaar voor alle dingen die 
je me hebt geleerd, al ging het soms met wat tegenzin van mijn kant (celkweek…). Een 
groot deel van de ontwikkeling die ik heb doorgemaakt de afgelopen jaren mag je op 
jouw conto schrijven, door jouw geduld, toewijding, interesse en kennis heb je mij en 
het onderzoek op een hoger niveau gebracht. Ik heb buitengewoon veel respect voor je 
drive en commitment aan de wetenschap en je AIO’s. Ik had me geen betere begeleider 
kunnen wensen!
Patrick, al was je rol als promotor wat meer op afstand (letterlijk en figuurlijk), ik heb 
bijzonder veel gehad aan je kritische blik op mijn artikelen en de discussies die we over 
het onderzoek hebben gehad. Marco, vooral in het eerste jaar hebben we intensief 
samengewerkt en hebben we een hele mooie humane studie neergezet. Bedankt voor je 
hulp en interesse! Hopelijk heb je inderdaad wat meer opgestoken over het moleculaire 
deel van de wetenschap ;).
I would like to thank my committee (Maria Hopman, Renger Witkamp, Jürgen Eckel 
and Mireille Serlie) for reading my thesis and being present at my defence.
Ik wil de projectpartners Eric, Inkie en Bram bedanken voor alle discussies die we 
hebben gehad bij verschillende meetings. Inkie en Bram, succes met de laatste periode 
van jullie promotie! En Inkie, ik hoop dat je een mooi verhaal kan gaan maken met de 
MCP-1-muizen, dat verdien je!
Een belangrijke reden dat ik mij zo thuis voelde in Wageningen was de supersfeer in het 
lab. Wat een fijne plek om te werken en wat veel fijne collega’s! 
Sheril, thanks for our cooperations and your help in the lab. We can be proud on the 
result in the form of a great paper! I wish you all the best in the future with your family 
and hopefully you can return to India in the near future. Karin, bedankt voor al je geduld 
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dat je met deze lab-baby had. Je zal je wel af en toe achter de oren gekrabd hebben. 
Dankzij jouw geduldige uitleg kan ik me nu toch heel aardig redden in het lab.
En dan de Pink Ladies Jvalini, Katja, Inge en Nikkie. Ik ben nu de eerste de promoveert, 
wel als semi-Pink Lady natuurlijk en ik weet zeker dat jullie mij binnen niet al te lange tijd 
gaan volgen (ook al lijkt het nu nog heel ver weg). Bedankt voor alle niet-werkgerelateerde 
dingen die we samen hebben gedaan en voor al die uren die ik met jullie chocolade 
etend en kletsend heb doorgebracht! Het was fijn om af en toe het testosteron te kunnen 
ontvluchten en letterlijk met open armen ontvangen te worden. Jvalini, je moet toch 
maar iemand anders gaan vinden om te knuffelen! Succes met de laatste periode van 
je PhD, je zal denk ik supertrots zijn op het eindresultaat, uiteindelijk is het het allemaal 
waard . Nikkie, bedankt voor al je vrolijkheid en betrokkenheid. Jij hebt nog iets langer 
en ook jij gaat het super afmaken! Inge, jij wordt de laatste Pink Lady die het pand gaat 
verlaten en ook bij jou gaat er ongetwijfeld een mooi eindresultaat uitkomen. Alles komt 
uiteindelijk goed! Ik ga jullie missen! 
En dan mijn eigen kamergenootjes, ondanks (of dankzij) het testosteron en alle slechte 
mannengrappen voelde ik me er vanaf het begin thuis. Diederik en Rinke, bedankt 
voor jullie slechte grappen die ervoor zorgden dat een dag nooit saai was. Mijn eigen 
grappen zijn ook echt slechter geworden en dat is een prestatie waar jullie trots op 
mogen zijn. En (daar is hij) bedankt voor het keer op keer bevestigen dat ik toch echt 
op vrouwen val. Mocht ik nog getwijfeld hebben ;). En serieus, Diederik bedankt voor je 
hulp rond mijn humane studie en tijdens de laatste loodjes en Rinke, bedankt voor de 
gesprekken die we hebben gehad, ik heb superveel van je geleerd! Juri, bedankt voor 
de rust die je uitstraalt en dat je het evenwicht in de kamer een beetje herstelde. Je bent 
een fijne kamergenoot en ik wens je veel succes met de rest van je project! Sophie, je 
was de laatste die erbij kwam, maar wat ben ik je dankbaar voor je steun in de laatste 
maanden. Je hebt aardig wat promotiefrustraties over je heen gehad en hebt door te 
luisteren heel veel betekend! Ik wens je alle succes met je project, maar ik weet 100% 
zeker dat je het geweldig gaat doen. En superbedankt dat je naast me wil staan op deze 
dag! Verder wil ik oud-kamergenootjes Daniëlle en Noortje bedanken! Jullie zijn allebei 
al even weg, maar bedankt voor jullie hulp en gezelligheid. En Daniëlle bedankt voor 
het samen overleven van de 2 heren ;). 
Shohreh, Jenny en Mechteld thanks for your help in the lab with RNA isolations and 
microarrays. En Mechteld bedankt voor de BBQ’s en etentjes bij jou en Menno thuis. 
Aafke, Lily en Wieneke, jullie zijn de overgebleven AIO’s in de Sander-groep. Succes, 
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maak er een mooie tijd van en zorg dat jullie de heren een beetje in toom houden. 
Mark en Philip, bedankt voor jullie hulp met de arrays en Mark bedankt voor de goede 
discussies die we hebben gehad over mijn array-datasets. Carolien, bedankt voor de 
toffe vakantie in Myanmar vorig jaar! En dat je na Apeldoorn dit jaar volgend jaar nog 
meer triatlons gaat doen en als je nog wat zwemadviezen nodig hebt, je weet me te 
vinden. Wilma en Lydia, bedankt voor de discussies over mijn onderzoek die ik met 
jullie heb gehad, ik heb er heel veel aan gehad! Guido, de handyman, bedankt voor je 
hulp bij de verschillende bioinformaticatools en het integreren van mijn data. Zonder 
jou waren mijn figuren toch een stuk minder kleurrijk geweest ;). Fenni, good luck with 
the last period of your PhD, I am sure that the impressive study you performed will result 
in a great thesis. Ya, Rogier, Parastoo and Neeraj, good luck with your PhD projects. 
Michiel, Mieke and Pierluigi, thanks for all the nice dinners and fun we had. Jocelijn 
en Klaske, bedankt voor jullie interesse!
Ik heb tijdens mijn promotie een humane studie mogen doen en daarom wil ik graag de 
proefpersonen die aan deze studie hebben deelgenomen bedanken. Het was toch niet 
niets om 4 biopten te ondergaan in 1,5 uur tijd. Tijdens mijn humane studie heb ik de 
onmisbare hulp gehad van Roland, bedankt hiervoor! Ik vind het super dat je toch ook 
als AIO verder bent gegaan. Succes met je project! Verder wil ik ook Nicolas en Anita 
bedanken voor hun onmisbare bijdrage aan het PNAS-artikel. Ik wens jullie alle succes 
met jullie verdere carrière! I would like to thank José for the time you spent with me 
during your thesis, you were a truly great person to supervise. I wish you all the best with 
your future career, I think you will be a great PhD student! Verder wil ik Anita, Jantien 
en alle prikmedewerkers bedanken voor hun hulp tijdens de studie.
Een aantal mensen heeft de NMG-groep verlaten, maar wil ik toch graag bedanken. 
Michael, bedankt voor het opbouwen van de groep en voor je interesse in mijn project! 
Veel succes in Norwich! Vera, ook jij heel veel succes in Norwich, ik wens je daar het 
allerbeste! Ik wil je bedanken voor de leuke trips die we hebben gemaakt en het feit dat 
we het irritantste in elkaar bovenhaalden ;). Met -25 in de sneeuw duiken zal me altijd 
bijblijven! Fritsje, het was fijn om jou in de buurt te hebben als al-wetend-labwonder en 
al mijn vragen op je af te kunnen vuren. Veel succes in Heidelberg/München?! Jessica, 
bedankt voor het samen met Katja aangaan van de trailwalkuitdaging! Het was iets 
supermoois om te mogen doen en iets wat ik nooit zal vergeten. We mogen nog steeds 
trots op onszelf zijn dat we het hebben geflikt! En bedankt voor alle etentjes, (mislukte) 
BBQ’s, voetbalwedstrijden en borrels. Het ga je goed in Frankrijk!
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Naast mijn werk ben ik vanaf het begin van mijn promotie vol de zwemwereld ingedoken, 
wat voor mij voor de broodnodige afleiding heeft gezorgd tussen de promotieperikelen 
in. Ik weet zeker dat alles niet zo soepel was gelopen zonder de vele trainingen die ik heb 
gegeven. Daarom wil ik mijn zwemmers van De Vrije Slag en Aqua Novio ’94 bedanken 
dat ik ze heb mogen trainen. Ik heb er heel veel plezier aan beleefd en heb het enorm 
naar mijn zin gehad (DVS) en ook nu geniet ik nog van iedere training en hoop ik nog 
lang met jullie te mogen werken (AN94). Ik wil natuurlijk ook mijn medetrainers bedanken 
en alle andere mensen die het leven van een zwemtrainer makkelijk hebben gemaakt. 
Speciaal wil ik Cobi bedanken, ik ben je heel dankbaar voor de jaren die we samen aan 
de bak hebben gestaan en jij mijn verhalen over van alles hebt aangehoord! Hopelijk 
komt na dit seizoen de tijd dat andere mensen het stokje van je overnemen.
Naast werk en zwemmen heb ik natuurlijk ook andere dingen gedaan. Ik wil Ineke, 
Linda, Kim, Vonne, Steph, Sas en Nienke bedanken voor alle etentjes, weekenden 
weg en andere leuke dingen die we hebben gedaan! Het was fijn om vriendinnen te 
hebben die in hetzelfde schuitje zaten/zitten of door buiten de wetenschap te werken 
een frisse blik hadden op promoveren. Hopelijk volgen er nog veel weekenden weg! 
Nien, bedankt voor je luisterend oor en alle goede gesprekken die we hebben gehad! 
Afgelopen 4 jaar waren voor jou heftig en ik heb heel veel respect hoe je met alles om 
bent gegaan. What doesn’t kill you, makes you stronger! Sas, bedankt voor je steun 
tijdens mijn promotie, het was heel fijn dat je na mijn voormalig afstudeerbuddy te zijn 
geweest ook een promotietraject bent ingegaan. Hopelijk kan je volgend jaar je project 
goed afronden, ik heb echt diep respect voor het project dat jij aan het managen bent! 
We blijven iig regelmatig samen fietstochtjes maken!
Katja, iets meer dan 4 jaar geleden zijn we gelijktijdig dit avontuur begonnen en zoals we 
aan het begin zeiden, het staat in ons contract dat we elkaar helpen en naar het eind van 
de promotie loodsen. Bedankt voor de honderden leuke dingen die we hebben gedaan 
afgelopen jaren! Zonder jou was mijn promotie onnoemelijk veel saaier en minder leuk 
geweest en ik weet zeker dat jij ook die eindstreep gaat halen!
Lisette, bedankt voor al die jaren onvoorwaardelijke vriendschap, bedankt dat je er altijd 
voor mij bent, bedankt voor het aanhoren van al mijn verhalen over alle dingen die je maar 
kan bedenken. En natuurlijk bedankt voor je steun de afgelopen 4 jaar gegeven tijdens 
mijn promotie. Ik ben heel blij en trots dat jij naast me wilt staan op deze bijzondere 
dag. Die vakantie naar Peru komt er wel en hopelijk kan jij binnenkort een nieuwe stap 
in je carrière maken en de MDL-opleiding in.
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Lieve Papa en Mama, bedankt voor jullie onvoorwaardelijke steun en geloof in mij. Ik 
kan niet beschrijven hoe blij ik met jullie ben, hoe dankbaar ik ben en hoe fijn ik het 
vind dat jullie er altijd voor me zijn! Bedankt voor jullie liefde en alles wat jullie voor 
me hebben gedaan. Ik hou van jullie en ik hoop dat jullie nog meer gaan genieten van 
het leven als pensionado’s. Doe wat jullie graag willen en geniet! Adri, Ria, Jacqueline 
en Dick, bedankt voor jullie interesse in me al die jaren! De familie mag dan niet groot 
zijn, maar dat maakt niks uit als je een goede band hebt! En Dick, ik hoop wel dat ik je 
favoriete nichtje blijf ;).
En toen was je daar in ene, een paar maanden voor het einde van mijn promotie. Lieve, 
lieve Eva, wat ben ik blij dat ik je ben tegengekomen en wat ben ik blij dat we samen 
zijn. Soms weet je gewoon dat het goed is . Bedankt voor je steun in die stressvolle 
laatste maanden en ik kan niet wachten op onze toekomst samen!
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